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1. Introduction 
1.1 Transcriptional regulation in Eukaryotes 
In eukaryotes, RNA polymerase II transcribes protein-coding genes. Eukaryotes have 
three nuclear RNA polymerases (Table. 1), each with distinct roles and properties (Carter 
and Drouin 2009). RNA pol II is located in the nucleoplasm and is responsible for 
transcription of the vast majority of genes including those encoding mRNA, small 
nucleolar RNAs (snoRNAs), some small nuclear RNAs (snRNAs), and microRNAs. 
Gene transcription is a remarkably complex process. The synthesis of tens of thousands 
of different eukaryotic mRNAs is carried out by RNA pol II (Kettenberger, Armache et 
al. 2003). During the process of transcription, RNA pol II associates transiently not only 
with the template DNA but with many different proteins, including general transcription 
factors. The initiation step alone involves the assembly of dozens of factors to form a pre-
initiation complex. Transcription is mediated by the collective action of sequence-
specific DNA-binding transcription factors along with the core RNA pol II transcriptional 
machinery, an assortment of co-regulators that bridge the DNA-binding factors to the 
transcriptional machinery, a number of chromatin remodeling factors that mobilize 
nucleosomes, and a variety of enzymes that catalyze covalent modification of histones 
and other proteins. There are two other important eukaryotic polymerases – RNA 
polymerase I and RNA polymerase III (Hurwitz 2005). RNA polymerase I reside in the 
nucleolus and is responsible for synthesis of the large ribosomal RNA precursor. RNA 
polymerase III is also located in the nucleoplasm and is responsible for synthesis of 
transfer RNA (tRNA), 5S ribosomal RNA (rRNA), and some snRNAs (Hurwitz 2005). 
Plants have a fourth nuclear polymerase, named RNA polymerase IV, which is an RNA 
silencing-specific polymerase that mediates synthesis of small interfering RNAs 
(siRNAs) involved in heterochromatin formation (Onodera, Haag et al. 2005). For RNAP 
II (protein-coding genes), initiation requires several transcription factors that assist 
binding to promoter sites.  Promoter sites recognized by RNAP II (and associated protein 
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factors) are several conserved elements that are located upstream from the transcription 
start point (the +1 base). 
 
 
Table 1. The three nuclear RNA polymerases present in Eukaryotes 
The basal level of transcription requires a set of basal transcription factors that bind to 
DNA or other proteins. Firstly, a protein recognizes and binds to the TATA sequence at 
the promoter. TATA binding protein (TBP) bends the DNA and auxiliary factors binds to 
the TBP.  This protein complex promotes the binding of RNA polymerase and its 
association with the proteins. The complete pre-initiation complex denatures the nearby 
DNA helix. RNA polymerase II and its associated proteins move along the unwound 
DNA and produce a messenger complex complimentary to the DNA template.  
 The consensus sequences of the conserved elements are a) −30 = TATAAAA [TATA 
homology or Goldberg-Hogness box] b) −80 = GGCCAATCT [CAAT box] c) 
GGGCGG [GC box] and often present but occur in different positions and in 
ATTTGCAT [octamer box] different copy numbers. The TATA homology is found in all 
eukaryotic promoters known to date. The remaining “consensus” sites are found but not 
necessarily in the same promoter.  All “consensus” sites affect binding efficiency of RNA 
polymerase/transcription factors (Smale and Kadonaga 2003). RNAP I and RNAP III 
 
Name 
 
transcribed 
 
RNA Polymerase I 
(Pol I, Pol A) 
 
nucleolus 
 
Larger ribosomal RNA (rRNA) 
(28S, 18S, 5.8S) 
 
RNA Polymerase II 
(Pol II, Pol B) 
 
nucleus 
 
Messenger RNA (mRNA) and 
most small nuclear RNAs 
(snRNAs) 
 
RNA Polymerase III 
(Pol III , Pol C) 
 
nucleus (and possibly the 
nucleus-nucleoplasm 
interface) 
 
Transfer RNA (tRNA) and other 
small RNAs (including the small 
5S rRNA) 
Introduction 
 
 3
utilize some of the same transcription factors as RNAP II but the promoters are quite 
different.  RNAP III utilizes internal promoters that are present within the transcriptional 
units (Veras, Rosen et al. 2009). The level of transcription is increased above the lower 
basal levels by activators bound to specific enhancer sequences. Activators can act to 
stabilize the pre-initiation complex and make it easier for the TBP or the RNA 
polymerase to bind to the DNA. Stabilization of the complex by activator proteins may 
also allow binding of subsequent RNA polymerase molecules. Activator proteins increase 
transcription while inhibitor proteins decrease transcription. Together, these regulatory 
proteins modulate transcription by determining where, when and how much transcription 
occurs in a particular type of cells. 
1.1.1 Protein-coding gene regulatory elements 
Expression of protein-coding genes is mediated in part by a network of thousands of 
sequence-specific DNA-binding proteins called transcription factors (Lee and Young 
2000). Transcription factors interpret the information present in gene promoters and other 
regulatory elements, and transmit the appropriate response to the RNA pol II 
transcriptional machinery. Information content at the genetic level is expanded by the 
great variety of regulatory DNA sequences and the complexity and diversity of the multi-
protein complexes that regulate gene expression. Many different genes and many 
different types of cells in an organism share the same transcription factors. What turns on 
a particular gene in a particular cell is the unique combination of regulatory elements and 
the transcription factors that bind them (Lee and Young 2000). 
1.1.2 Transcription factors 
mRNA and eventually proteins are most often produced when and where they are needed 
in an organism. Some genes, such as those for housekeeping proteins and processes like 
glycolysis are expressed all of the time. These genes undergo what is known as 
constitutive transcription. Other proteins are only produced at specific times in certain 
cells. In these cells, genes undergo a process called regulated transcription. Transcription 
is regulated by proteins called transcription factors. These factors are proteins produced 
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in the cytoplasm and eventually migrate into the nucleus where they interact with DNA 
and activate transcription. These transcription factors only interact with specific genes, 
those genes whose transcription they control. Most eukaryotic species have over 1000 
transcription factors. 
    Regulated transcription begins when a signal is received by the cell. The signal, often a 
protein begins the signal transduction cascade that lets the cell know that certain proteins 
are now needed. The most common activation event for a protein in a signal pathway is 
the addition of a phosphate group. That activated protein in turn interacts with another 
protein. This interaction leads to the phosphorylation of the next protein in the pathway. 
There is often a series of proteins activated by phosphorylation. At the end of this 
cascade, the final protein will be activated and then enter the nucleus. It must make this 
journey because transcription only occurs inside the nucleus. After entering through the 
nucleopore, the protein interacts with the specific transcription factor responsible for 
activating mRNA production.  As with the earlier proteins, the transcription factors are 
modified through phosphorylation. The activated transcription factor will next bind to an 
enhancer region. The enhancer is a region of DNA upstream of the transcription start site 
that binds the transcription factor. The transcription factor then binds to the DNA and 
moves to interact with the rest of the transcription protein complex located at the 
transcription start site. When the formation of this complex is complete, transcription of 
the gene will begin. It is the sequence of events that ensures the gene required for specific 
tissue only a t a specific time are expressed appropriately. 
The regulation of gene activity at the transcriptional level generally occurs via changes in 
the amounts or activities of transcription factors. The genes encoding the transcription 
factors themselves may be transcriptionally induced or repressed by other regulatory 
proteins, or the transcription factors may be activated or deactivated by proteolysis, 
covalent modification, or ligand binding (Spiegelman and Heinrich 2004). Transcription 
factors influence the rate of transcription of specific genes either positively or negatively 
(activators or repressors, respectively) by specific interactions with DNA regulatory 
elements) and by their interaction with other proteins (Latchman 1997). Transcription 
factors mediate gene-specific transcriptional activation or repression. Transcription 
Introduction 
 
 5
factors that serve as repressors block the general transcription machinery, whereas 
transcription factors that serve as activators increase the rate of transcription by several 
mechanisms like stimulation of the recruitment and binding of general transcription 
factors and RNA pol II to the core promoter to form a pre-initiation complex (Abrahem 
and Pelchat 2008),   inducing a conformational change or post-translational modification 
(such as phosphorylation) that stimulates the enzymatic activity of the general 
transcription machinery and interaction with chromatin remodeling and modification of 
complexes to permit enhanced accessibility of the template DNA to general transcription 
factors or specific activators. These different roles can be promoted directly via protein–
protein interaction with the general transcription machinery or through interactions with 
transcriptional co-activators and co-repressors (Latchman 1997).  
1.1.2.1 Transcription factors are modular proteins 
Transcription factors are modular proteins (Yang 1998) consisting of a number of 
domains (Fig. 1). Recognition of this feature triggered the development of a powerful 
technique for analyzing protein–protein interactions in vivo – the yeast two-hybrid assay. 
The three major domains are a DNA-binding domain, a transactivation domain, and a 
dimerization domain. 
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Figure 1. Transcription factors are composed of separable, functional components. 
They typically include a DNA-binding domain, a transactivation domain, a dimerization 
domain, nuclear localization sequence (NLS), and some also have a nuclear export 
sequence (NES). Some transcription factors also have ligand-binding (regulatory) 
domains, such as hormone-binding domains, which are essential for controlling their 
activity.  
In addition, transcription factors typically have a nuclear localization sequence (NLS) 
(Kalderon, Richardson et al. 1984; Kalderon, Roberts et al. 1984), and some also have a 
nuclear export sequence (NES) like in the case of nuclear factor of activated T cells 
(NFAT) (Beals, Clipstone et al. 1997; Klemm, Beals et al. 1997). Some transcription 
factors also have ligand-binding (regulatory) domains, such as hormone-binding 
domains, which are essential for controlling their activity. Many transcription factors 
become activated or inactivated as a result of ligand binding (Grove and Walhout 2008). 
1.1.2.2 Transactivation domain 
The transactivation domain of a transcription factor is involved in activating transcription 
via protein–protein interactions. Transactivation domains may work by recruiting or 
accelerating the assembly of the general transcription factors on the gene promoter, but 
their mode of action remains unclear. Some transcription factors do not contact the 
general transcription machinery directly but instead bind co-activators that in turn contact 
the general apparatus. Unlike the well-defined DNA-binding domains, transactivation 
domains are structurally more elusive (Biochemistry of signal transduction and regulation 
– Gerhard Krauss 2008). They are often characterized by motifs rich in acidic amino 
acids, so-called “acid blobs” (Pandit, Bednarski et al. 2003) In addition to acid blobs, 
there are other distinct motifs. For example, transcription factor Sp1 contains a nonacidic 
transactivation region with multiple glutamine-rich motifs (Courey and Tjian 1988; 
Kadonaga, Courey et al. 1988). Other motifs associated with transactivation include 
proline-rich regions and hydrophobic β-sheets. 
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1.1.2.3 Dimerization domain 
The majority of transcription factors bind DNA as homodimers or heterodimers. 
Accordingly, they have a domain that mediates dimerization between the two identical or 
similar proteins. In contrast to our detailed knowledge of protein–DNA interactions, far 
less is known about the exact molecular characteristics of these protein–protein contacts. 
As described above, two dimerization domains that are relatively well characterized 
structurally are the basic helix-loop-helix (bHLH) and basic region leucine zipper (bZIP) 
motifs. Several TFs bind DNA as obligatory dimers, including members of bZIP, bHLH 
and nuclear hormone receptor (NHR) families (Wolberger 1999); (Newman and Keating 
2003); (Lamb and McKnight 1991).   
1.1.3 Transcriptional Co-activators and Co-repressors 
Gene transcription is a multistep process involving a very large number of proteins 
functioning in discrete complexes. As described above, transcription factors bind to DNA 
in a sequence-specific manner. They mark a gene for activation or repression through the 
recruitment of co-activators or co-repressors. Co-activators and co-repressors are proteins 
that increase or decrease transcriptional activity, respectively, without binding DNA 
directly. Instead they bind directly to transcription factors and either serve as scaffolds for 
the recruitment of other proteins containing enzymatic activities, or they have enzymatic 
activities themselves for altering chromatin structure. Co-activators and co-repressors 
have been much harder to study compared with transcription factors. In general, assays 
for protein–protein interactions are more difficult to perform than techniques for studying 
DNA–protein interactions. In addition, techniques for determining which co-activator is 
docking on a particular transcription factor in vivo were not available until recently. 
 Most known co-activators are very large proteins that harbor multiple activation domains 
and receptor-interacting domains (L'Horset, Dauvois et al. 1996; Ding, Anderson et al. 
1998; Onate, Boonyaratanakornkit et al. 1998; Voegel, Heine et al. 1998). Interestingly, 
some co-activators share significant sequence homology. More interestingly, some co-
activators are able to acetylate histones (Tsukiyama and Wu 1997). Acetylation of the 
conserved lysine residues in the N-terminal domain of histones results in the loosening of 
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the nucleosome structure, making the DNA more accessible to transcription factors Co-
activators, in the broadest sense, can be divided into two main classes namely Chromatin 
modification complexes: multi-protein complexes that modify histones post-
translationally, in ways that allow greater access of other proteins to DNA and Chromatin 
remodeling complexes: multi-protein complexes of the yeast SWI/SNF family (or their 
mammalian homologs BRG1 and BRM) and related families that contain ATP-dependent 
DNA unwinding activities (Chiba, Muramatsu et al. 1994) and (Ichinose, Garnier et al. 
1997). On the other hand co-repressors have the opposite effect on chromatin structure, 
making it inaccessible to the binding of transcription factors or resistant to their actions 
(Jenster 1998). Deacetylating histones and thereby compacting nucleosomes into a tight 
and inaccessible structure is a potent mechanism for shutting down gene expression. 
Inhibitors of HDAC, such as trichostatin A, therefore relieve repression by unliganded 
receptors (Wong, Patterton et al. 1998). 
1.2 Transcription Enhancer Factors (TEFs) 
Transcription enhancer factors (TEFs) are essential for cardiac, skeletal, and smooth 
muscle development and uses its N-terminal TEA domain (TEAD) to bind M-CAT 
elements. The MCAT element was originally identified as a muscle-specific cytidine-
adenosine-thymidine sequence, 5'-CATTCCT-3', in the chicken cardiac troponin T 
promoter (Cooper and Ordahl 1985). MCAT element has been found in a number of 
cardiac, smooth, and skeletal muscle-specific genes, including cardiac troponin T (Mar 
and Ordahl 1988), β-myosin heavy chain (β-MHC),(Rindt, Gulick et al. 1993) smooth 
muscle -actin (SM -actin), (Swartz, Johnson et al. 1998) and skeletal -actin (Karns, 
Kariya et al. 1995). It has been shown to play a key role in the transcriptional regulation 
of these genes, although it is also present in the promoter regions of some non-muscle 
genes.   
The proteins that bind to the MCAT element belong to the TEF-1 family of transcription 
factors (Xiao, Davidson et al. 1991), (Farrance, Mar et al. 1992). This family shares a 
highly conserved DNA binding domain called the TEA domain and consists of four 
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members (Table. 2) including TEF-1 (NTEF-1/Tead1), RTEF-1 (TEF-3/ETFR-2/FR-
19/Tead4), ETF (TEF-4/Tead2), and DTEF-1 (TEF-5/ETFR-1/Tead3).  
 
 
Table 2. The TEF Family Members 
 
                                                  - Yoshida, T. et al, 2008, Arterioscler Thromb Vasc Biol  
Figure 2. Regulation of TEF-1 family members 
TEF-1 family member-dependent transcription of MCAT element-containing muscle-
specific genes is modulated by: (A) phosphorylation of TEF-1 family members; (B) 
interaction with cofactors; (C) interaction with SRF/MEF2/Max; (D) flanking sequence 
Name Alternative Name Percent Identity to TEF-1
Percent Identity to TEF -1 
within the TEA Domain
TEF -1 NTEF -1, Tead1 … …
ETF ETEF -1, TEF -4, Tead2 64% 100%
RTEF -1 TEF -3, ETFR -2, FR -19, Tead4 74% 100%
DTEF -1 TEF -5, ETFR -1, Tead3 70% 99%
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and its binding factors; (E) accessibility of TEF-1 family members to MCAT elements; 
and (F) alternative splicing of TEF-1 family member. 
The TEA domain is also referred to as the ATTS domain, because it appears in yeast, 
vertebrate, plant, and fly transcription factors AbaA, TEC1, TEF-1, and Scalloped 
(Burglin 1991), (Campbell, Inamdar et al. 1992). AbaA regulates development of the 
asexual spores in Aspergillus nidulans and terminates vegetative growth, TEC1 is 
involved in the activation of the Ty1 retro transposon in yeast Saccharomyces cerevisiae, 
and the Drosophila gene Scalloped plays an important role in sensory neuron and wing 
development. Conservation of the TEA domain in multiple organisms indicates its critical 
role in regulation of gene transcription. TEF-1, RTEF-1, and DTEF-1, respectively, 
initiate translation at an isoleucine (AUU), leucine (UUG), and isoleucine (AUA) codon 
that lies upstream of the first methionine codon (Xiao, Davidson et al. 1991; Stewart, 
Richard et al. 1996; Jiang, Wu et al. 1999). ETF, however, uses the methionine (AUG) 
codon for the initiation of translation.(Yasunami, Suzuki et al. 1995) Second, TEF-1 
family members bind to the double-stranded form of the MCAT element, but not to the 
single-stranded MCAT element (Carlini, Getz et al. 2002). The tissue distribution of TEF-
1 family members has been examined by a number of studies. TEF-1, DTEF-1, and 
RTEF-1 are widely expressed in multiple tissues including the skeletal muscle, pancreas, 
placenta, lung, and heart. In contrast to these three factors, ETF is selectively expressed in 
a subset of embryonic tissues including the cerebellum, testis, and distal portion of the 
forelimb and hind limb buds as well as the tail bud, but it is essentially absent from the 
adult tissues (Yasunami, Suzuki et al. 1995). ETF has also been shown to be expressed 
from the 2-cell stage during development (Kaneko, Cullinan et al. 1997).  
1.2.1 Role of Transcription Enhancer Factors   
1.2.1.1 Cardiac development and hypertrophy 
TEF-1 plays a vital role in cardiac development. TEF-1 knockout mice exhibited an 
enlarged pericardial cavity, bradycardia, a dilated fourth ventricle in the brain, and died 
by embryonic day (E) 12.5. Histological examination revealed that the ventricular wall in 
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the heart of TEF-1 knockout mouse embryos was abnormally thin with a reduced number 
of trabeculae. These results indicate that TEF-1 is required for cardiac morphogenesis and 
that other TEF-1 family members cannot compensate for TEF-1 function during 
embryogenesis. Cardiac hypertrophy occurs in a number of pathophysiological conditions 
such as hypertension, valvular disease, myocardial infarction, and cardiomyopathy. At the 
cellular level, it is characterized by an increase in cell size and protein synthesis and by 
reactivation of the fetal cardiac genes including β-MHC and skeletal α-actin (Simpson, 
Kariya et al. 1991). Stimulation of α1-adrenergic signaling has been shown to induce 
cardiac hypertrophy and activate transcription of the β- MHC gene and the skeletal α – 
actin gene in cultured neonatal rat cardiomyocytes. Interestingly, α1-adrenergic receptor-
mediated induction of these genes is abolished by mutation of the MCAT element within 
the promoters (Kariya, Karns et al. 1994).  In addition, RTEF-1, but not TEF-1, 
potentiates the α1-adrenergic response of the β-MHC and skeletal α-actin promoters 
(Stewart, Richard et al. 1996). In addition, MCAT elements might contribute to the 
induction of fetal cardiac genes in other in vivo models of cardiac hypertrophy. 
1.2.1.2 Smooth Muscle Development  
Studies provide evidence that the MCAT element plays a critical role in smooth muscle 
development (Creemers, Sutherland et al. 2006; Gan, Yoshida et al. 2007). 
Transcriptional regulation of Myocardin which is exclusively expressed in SMCs and 
cardiomyocytes was recently identified to contain an MCAT element as well as a MEF2 
binding site and multiple FoxO binding sites. Mutation of the MCAT element selectively 
abolished LacZ expression in SMCs, but not in the heart, whereas mutation of either the 
MEF2 binding site or FoxO binding sites dramatically reduced LacZ expression in both 
SMCs and cardiomyocytes. These results suggest that the MCAT element behaves as a 
SMC-specific upstream signaling pathway for the induction of the myocardin gene. 
However, it remains undetermined which TEF family members bind to this MCAT 
element, and how the MCAT element functions selectively in SMCs.  
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1.2.1.3 Skeletal Muscle Hypertrophy and Regeneration 
The MCAT element has been shown to be involved in the regulation of muscle-specific 
genes in skeletal muscle like α-actin (Carson, Yan et al. 1995) and β-MHC (Rindt, Gulick 
et al. 1993). Denervation-induced decrease in β-MHC expression is also mediated by the 
proximal MCAT element in rat soleus (Huey, Haddad et al. 2003) which indicates the 
regulation of muscle-specific genes by MCAT element in skeletal muscle. However, a 
series of studies by Tsika and colleagues showed that induction of the β-MHC gene in 
overloaded skeletal muscle was not mediated by the MCAT elements, but by the 
association of TEF-1 proteins with the A/T-rich element located between two MCAT 
elements (Tsika, Wiedenman et al. 1996; Vyas, McCarthy et al. 1999; Karasseva, Tsika 
et al. 2003). Additional work is required to reconcile the discrepancy. Zhao et al. (Zhao, 
Caretti et al. 2006) showed that the MCAT element and ETF were implicated in a process 
of skeletal muscle regeneration. They showed that cardiotoxin-induced 
degeneration/regeneration of skeletal muscle occurred abnormally in fibroblast growth 
factor receptor 4 (FGFR4) knockout mice as compared with wild-type mice. By 14 days 
after cardiotoxin injection, much of the skeletal muscle exhibited impaired regeneration 
and was replaced by fat and calcifications in FGFR4 knockout mice. They found that ETF 
expression was induced in skeletal muscle during regeneration in vivo and that ETF 
induced the promoter activity of the FGFR4 gene via a MCAT element in C2C12 
myoblasts. These results suggest the importance of the MCAT element and ETF in 
muscle regeneration, although evidence is indirect. Further studies are needed to 
determine whether knockout of ETF also exhibits abnormal skeletal muscle regeneration 
in vivo. 
1.2.2 Cofactors of TEF-1 Family Members 
Ectopic expression of TEF-1 does not induce target gene transcription in cell lines in 
which the endogenous TEF-1 protein is absent. Overexpression of TEF-1 in cells that 
express TEF-1 family members results in the transcriptional repression of MCAT 
element-containing genes (Xiao, Davidson et al. 1991). Because these observations are 
consistent with a squelching phenomenon of co-activator activity, the presence of 
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cofactors for TEF-1 family members has long been predicted. Recently, multiple 
cofactors for TEF-1 family members have been identified. They include the p160 family 
of nuclear receptor co-activators (SRC1, TIF2, and RAC3) (Belandia and Parker 2000), a 
Src/Yes-associated protein YAP65 (Vassilev, Kaneko et al. 2001), TAZ, (Mahoney, 
Hong et al. 2005). Vgll-2 / VITO-1  (Mielcarek, Gunther et al. 2002) and Vgl-4 (Chen, 
Mullett et al. 2004). Of these, Vgl-2 is expressed in a tissue-specific manner and 
contributes to the cell-specific transcription of MCAT element-containing genes.  
VITO-1 (also called as Vgl-2) interacts with TEF-1 and RTEF-1 (Maeda, Chapman et al. 
2002), and regulates the binding activity of TEF-1 family members to MCAT elements 
(Chen, Maeda et al. 2004; Gunther, Mielcarek et al. 2004). Co-transfection assays have 
shown that RTEF-1 and Vgl-2 cooperatively increase the promoter activity of the skeletal 
α-actin gene in cultured cells. Of importance, suppression of Vgl-2 by antisense 
morpholino decreases MHC expression in C2C12 myocytes and chicken limb muscles in 
vivo. As such, VITO-1 is a key cofactor of TEF-1 family members regulating muscle-
specific gene transcription in skeletal muscle (Gunther, Mielcarek et al. 2004). In 
contrast, Vgl-4 does not exhibit cell type–specific expression patterns and functions 
differently from Vgl-2 (Chen, Mullett et al. 2004). Vgl-4 is relatively widely expressed in 
multiple tissues including the heart, brain, kidney, small intestine, lung, and placenta. 
Vgl-4 physically interacts with TEF-1 and MEF2. Overexpression of Vgl-4 interferes 
with the basal and α1-adrenergic agonist-induced activity of the skeletal α-actin promoter 
in neonatal cardiomyocytes. In addition, α1-adrenergic signaling elicits nuclear export of 
Vgl-4 in cardiomyocytes. These results suggest that Vgl-4 acts as a repressor of TEF-1 
family member-dependent gene transcription under normal conditions, and that it 
translocates to the cytoplasm and modifies the transcriptional activity of these genes after 
stimulation. 
1.3 VITO-1 (Vestigial like 2, Vgl-2) 
VITO-1 is a homolog of Drosophila vestigial and human TONDU protein identified 
using a subtractive hybridization approach (Mielcarek, Gunther et al. 2002). VITO-1 is 
characterized by the presence of a scalloped interaction domain (SID) which has been 
Introduction 
 
 14
described in both Drosophila vestigial and TONDU proteins. It is presumed that the 
interaction and regulation of VITO-1 with its target genes are mediated through this SID 
domain. VITO-1 is expressed in the differentiating somites and branchial arches during 
embryogenesis and is exclusively expressed in skeletal muscle in the adult (Maeda, 
Chapman et al. 2002). The expression of VITO-1 starts from E8.75 in the somatic 
myotome during mouse embryonic development. In addition, transient domains of VITO-
1 expression were found in the branchial arches, Pharyngeal pouches and clefts, cranial 
pharynx and Rathkes pouch during embryogenesis. In adult tissues its expression was 
restricted to skeletal muscles (Mielcarek, Gunther et al. 2002). VITO-1 was identified as 
the first known TEFs co-activator, which modulates transcription enhancer factors 
activity in a tissue specific manner. VITO-2 starts to be expressed from E8.0 in the 
prospective area of the midbrain followed by its expression in the myotome of the 
somites from E9.5. In contrast to VITO-1, VITO-2 is ubiquitously expressed in adult 
tissues and its expression domains overlap with TEF-3. Analysis of VITO-1/2 expression 
in delta1 and Myf-5 knockout embryos indicated that VITO-2 but not VITO-1 is under 
control of the Notch pathway and that the VITO family of genes is a direct target of Myf-
5 during specification of the myogenic precursor cells or myoblasts. However, VITO-1 
was still detectable in the branchial arches of embryos lacking Myf-5 indicating that 
VITO-1 in the brachial arch is not expressed in muscle precursor cells. It should be noted 
that VITO-1 and VITO-2 strongly stimulate TEF-1 and TEF-3 mediated transcriptional 
activation (Gunther S, Mielcarek et al 2004). Functional analysis of VITO-1 shows that 
VITO-1 is able to enhance MyoD mediated conversion of 10T1/2 and 3T3 fibroblasts 
cells into myotubes but are not able to activate trans-differentiation of these cell lines by 
itself indicating that it plays a supportive role, which enhances and modifies a cellular 
decision imposed by other target genes (Gunther, Mielcarek et al. 2004). VITO- 1 
together with MyoD and TEF-3 induced MyHC expression in 293T cells, which are not 
able to differentiate into myotubes thus indicating an important role in control of muscle 
gene regulation. Disruption of VITO-1 using siRNA approach resulted in an inhibition of 
myogenin expression and an obstruction of C2C12 myotubes formation (Mielcarek, 
Gunther et al. 2002). VITOs act as specific modulators of TEF proteins without the 
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ability to activate transcription directly as they lack the transactivation domain or nuclear 
localization signal (NLS). 
1.4 Contractile proteins in skeletal and cardiac muscle 
are organized in sarcomeres 
In general all muscles use actin and myosin for contraction, but only in skeletal and 
cardiac muscles are these proteins organized into defined structures called sarcomeres, 
which are the fundamental contractile units of striated muscle. The sarcomere is 
composed of ordered thick (myosin) and thin (actin, tropomyosin, troponin) filaments 
that slide past each other during contraction. The Z-disc is the boundary of individual 
sarcomeres where thin filaments are anchored (Stromer 1998). Some of the key features 
of Z-discs from electron microscopy studies are: 1) anchoring points for actin filaments; 
2) placed in a precise and complicated context of intracellular sarcoplasmic cisternae and 
T-tubules; 3) seen as dense, protein-rich formations. However, despite these features 
being known for some time, most Z-disc proteins have only recently been discovered and 
characterized at the molecular level (Faulkner, Lanfranchi et al. 2001).  
At a molecular level in the sarcomere, the mechanical force produced by the interaction 
of myosin and actin within the sarcomere requires a suitable structure able to collect it. 
The emerging structural complexity of the Z-disc is an extraordinary example of intricate 
molecular architecture, while the mechanisms of its assembly and adaptation remain 
mostly unknown (Faulkner, Lanfranchi et al. 2001). 
1.4.1 The Z-disc is a complex integration of several proteins 
As shown in Figure 3, EM studies show that within the Z-disc the actin filaments are 
organized in a square pattern (Yamaguchi, Robson et al. 1982). Furthermore, for several 
proteins it was possible to determine the approximate localization using EM 
immunolabeling; for instance, telethonin maps near the edge of the Z-disc (Gregorio, 
Trombitas et al. 1998; Mues, van der Ven et al. 1998), whereas titin, the giant protein that 
spans across half a sarcomere, has its N-terminus located near the Z-disc and it’s C-
terminus near the M-band at the center of the sarcomeres (Labeit, Gautel et al. 1992).  
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                                          - Georgine Faulkner el al IUBMB Life, 51: 275–282, 2001 
 
Figure 3. Schematic representation of the Z-disc proteins embedded in muscle fibers 
The Z-disc has been schematically represented as a single pair of anti-parallel F-actins 
(red rods) joined by α-actinin 2 (yellow/brown). The N-terminal of titin (green) is 
interacting with telethonin (yellow) and with the C-terminal of nebulin (blue rod) before 
crossing the Z-disc where a variable number of z-repeats (green ovals) organize the 
binding of α-actinin 2. Titin also interacts with the central portion of α-actinin 2, before 
proceeding towards the center of the sarcomere (not shown). FATZ (Myozenin) is 
interacting with α-actinin 2, telethonin, calcineurin (white), and γ-filamin (gray). The 
latter is also binding F-actin and myotilin (light blue), as well as sarcoglycans on the 
sarcolemma (not shown). ALP and ZASP (dark blue and brown) are shown attached to 
the spectrin-like repeats of α-actinin 2. It should be noted that in some cases, where there 
is more than one protein partner, competition rather than simultaneous binding could 
occur  
 
The above figure gives a very simplified representation of Z-disc proteins, in which 
everything has been squeezed between two antiparallel F-actins. The actual 3D 
organization of the Z-disc is certainly more complex. Alpha-actinin connects two anti- 
parallel F-actins at the “sides” of the square pattern in which F-actins are arranged. 
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However, an alternative pattern could be obtained by diagonally connecting F-actins 
(Schroeter, Bretaudiere et al. 1996), on the basis of a computational analysis from EM 
data. Furthermore, from EM data it appears that during contraction the structure of the Z-
disc undergoes conformational modifications that may play an active role in the 
mechanism of contraction (Jarosch 2000). However, the molecular basis of these 
modifications remains uncertain and it is unknown whether they are accompanied by 
topological alterations. 
1.4.2 Proteins of the Z-discs 
Actin, one of the best-studied proteins belongs to a highly conserved family of 
cytoplasmic proteins present in two physical forms-globular actin and F-actin polymers. 
Six genes code for different isoforms: α-skeletal, α-cardiac, α-vascular smooth, and γ -
enteric smooth actin are found in muscle cells whereas the non-muscle cytoskeletal 
isoforms β- and γ -actin are components of the microfilament network. In the sarcomere, 
F-actin forms thin filaments that are both structurally and functionally polarized. CapZ is 
a heterodimeric protein, which in muscle is composed principally of two subunits (α 2 
and β1). It attaches actin filaments to the Z-disc and binds to the (C) end of the actin 
filaments to prevent de-polymerization, thus rendering the thin filaments stable. CapZ 
also binds to the spectrin-like repeats of α -actinin 2 (Papa, Astier et al. 1999), a Z-disc 
protein that binds actin. Alpha-actinins belong to a family of proteins that cross-link F-
actin as antiparallel homodimers. There are four different isoforms of α -actinin in cells, 
isoform 2 that is found in skeletal and cardiac muscle (Beggs, Byers et al. 1992) is a 
major component of the Z-disc. It is found in all fiber types where it links overlapping 
antipolar F-actin thin filaments from adjacent sarcomeres (Yamaguchi, Izumimoto et al. 
1985). The α -actinin 3 isoform (Beggs, Byers et al. 1992) is not found in heart but only 
in skeletal muscle in a subset of type 2 fast muscle fibers where it can form heterodimers 
with the α -actinin 2 isoform (Chan, Tong et al. 1998). Several Z-disc proteins have been 
reported to bind α -actinin 2, including nebulin (Nave, Furst et al. 1990), ALP (Xia, 
Winokur et al. 1997), Myozenin (FATZ) (Faulkner, Pallavicini et al. 2000), myotilin 
(Salmikangas, Mykkanen et al. 1999), titin (Ohtsuka, Yajima et al. 1997; Sorimachi, 
Freiburg et al. 1997; Young and Gautel 2000), and ZASP (Faulkner, Pallavicini et al. 
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1999). Titin (connectin) is one of the largest known proteins having a molecular weight 
greater than 3,000 kD. It is an elastic filament that is anchored in the Z-disc and extends 
to the M-line at the center of the sarcomere where actin and myosin fibers overlap 
(Trinick 1996). The N-terminal region of titin (30 kD) is located at the periphery of the 
Z-disc and the following 60-kD region extends across the Z-disc. The Z-disc region is 
composed of two Ig-like repeats (Z1 and Z2) followed by a series of alternatively spliced 
z-repeats (zr1–zr7). The difference in number of alternatively spliced repeats in titin 
isoforms has been suggested to affect the number of cross-links between α -actinin 2 and 
F-actin filaments and hence to cause variation in Z-disc thickness (Gautel, Goulding et al. 
1996). There appear to be two types of binding sites for titin in α -actinin 2: 1) the C-
terminal CaM domain that interacts with several z-repeats of titin; 2) the zq-Z4 region 
that binds to two spectrin-like repeats (R2 and R3 The latter binding is independent of 
dimer formation (Young and Gautel 2000), whereas the binding of titin z-repeats to α -
actinin 2 does not occur if the α -actinin 2 is present in the form of a dimer. This auto- 
inhibition can be released by phosphatidylinositol-bisphosphate binding to the actin-
binding domain of the dimer. This mechanism has been proposed as a means of 
controlling α -actinin 2 interactions with titin during sarcomere formation (Young and 
Gautel 2000).  
Nebulin is a large inextensible protein (800 kD) that is anchored at the Z-disc by its C-
terminal region and spans the length of the thin filament ending at the edge of the H-zone 
(Kruger, Wright et al. 1991; Wright, Huang et al. 1993). It is found in skeletal, but not 
heart, muscle whereas nebulette (107 kD) a smaller protein with a very high similarity to 
the C-terminal region of nebulin is only found in heart muscle (Moncman and Wang 
1995; Millevoi, Trombitas et al. 1998). As nebulin has the same length as the thin 
filaments in skeletal muscle, it has been suggested to be a “protein ruler” regulating the 
length of these filaments (Kruger, Wright et al. 1991). Nebulin can bind strongly to actin 
in vitro and may have many actin binding sites along its length (Wright, Huang et al. 
1993). It has also been shown to bind α -actinin 2 and its N-terminal domain binds 
tropomodulin.  
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Figure 4. The complexity of Z-disc proteins and their interaction with other partners 
 
Telethonin (T-cap) has been identified as one of the most abundant transcripts expressed 
in striated muscle (Valle, Faulkner et al. 1997). It co-localizes with actin in the Z-disc, 
not myosin as originally thought. Two other Z-disc proteins interact with telethonin, 
namely Myozenin (FATZ) and titin. Telethonin binds to the Z1 and Z2 Ig-like N-terminal 
repeat region of titin (Mues, van der Ven et al. 1998). The C-terminal region of titin can 
function as a kinase that has been shown to phosphorylate a serine (S157) of telethonin in 
early differentiating myocytes (Mayans, van der Ven et al. 1998). The activation of this 
titin serine kinase occurs when tyrosine (Y170) on titin is phosphorylated and 
calcium/calmodulin binds to the C-terminal of titin. Interestingly, the titin kinase site is in 
the C-terminal of titin that is located at the edge of the M-band, whereas telethonin, its 
substrate, is located in the Z-disc approximately 1 µm from this site. Therefore, it is 
difficult to explain how they can interact. However, both telethonin and the C-terminal 
domain of titin have been found to co-localize in stress fiber-like structures 
Actinin-2
Fatz
Zasp
telethonin
Ankrd2
myotilin
filamin
actin
titin
calcineurin
MURF-1
mink
myostatin
MLP
obscurin
PML
p-53
YB-1
PKC
PKD
integrins
talin
desmin
nebulin
myopalladin
MURF-1
ALP
sarcoglycans
FHL2
Introduction 
 
 20
differentiating myocytes; thus, it has been proposed that during myofibrillogenesis when 
the cytoskeleton undergoes reorganization, the titin C-terminal could be transiently in 
close proximity to telethonin thus allowing phosphorylation (Mayans, van der Ven et al. 
1998). Recently, the absence of full-length telethonin has been found to be responsible 
for a form of autosomal recessive limb-girdle muscular dystrophy (AR LGMD) type 2G 
(Moreira, Wiltshire et al. 2000). LGMDs are a genetically heterogeneous group of 
disorders that affect mainly the proximal musculature. Two different mutations in 
telethonin were identified in three families with LGMD 2G; both gave rise to premature 
stop codons resulting in truncated telethonin. Interestingly, the C-terminal truncation 
eliminates the domain of telethonin that is phosphorylated by titin kinase. Telethonin is 
the first sarcomeric protein associated with an AR LGMD (Moreira, Wiltshire et al. 
2000).  
Myozenin also known as FATZ or Calsarcin (γ-filamin, α-actinin, and telethonin-binding 
protein of the Z-disc) is a novel protein expressed in skeletal muscle, which is up-
regulated during differentiation. The C-terminal region of myozenin binds to two of the 
spectrin-like repeats (R3-R4) of α-actinin 2 (Faulkner, Pallavicini et al. 2000). The same 
region of myozenin also binds γ-filamin, as detected by yeast-two-hybrid experiments, 
whereas the region binding telethonin remains undefined. Frey and colleagues (Frey, 
Richardson et al. 2000) found that an interaction may occur between myozenin and 
calcineurin. Calcineurin has been implicated in the transduction of signals that control the 
hypertrophy of cardiac muscle and slow fiber gene expression in skeletal muscle. How 
myozenin can bind all of these different proteins is not clear, especially because it has no 
canonical protein-protein interaction domains. However, Takada and colleagues (Takada, 
Vander Woude et al. 2001) have shown that α-actinin 2 and γ-filamin compete with each 
other for binding to the C-terminal region of Myozenin. Myozenin could have a structural 
role in Z-disc assembly via its ability to bind different Z-disc proteins as well as a 
possible role in signaling pathways via its binding to calcineurin.  
ZASP (Cypher/Oracle) is a Z-band protein that has recently been characterized in human 
skeletal muscle, as an acronym for “Z-band alternatively spliced PDZ motif protein.” 
(Zhou, Ruiz-Lozano et al. 1999), (Passier, Richardson et al. 2000). ZASP1 (Cypher2) 
binds α-actinin 2 via the interaction of its N-terminal PDZ domain with the C-terminal 
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CaM domain of α-actinin 2 (Faulkner, Pallavicini et al. 1999; Zhou, Ruiz-Lozano et al. 
1999). The LIM domains of Cypher1, one of the alternatively spliced forms of ZASP 
(Cypher), can bind equally well all six isoforms of protein kinase C (PKC)-α, -β1, -δ, - ε, 
- γ, -ξ (Zhou, Ruiz-Lozano et al. 1999). Therefore, it has been proposed that Cypher1 
could function as an adapter to couple PKC–mediated signaling to the sarcomere. 
Another interesting hypothesis is that the major form in skeletal muscle ZASP1 
(Cypher2) that lacks LIM domains may inhibit the LIM domain forms in a dominant-
negative manner. ALP (Actinin-associated LIM protein) is another PDZ/LIM domain 
protein of the Z-band that is up-regulated on differentiation. In contrast to ZASP, its N-
terminal PDZ domain binds to the spectrin-like repeats of α-actinin 2 (Xia, Winokur et al. 
1997). There are two isoforms of ALP derived by alternative splicing; one is found in 
heart and the other in skeletal muscle. The skeletal muscle isoform has a central region of 
111 amino acids that is spliced out and replaced by a different region (63 amino acids) in 
the heart isoform (Pomies, Macalma et al. 1999).  
 
Filamins (or actin-binding proteins) belong to a family of dimeric proteins that cross-link 
actin filaments. There are three isoforms, filamin (ABP-280) that is ubiquitous, γ -filamin 
(ABP-L, filamin2) that is specific for striated muscle (Thompson, Chan et al. 2000; van 
der Ven, Obermann et al. 2000), and β-filament. All of these isoforms have an N-terminal 
actin binding domain followed by 24 Ig-like repeats and a C-terminal domain necessary 
for dimer formation. Interestingly, γ-filamin is the only isoform with a unique 78-amino 
acid insertion in the Ig-like domain 20, and this insertion has been shown to be 
responsible for targeting γ-filamin to Z-disc of striated muscle (van der Ven, Wiesner et 
al. 2000). The N-terminal of γ-filamin is located at the periphery of the Z-disc and 
recently this region has been found to bind to myotilin, an α-actinin-binding protein. 
During a search for proteins binding to sarcoglycans, γ-filamin was found to bind 
specifically to γ- and δ- but not α- and β-sarcoglycans (Thompson, Chan et al. 2000). In 
normal muscle γ-filamin is found mainly in the Z-disc but also at low levels in the 
sarcolemma, whereas in muscle with mutations in γ-sarcoglycan, δ-sarcoglycan, or 
dystrophin, there is an increase in the γ -.filamin level in the sarcolemma. Although γ -
filamin is not expressed in undifferentiated muscle cells, it is very quickly up-regulated 
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during differentiation and may therefore be involved in the formation of the Z-disc (van 
der Ven, Wiesner et al. 2000).  
Myozenin can also bind γ-filamin, α-actinin 2, and telethonin (Faulkner, Pallavicini et al. 
2000), therefore, this would be another case of γ-filamin forming a link between γ- and δ-
sarcoglycans and indirectly α-actinin 2. Mutations in telethonin can lead to LGMDs, 
respectively type 1A (Hauser, Horrigan et al. 2000) and type 2G, and that telethonin has 
been suggested to be involved in signal transmission in myofibrillogenesis (Mayans, van 
der Ven et al. 1998; Mues, van der Ven et al. 1998).  
In conclusion, the complex z-disc proteins found in sarcomeres mediate multiple protein-
protein interactions, thereby playing a major role in integrating structure and signaling in 
this complex three-dimensional network 
1.4.3 The Z-discs act as Stretch sensing sensors in transmitting signals 
It is known from previous studies that in heart, active muscle contraction is produced 
by membrane depolarization that stimulates Ca2+ efflux from the sarcoplasmic 
reticulum (SR), initiating discrete pulses of Ca2+ transients called sparks. These 
coalesce and raise Ca2+ levels throughout the cytoplasm surrounding the contractile 
filaments (Maier and Bers 2002). Contraction is switched on by the binding of Ca2+ to 
the thin filament troponin-tropomyosin complex, producing a conformational change 
that enables cross-bridge formation. Calcium uptake back into the SR through an ATP-
dependent pump relaxes the muscle. This pump (SERCA) is partially inhibited by 
phospholamban (PLB), which can be reversed by cAMP-dependent protein kinase 
(PKA)-mediated PLB phosphorylation. The release of this inhibition is mediated by 
the β-adrenergic signaling pathway, which increases the rate of force production and 
relaxation under exercising conditions and is blunted in heart failure. It is during the 
relaxed phase of the heart cycle that inflowing blood passively stretches the chambers 
of the heart. Stretch induces changes in cardiomyocyte biology that are implicated in 
heart failure, but the mechanism by which stretch is sensed and signals are transduced 
is unknown. New understanding of the Z disc elements of contractile units is beginning 
to elucidate the mechanism of stretch sensing and its relation to cardiac adaptation and 
disease (Epstein and Davis 2003). 
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Cardiac architecture at the cellular level is determined by myocytes, which contain the 
bundled myofibrils with repeating series of contractile units, the sarcomeres bounded 
by Z discs. Titin spans the distance from Z disc to M line and holds myosin-containing 
thick and actin-containing thin filaments in longitudinal register. Human titin 
mutations are associated with dilated cardiomyopathy in which the ventricular cavity 
enlarges as the walls stretch and become thinner (Gerull, Gramlich et al. 2002). Titin 
contains distinct motifs with different elasticity that sequentially unfold as the muscle 
is stretched and which provide much of the cardiac cell's passive tension when it is 
stretched (Granzier and Labeit 2002). Mutations in many sarcomeric protein-encoding 
genes have been identified as causing hypertrophic cardiomyopathy, an inherited 
predisposition to increased ventricular wall thickening and corresponding decrease in 
size of the ventricular cavity. Some of the same genes and other cytoskeletal genes 
have been shown to cause dilated cardiomyopathy. The Z disc transmits the tension 
between sarcomeres and its architecture is believed to be partly organized by unique 
N-terminal titin Z repeats that bind α-actinin. Additional Z disc-associated proteins are 
being reported, and mutations in many of these are associated with disease in humans 
or mice. 
The Starling Law of the Heart suggests that a primary stretch sensor and responder 
operate on a beat-to-beat time scale. The work done by Chien and colleagues (Knoll, 
Hoshijima et al. 2002) describes a primary stretch sensor, which when disrupted, leads 
to cardiac dilation and failure. The study focuses on their previously reported mouse 
model of dilated cardiomyopathy produced by knocking out MLP, a two LIM domain 
protein that binds to α-actinin in the Z disc (Arber, Hunter et al. 1997). Hearts from 
MLP null mice appear normal at 2 weeks of age but dilate and display contractile 
dysfunction by 4 weeks. The fact that MLP expression is restricted to striated muscle 
strongly suggested that this was due to a primary defect at the level of the cardiac 
myocytes. A striking finding is seen when neonatal cardiomyocytes from these mice are 
cultured on deformable membranes and stretched. Under these conditions, the cells fail 
to upregulate brain natriuretic peptide (BNP) and atrial natiuretic factor (ANF) mRNA, 
both reliable in vivo indicators of mechanical stress (Epstein and Davis 2003). Despite 
Introduction 
 
 24
the uncoupling of this response from mechanical load, the hormonally activated portion 
of the pathway remains functional in the null MLP cells, since treatment with endothelin 
or the α-adrenergic agonist phenylephrine triggers BNP mRNA synthesis. T-cap and 
MLP are shown to interact, and the authors observe the loss of T-cap from the Z discs of 
some muscle fibers in the MLP null mouse heart. Consistent with this is the detection of 
T-cap in the soluble fraction of homogenates. These findings to the hypothesis that a 
titin/T-cap/MLP complex is critical to the sensing of muscle length and those distortions 
of the architecture and associated structures uncouple the normal response to stretch 
(Granzier and Labeit 2002).  
Transcriptional control of skeletal muscle-specific gene expression is achieved by 
combined action of various transcription factors that are either specifically expressed 
in the skeletal muscle lineage or show a more widespread expression pattern. 
Transcriptional regulation in heart and skeletal muscles is basically governed by 3 
major families namely the bHLH, MADs box transcription factors and the 
Transcriptional enhancer factor (TEFs) which play important roles for the development 
of muscle tissues and for the regulated expression of muscle specific genes. It seems 
rather easy to anticipate how tissue-specific regulation of muscle cell-specific genes 
might be achieved by transcription factors that are themselves tissue-specific such as 
the MyoD family of transcription factors. Vito1 is a 33 kD protein expressed only in 
skeletal muscle but not in other tissues. Skeletal actin and cardiac TroponinT genes 
depend on SRF and TEF transcription factors, respectively. In such cases muscle 
specific transcription might be achieved by the assembly of larger transcriptional 
complexes, which utilize DNA-binding proteins as docking stations for tissue-specific 
bridging or co-activating factors that might confer additional activities to DNA-bound 
proteins. Recently a new family of transcriptional co-regulators (VITO gene family) 
(Mielcarek et al., 2002) was identified, which bind to different TEF transcription 
factors (Gunther et al., 2004). Vito1 was found to be an essential co-factor of TEF1 
thereby activating TEF1, which results in the activation of its downstream target genes 
leading to muscle-specific gene regulation.  
Introduction 
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The aim of this study was: 1) to find the specific role of individual components of the 
TEF/VITO complex for muscle specific gene activation. 2) Does the TEF/VITO/ 
complex contain additional proteins and do they affect DNA binding specificity and/or 
transactivation? 3) Identification and investigation of new interacting partners of 
VITO-1 and establish their biological significance in skeletal muscle gene regulation. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Basic materials 
Bacterial / Yeast Plates   
Cell culture Plates   
Filters Minisart NML 
Whatmann filter paper 
Cover slips  
Cover slides 
Glass wares  
Polyacrylamide gel 
Nitrocellulose membranes 
Plastic Pipettes 
Protein G beads 
Cell scraper 
Surgical instruments 
2.1.2 Chemicals / Reagents 
In general the basic reagents and chemicals were ordered from the following companies: 
Roth (Hamburg/Karlsruhe, Germany), BD BioSciences, Boehringer Mannheim 
(Mannheim), Invitrogen (Karlsruhe), Merck (Darmstadt), Molecular Probes (Göttingen), 
New England Biolabs (Schwalbach), Pharmacia (Frieberg), Promega (Mannheim), 
Qiagen (Hilden), Serva Feinbiochemika (Heidelberg), Sigma-Aldrich (Deisenhofen), 
Stratagene (Heidelberg).  
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2.1.3 Radiochemicals 
Radioactive labeling of translated proteins were used in TNT Coupled Reticulocyte 
Lysate Systems and was purchased from Promega 
• (35S)methionine (> 1000Ci/mmol at 10 Ci/ml) 
 
2.1.4 Specific reagents 
   -     DAPI (4’,6-diamidino-2-phenylindole)   Invitrogen (Karlsruhe) 
   -     Dimethylsulfoxid      Sigma-Aldrich(Deisenhofen) 
   -     Dubelcco’s Modified Eagle Medium (DMEM)  Invitrogen (Karlsruhe) 
   -     Fetal Bovine Serum      Invitrogen (Karlsruhe) 
   -     Fluoromount       Sigma-Aldrich(Deisenhofen 
   -     Horse serum       Invitrogen (Karlsruhe) 
   -     IPTG (Isopropyl-β-D-tiogalactopyranosidase)  Roth (Karlsruhe) 
   -     NP-40                                       Roth (Karlsruhe) 
   -     Penicillin-Streptamycin-Glutamine    Invitrogen (Karlsruhe) 
   -    (Y2H) All the yeast reagents used   BD Biosciences - Clontech 
- PFA (paraformaldehyde)                Merck (Darmstadt) 
-  Prestained Protein Ladder 10-180 kDa              Fermentas (Lithuania) 
- Protease inhibitor coctail EDTA-free               Roche (Karlsruhe) 
-  RNasin®       Invitrogen (Karlsruhe) 
- Triton X-100       Roche (Karlsruhe) 
- Trypsin 2,5%       Invitrogen (Karlsruhe) 
- Tween-20       Roche (Karlsruhe) 
- X-Gal (5-bromo-4-chloro-3-indolyl  
- β-D-galactopyranoside)     Roth (Karlsruhe) 
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2.1.5 Instruments / Equipments 
Confocal Laser scanning microscope 
Normal Microscope  
Cell culture laminar flow hood 
Cell culture incubator 
PCR machine  
Spectrophotometer 
pH meter 
Yeast incubator 
Versadoc  
Centrifuge  
Microcentrifuge 
Vortex 
Sonicator 
Protein measurement 
Vacuum / drier for gels  
 
2.1.6 MATERIALS COMPANY 
Biodyne® Nylon Membrane Pall (Dreieich, Germany) 
Bio-Traces® Nitrocelulose Pall (Dreieich, Germany) 
Blotting Paper 3MM Whatman International (Maidstone, 
England) 
Cell culture plates Nunc (Roskilde, Denmark), Falcon 
Glass slides and cover slides Roth (Karlsruhe, Germany) 
Glassware Schütt (Göttingen, Germany) 
Filters Minisart NML (0.2 and 0.45 μm) Sartorius (Göttingen, Germany) 
Filters 
Schleicher & Schüll (Hannover, 
Germany) 
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NAP-5™ columns (Sephadex® G-25) Pharmacia Biotech (Sweden) 
Plastic ware Nunc (Wiesbaden, Germany) 
Pro-Bond Ni-chelating Resins Invitrogen (Karlsruhe, Germany) 
Round cover slides Roth (Karlsruhe, Germany) 
X-ray developer Kodak (Frankfurt/Main, Germany) 
X-ray Film Kodak (Frankfurt/Main, Germany) 
2.1.7 Kits used 
Yeast transformation kit                                          BD Biosciences 
 
Yeast plasmid isolation kit    BD Biosciences  
 
Qiagen mini prep kit                                                 Qiagen 
 
Nucleobond AX 500 Maxi kit   Macherey-Nagel 
 
DNA Cycle sequencing kit    Abi, Weitersadt 
 
TnT® Coupled Reticulocyte Lysate System  Promega 
 
QIAEX II Gel Extraction Kit    Qiagen 
 
Nucleofector TM electroporation kit   Amaxa Biosystems   
  
FuGENE 6 transfection kit    Roche  
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2.1.8 Bacterial Strains used 
BL21 (DE3 F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI  lacUV5-T7 
gene 1 ind1 sam7 nin5] 
BL21 (DE3) pLysS F- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) pLysS(cmR) 
DH10B (Invitrogen) F- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 
Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-
mcrBC) λ- 
JM109 endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ Δ(lac-proAB) 
e14- [F' traD36 proAB+ lacIq lacZΔM15] hsdR17(rK-mK+) 
TOP10 (Invitrogen) F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG 
recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) 
endA1 λ- 
XL1-Blue 
(Stratagene) 
endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 
proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+) 
 
2.1.9 Cell lines used 
Cell line Organism Origin tissue Morphology ATCC-Nr 
HEK-293 Homo sapiens Embryonic kidney epithelial CRL-1573 
C3H-10T1/2 Mus musculus Embryonic 
mesenchymal 
fibroblast CCL-226TM 
C2C12 Mus musculus muscle myoblast CCL-1772 TM 
COS-1 Cercopithecus 
aethiops 
kidney fibroblast CRL-1650 TM 
Table 3. Cell lines used  
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2.1.10 Vectors used 
Vector Size Selection markers Source 
pGBKT7 7.3 kb E.coli – Kanamycin 
Yeast – W (Trp) 
Clontech 
pGADT7 8.0 kb E-coli – Ampicillin 
Yeast – L (Leu) 
Clontech 
pEGFP-C2 4.7 kb Kanamycin Clontech 
pDsRed2-N1 4.1 kb Kanamycin Clontech 
pCS2 4.1 kb Ampicillin Kind gift from Prof. 
T. Braun 
pCDNA3.1 5.4 kb Ampicillin Kind gift from    
Prof. T. Braun 
HA-N1 4.1 kb Kanamycin Kind gift from Prof. 
M.S. Gautel 
pCR®2.1-TOPO ® 3.9 kb Kanamycin/ampicillin Invitrogen 
pRSETA 2.9 kb Ampicillin Invitrogen 
pT7T3-Pac 2.9 kb Ampicillin Pharmacia 
Table 4. Vectors used during this project 
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2.1.11 Sequencing primers    
Primers Sequences 
T7 TAA TAC GAC TCA CTA TAG GG 
T3 ATT AAC CCT CAC TAA AGG GA 
Sp6 ATT AGG TGA CAC TAT AG 
M13 forward GTA AAA CGA CGG CCA G 
M13 reverse CAG GAA ACA GCT ATG AC 
5`- GFP CAA GTC CGG CCG GAC TCA GAT C 
5`- pDsRed 2.1 CCA AAA TGT CGT AAC AAC TC 
5`AD LD-Insert screening 
amplimer 
CTA TTC GAT GAT GAA GAT ACC CCA 
CCA AAC CC 
3`AD LD-Insert screening 
amplimer 
GTG AAC TTG CGG GGT TTT TCA GTA TCT  
ACG AT 
pGBKT7 (T7) TAA TAC GAC TCA CTA TAG GGC GA 
3`DNA-BD sequencing 
primer 
AAA AGC AAA ATT TTG GAT TTC TCA G 
GST GAC CAT CCT CCA AAA TCG GAT CTG 
Vito1 GAG TAG TAG GCT AGT TTC TGG 
Vito1 –SID CTC CAG ATG TGT CCT CTT CAC 
Table 5. Primers used for sequencing plasmids during this study 
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2.1.12 Antibodies used 
Primary antibody 
C-myc     anti-mouse (Santacruz) 
Hemagglutinin (HA)   anti-mouse (Abcam) 
α – actinin       anti-rabbit (Sigma) 
α – sarcomeric actinin  anti-rabbit (Sigma) 
α – tubulin    anti-mouse (Sigma) 
α – sarcomeric actin   Sigma 
telethonin (T-cap)   BD Bioscience 
Myozenin1    Eurogentec 
eGFP     anti-mouse (Invitrogen), anti-rabbit (Abcam) 
Secondary antibody 
Alexa fluor 488       anti-mouse, rabbit (Invitrogen) 
Alexa fluor 594      anti-mouse, rabbit (Invitrogen) 
Cy3     anti-mouse (Rockland) 
Horse radish peroxidase (HRP) anti-mouse (Pierce) 
HRP     Anti-rabbit (Pierce) 
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2.2 Materials for Y2H Screen 
2.2.1 Testing for GAL1-HIS3 Auto-Activation  
Yeast media containing additives such as 3-amino triazole (3-AT) should be produced by 
adding the appropriate amount of a concentrated filter-sterilized solution after 
autoclaving and cooling the medium to at least 60°C.  
2.2.2 Testing for Colony β-Galactosidase Activity 
Z Buffer: NaH2PO4·H2O 13.79 g/L, KCl 0.75 g/L, MgSO4·7H2O 0.246 g/L, Titrate 
with 10 N NaOH to pH 7.0. Z buffer/β-ME: This should be made fresh by adding 270 µL 
of β-mercaptoethanol (β-ME)/100 mL of Z buffer. X-GAL: 20 mg/mL, dissolve 1.0 g of 
X-GAL in 50 mL of N, N-dimethyl-formamide and store at −20°C. Z buffer/β-ME/X-
GAL: This should be made fresh by adding 270 µL of β-ME and 1.67 mL of X-GAL 
solution to 100 mL of Z buffer 
2.2.3 Preparation of Yeast Lysates for Western Blotting  
Extraction buffer: 50 mM HEPES, pH 7.4, 200 mM NaCl. 10 mM EDTA 
(ethylenediaminetetraacetic acid) , 2 mM NaVO4, 10 mM NaF, 5 µg/mL aprotinin, 5 
µg/mL leupeptin, 2 µg/mL E-64 (trans-Epoxysuccinyl-L-leucyl-amido (4-
guanidino)butane; N-(trans-Epoxysuccinyl-L-leucyl-amido) 4-guanidinobutylamide; L-
trans-3-Carbonxyoxiran-2-carbonyl-L-leu-cylagmatine), 2.5 µg/mL pepstatin A, 1 mM 
phenylmethylsulfonyl fluoride (PMSF). Acid washed glass beads, 425–600 microns 
(Sigma, cat. no. G-8772). Sodium dodecyl sulfate (SDS) loading buffer: 3% (w/v) SDS, 
62.5 mM Tris, pH 6.8, 720 mM β-mercaptoethanol, 10% (v/v) glycerol, 0.125% (w/v) 
bromophenol blue. 
2.2.4 AD: cDNA Library Amplification 
LB (Luria Bertani) Medium + ampicillin (600 mL), tryptone 6 g, yeast extract 3 g, NaCl 
6 g, distilled water 600 mL. Titrate to pH 7.0 with 10 N NaOH. For plates: add 10 g 
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Difco Bacto Agar to 600 mL volume in each flask prior to sterilization. When cooled to 
60°C add 300 µL of a 100 mg/mL stock of ampicillin, mix, and pour plates. Sterile 
saline: 150 mM NaCl, dissolve 8.7 g/L and autoclave. TE (Tris EDTA) Buffer: 10 mM 
Tris, pH 8.0, 1 mM EDTA. Make 100 mL by adding 1 mL of 1.0 M Tris Cl, pH 8.0, and 
0.2 mL of 0.5 M EDTA, pH 8.0 to 98.5 mL of double-distilled H2O. 
2.2.5 Library Transformation Efficiency Test  
All solutions for transformation can be referred to (R. Daniel Gietz – Yeast Protocol) or 
Yeast protocols handbook BD Biosciences 
2.2.6 Isolation of AD: cDNA Plasmid  
 Yeast Lysis buffer, 20 mM Tris, pH 8.0, 10 mM EDTA, 100 mM NaCl, 1% (w/v) SDS, 
2% (v/v) Triton X-100. Make 100 mL by adding 2 mL of 1.0 M Tris, pH 8.0, 2 mL of 0.5 
M EDTA, pH 8.0, 2 mL of 5.0 M NaCl, 5 mL of 20% (w/v) SDS, and 2 mL of Triton X-
100.  
2.2.7 Transforming chemically Competent E.coli and Selection of LEU+ 
Colonies 
M9 salts (10X): Na2HPO4 60 g, KH2PO4 30 g, NaCl 5 g, NH4Cl 10 g, per L of distilled 
water and autoclave. M9 Leucine prototrophy medium (M9-L): 60 mL 10X M9 salts, 540 
mL distilled water, 10 g Difco Bacto-agar. Autoclave this solution and allow to cool to 
60°C, then add the following amounts (each solution is sterile) 0.6 mL 1.0 M MgSO4, 0.6 
mL 0.1 M CaCl2 0.5 mL thiamine (4 mg/mL), glucose (20% [w/v]), 0.15 mL FeCl3 (0.01 
M), 0.6 mL vitamin B1 (2 mg/mL). Depending on the genetic markers found in the E. 
coli strain, add the appropriate amino acids. E. coli strain KC8 (genotype; hsdR, leuB600, 
trpC9830, pyr::Tn5(kan r), hisB463, lacDX74, strA, galU, galK) add the following; 6 mL 
histidine (2 mg/mL), 6 mL uracil (2 mg/mL), 6 mL tryptophan (2 mg/mL). 
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2.3 Methods  
2.3.1 Two-Hybrid Screen Preparation 
2.3.1.1 Construction of the DNA Binding-Domain Bait Gene Fusion Plasmid 
The first step is to construct the DNA binding-domain bait gene fusion plasmid. Our 
favorite gene encoding the protein of interest (considered the bait), VITO-1 is cloned into 
a suitable Y2H vector (here pGBKT7) in-frame with the chosen DNA binding domain.  
Plasmid 
DNA binding 
domain 
Restriction sites DNA sequence and frame 
Yeast selection 
marker 
pGBKT7 GAL4 BD  
NdeI SfiI/NcoI EcoRI SmaI BamHI SalI 
PstI 
TRP1  
CAT ATG GCC ATG GAG GCC CCG 
GGG ATC CGT CGA C 
  
pAS2 GAL4 BD  
NdeI SfiI/NcoI SmaI BamHI SaiI PstI  TRP1  
CAT ATG GCC ATG GAG GCC CCG 
GGG ATC CGT CGA CCT GCA GCC 
CYH2  
pGBT9 GAL4 BD  
EcoRI SmaI BamHI SalI PstI  TRP1  
GGA TTC CCG GGG ATC CGT CGA 
CCT GCA G 
  
pBTM116 LexA BD  
EcoRI SmaI BamHI SalI PstI  TRP1  
GGA TTC CCG GGG ATC CGT CGA 
CCT GCA G 
  
Table 6. Two-Hybrid System DNA Binding Domain Plasmid Vectors 
There are many different DNA binding-domain vectors available and are listed in (James 
2001). An important consideration is to match the DNA binding-domain plasmid used to 
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the appropriate yeast strain. A few of the DNA binding domain vectors used more 
frequently are listed in Table 6. 
2.3.1.2 Choosing the Right Y2H Reporter Strain 
Yeast strains for the GAL4 system include reporter constructs that utilize the HIS3, 
ADE2, LEU2, URA3, CYH2, lacZ, and MEL1 genes. The HIS3 reporter allows direct 
selection of Y2H positives; however, some strains contain “leaky” derivatives, which 
require the addition of the chemical 3-amino triazole (3-AT) to the medium to quench 
background expression of the HIS3 gene product (Durfee, Becherer et al. 1993). The 
HIS3 reporter gene also selects for the optimal ratios of fusion proteins to produce 
reporter gene expression for growth on selective medium (Aspenstrom and Olson 1995). 
In some strains, the ADE2 reporter can be used to select for co-activation giving rise to a 
more stringent screen. The lacZ and the MEL1 reporters can be used to verify positives 
through co-expression as well as generate quantitative measurements of gene expression. 
Another important quality of a Y2H yeast strain is its transformation characteristics. The 
ability to generate large numbers of transformants using current transformation protocols 
is essential for Y2H screening. 
2.3.1.3 Y2H Reporter Strains 
Table 7. Yeast two hybrid reporter strains used to regulate the expression of reporter 
gene 
Plasmid or         
host straina
Reporter           
gene
Origin of            
UAS
UAS          
regulated by
Origin of       
TATA sequence
Expression levelb 
Induced (uninduced)
lacZ UASG 17 -mer(x3)c GAL4 CYC1 low
HIS3 GAL1 GAL4 GAL1 high (tight)
lacZ GAL1 GAL4 GAL1 high 
HIS3 GAL1 GAL4 HIS3 (TC+TR) high (leaky)
Y187 lacZd GAL1 GAL4 GAL1 high
SFY526 lacZ GAL1 GAL4 GAL1 high
HIS3 GAL1 GAL4 GAL1 high (tight)
ADE2 GAL2 GAL4 GAL2 high (tight)
HIS3 GAL1 GAL4 GAL1 high (tight)
ADE2 GAL2 GAL4 GAL2 high (tight)
lacZ MEL1 GAL4 MEL1 low
AH109
Yeast Promoter Constructs Used To Regulate Reporter Gene Expression
HF7c
Y190
PJ69-2A
                                                                                             Materials and Methods 
  
 
 38
2.3.1.4 Testing for GAL1-HIS3 Auto-Activation 
The activation of reporter genes by the BD:bait plasmid in the absence of an activation 
domain plasmid is defined as auto-activation. Transform the BD:bait plasmid into the 
appropriate reporter yeast strain using the rapid transformation protocol (Gietz and 
Woods 2006) then proceed to test both reporter genes for auto-activation. To test for 
auto-activation of the GAL1-HIS3 reporter, yeast cells containing the BD:bait plasmid 
should be plated, not streaked, onto SC-H (synthetic complete medium minus histidine) 
medium containing increasing concentrations of 3-AT (1, 5, 10, 25, 50 mM). As well, 
these yeast cells should be plated onto SC-W (synthetic complete medium minus 
tryptophan) medium to select for the BD:bait plasmid as a control of growth. The 
addition of 3-AT into the medium is used to suppress the “leaky” nature of this reporter 
in most strains. The concentration of 3-AT needed to eliminate background growth is 
plasmid and strain-dependent.  
Grow the yeast transformant containing the verified BD:bait plasmid overnight in SC-W 
medium to select for maintenance of this plasmid. Alternatively, a 10-µL blob of cells 
can be scraped from a freshly grown SC-W plate and resuspended in 1 mL of sterile 
water. Titer the liquid culture using a spectrophotometer (OD600 0.1= ~ 1 × 106 cells/mL) 
or a hemocytometer Plate at least 500 cells/plate onto a pair of SC-W plates as well as 
pairs of SC-H plates containing 0, 1, 5, 10, 25, and 50 mM 3-AT and incubate at 30°C for 
up to 5 d. Examine the SC-H + 3-AT plates for growth. Most BD:bait plasmids will not 
produce colonies on the medium once the appropriate concentration of 3-AT is reached. 
The SC-W control plates should contain approximately 500 colonies. If growth cannot be 
inhibited completely even at a 50 mM concentration, its better considering either to clone 
a different gene fragment into the BD:bait plasmid, or cloning our gene of interest into 
another BD vector.  
2.3.1.5 Testing for Colony β-Galactosidase Activity 
In addition to testing for GAL1-HIS3 auto-activation, it is prudent to also test for GAL1-
lacZ auto-activation in those strains that contain this reporter gene. This can be 
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accomplished by using the pair of SC-W plates that were plated for the GAL1-HIS3 auto-
activation test above  
1. Carefully place a sterile 75-mm circle of Whatman #1 filter paper on top of the 
colonies or patches growing on selective medium. Ensure that the filter paper makes good 
contact with the colonies. Mark the orientation of the filter paper relative to the plate 
using an 18-gauge needle to punch through the filter in an asymmetric pattern.  
2. Remove the filter from the plate with sterile forceps after it has become fully absorbed 
to the colonies and immerse into liquid nitrogen for 10–15 s.  
3. Carefully remove the filter from the liquid nitrogen and thaw by placing on a piece of 
plastic wrap colony-side up. Repeat the freeze-thaw cycle twice more.  
4. Place another 75-mm sterile Whatman no. 1 filter into an empty petri plate (100 × 15 
mm) and dispense 1.25 mL of Z buffer/β-ME/X-GAL onto the filter.  
5. Place the filter, colony-side up, onto a filter paper soaked with Z buffer/β-ME/XGAL 
taking care that the filters line up to distribute the solution evenly.  
6. Place the lid on each plate and transfer to a plastic bag and incubate at 37°C. 
Strong activation of the lacZ gene will give a blue color within 1–2 h. If color does not 
develop, continue to incubate the filters overnight. Note the time needed for color 
production. A faint blue color after overnight incubation is considered minimal lacZ 
activation.  
2.3.1.6 Preparation of Yeast Lysates for Western Blotting 
Prior to screening, the steady-state expression of the BD:bait fusion protein should be 
assayed by Western blotting. This may be accomplished if the appropriate reagents are 
available, such as a specific antibody for the product of our gene of interest. Some 
vectors, such as pGBKT7 and pGADT7, contain the myc and HA tag that can be 
recognized by the commercially available monoclonal antibody (MAb). The Gal4BD 
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antibody (Santa Cruz Biotechnology Inc. or Invitrogen) can also be used. In addition to 
indicating the expression levels of the fusion protein, Western blotting can verify the in-
frame cloning strategy, because the size of the fusion protein detected should compare to 
the predicted value. Yeast lysates are prepared for electrophoresis following a modified 
method of (Rocchi, Tartare-Deckert et al. 1996). Inoculate the yeast strain containing the 
BD:bait plasmid into 50 mL of SC-W medium. Incubate at 30°C with shaking until a titer 
of 1.0 × 107 cells/mL is reached. This may take 16–24 h. Alternatively a 10-mL overnight 
culture can be used to inoculate 50 mL to 2.5 × 106 cells/mL and incubate until a titer of 
1–2 × 107 cells/mL is reached. This will take 4 to 6 h or longer in SC-W medium. Collect 
the yeast cells by centrifugation at 5000g for 5 min and wash the cells with 1/2 volume of 
sterile water. Determine the volume of the cell pellet by adding a specific volume of 
water and then measuring the total volume of the cell slurry. Transfer the slurry to a 1.5-
mL microfuge tube. Re-suspend the cells in 2 volumes of ice-cold Extraction buffer. Add 
1 volume of glass beads and place each sample onto ice. Vigorously vortex each sample 
for 30 s and return to ice to cool. Repeat six times for each sample. Centrifuge samples at 
14,000g at 4°C for 1 min to pellet unbroken cells and cell debris. Transfer the supernatant 
to another 1.5-mL microcentrifuge tube and cool each sample in ice slurry for 1 min. 
Centrifuge each sample again at 14,000g at 4°C for 1 min to further clarify extract. 
Carefully remove supernatant, mix 1:1 with SDS loading buffer, and heat in a boiling 
water bath for 2 min. These extracts can be used for Western blot analysis and stored at 
−70°C until needed. 
2.3.1.7 Library Transformation Efficiency Test 
Library transformation efficiency test is accomplished by transforming increasing 
amounts of library plasmid DNA into the two-hybrid yeast strain containing the BD:bait 
plasmid at a 1 x transformation scale. This experiment will allow you to use the library 
plasmid DNA efficiently, as well as target a specific number of transformants for Y2H 
screening. If the DNA concentration used for the transformation is too high, multiple 
AD:cDNA library plasmids will be transformed into a single yeast cell, making 
subsequent analysis of two-hybrid positives more difficult.  
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1. Using the “high-efficiency transformation protocol” (Gietz and Woods 2006), 
transform increasing amounts of the AD:cDNA library plasmid DNA into your Y2H 
yeast strain containing the BD:bait plasmid at the 1X transformation scale (e.g., 0.1 µg, 1 
µg, 2 µg , 5 µg, and 10 µg of AD:cDNA library plasmid DNA). Plasmid DNA 
preparations containing RNA can be estimated for concentration from agarose gels. 
Incubate the plates for 3–4 d at 30°C.  
2. Count the colonies on each set of plates to determine the Transformation Yield (total 
number of transformants) as well as the Transformation Efficiency (transformants/µg) for 
each transformation. 
2.3.1.8 The Library Screen 
Once the transformation yield test has been completed, a large-scale library screen can be 
performed as outlined in (Gietz and Woods 2006). Typically a 30x or 60x transformation 
scale-up is used. It is recommended to use at least 50–100 large (150 × 15 mm) Petri 
plates containing SC-W-L-H + 3-AT medium. Freshly made plates should be allowed to 
dry for a few days at room temperature to eliminate excessive condensation. Media 
should also be stored in the dark to prevent a reduction in plating efficiency owing to 
exposure to fluorescent lighting. Using the appropriate amount of AD:cDNA library 
plasmid DNA, transform the Y2H yeast strain containing the BD:bait plasmid using the 
methods outlined in (Gietz and Woods 2006) and plate onto medium that selects for 
reporter gene activation. Plating a 30X or 60X transformation onto 100 large plates can 
take up to 30 min. Spread the plates out on a counter top, 10 at a time, and dispense 400 
µL of transformed cells onto each plate. Using a sterile glass spreading wand, the 
inoculum was carefully spread onto the surface of the entire plate. Incubate plates in 
loosely taped Petri plate bags to reduce drying during growth for 4–21 d at 30°C.  
2.3.1.9 Picking Y2H Positives 
Transformation plates were checked for colonies after 4 d of incubation at 30°C. 
Continue to check the plates and pick positives every day for the first week and then 
every 2 d for up to 3 wk. When colonies become visible they were patched to fresh 
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selection plates (SC-W-L-H + 3-AT) in a grid pattern. These patched plates were 
incubated at 30°C until sufficient growth occurs. Colonies that do not produce growth on 
the patched plate after 5–7 d can be eliminated. When picking positives, colonies that are 
actively growing were selected. To be certain, observe the colony growth over a number 
of days. Depending on the strain and BD:bait plasmid, small colonies can usually be 
found in areas of the plate containing heavy inoculum. These types of colonies were 
avoided because they are usually not true positives. Positives were kept on medium that 
selects for reporter gene activation and all plasmids at all times (e.g., SC-W-L-H + 3-AT 
plates). This ensures that the BD:bait and AD:cDNA library plasmids encoding the 
interacting fusion protein are maintained. In cases where a yeast transformant contains 
multiple AD:cDNA library plasmids, this will ensure the maintenance of the correct 
plasmid. Yeast colonies were streaked to fresh plates weekly and/or cryo-preserved 
(positives) as soon as possible. 
2.3.1.10 LacZ Reporter Gene Activity  
A good indication of a true Y2H positive is co-activation of all reporter genes. The lacZ 
reporter can be used for this purpose. Once positives are patched and replicated, lacZ 
gene activation can be assayed. It is important to maintain positives on medium that 
selects for GAL1-HIS3 reporter activation. This will optimize the expression of fusion 
proteins to give good levels of reporter gene activity.  
2.3.1.11 Cryo-Preserving the His+ lacZ + Positives 
Patched colonies that activate the lacZ reporter should be cryo-preserved. Streak the His+ 
lacZ+ positives onto fresh SC-W-L-H + 3-AT plates and incubate at 30°C for 24 to 48 h. 
Scrape a blob of fresh inoculum using an inoculating loop or a sterile toothpick and 
resuspend in 1 mL of sterile 25% glycerol in a 1.5-mL microcentrifuge tube or cryo-tube. 
Store at -70°C.  
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2.3.1.12 Characterizing Two-Hybrid Positives 
Primary Y2H positives that activate both the HIS3 and the lacZ reporter genes can now 
be subjected to further analysis. Owing to the in vivo nature of this system, unforeseen 
obstacles may be encountered that may one to return to a previous step.  
2.3.1.13 Isolation of AD:cDNA Plasmid 
To isolate the AD:cDNA library plasmid, nucleic acids are extracted from the yeast cells 
of each Y2H positive. A quick and effective method described in (Hoffman and Winston 
1987) uses glass beads and phenol:chloroform to extract nucleic acids. Alternatively, a 
method (Cryer, Eccleshall et al. 1975) that uses lyticase to produce spheroplasts can also 
be used. These nucleic acid preparations will include both TRP1 and LEU2 plasmids and 
should be transformed into an E. coli host containing a leuB mutation to specifically 
select for the yeast LEU2 gene harbored on the AD:cDNA library plasmid.  
This protocol, modified from (Hoffman and Winston 1987), can be used to isolate DNA 
from yeast cells grown in either liquid culture or harvested from a plate. Inoculate 
individual Y2H positives from SC-W-L-H + 3-AT plates into 2 mL of SC-H or SC-W-L 
medium and incubate at 30°C overnight. Alternatively, scrape a 50-µL blob of cells from 
an SC-W-L-H + 3AT plate and resuspend in 500 µL of sterile water in a 1.5-mL 
microcentrifuge tube. Collect the yeast cells from the liquid culture by centrifugation at 
13,000g for 30 s. Remove the supernatant and add 200 µL of yeast lysis buffer and gently 
resuspend the cell pellet using a micropipet tip to avoid the generation of bubbles. Add an 
approx 200 µL volume of glass beads and 200 µL of buffer-saturated phenol:chloroform 
(1:1 [v/v]). Vortex each sample vigorously for 30 s and then place on ice. Repeat twice, 
leaving samples 30 s on ice between treatments. Centrifuge tubes at 13,000g for 1 min. 
Remove the aqueous phase (~ 200 µL) to a fresh tube and precipitate the nucleic acids by 
adding 20 µL of 3.0 M sodium acetate, pH 6.0, and 500 µL of 95% ethanol. Incubate at 
−20°C for 30 min and collect the precipitate by centrifugation at 13,000g for 5 min at 
4°C. Wash the pellet with 100 µL of 70% ethanol (room temp) and dry the pellet for 5 
min at room temperature. Dissolve the pellet in 25 µL of TE buffer and store at −20°C. 
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2.3.1.14 Transformation of Chemically Competent E. coli – selection of LEU+ 
colonies  
Transformation efficiency is significantly affected by temperature. Falcon tubes and 
pipette tips should be prechilled at 4°C. Prepare chemical competent cells and thaw them 
in ice.Add 10µl of yeast plasmid solution to a prechilled 10-ml Falcon tube. Add 100µl 
of competent cells to the tube and mix well by gently tapping the tube. Incubate on ice for 
30 min. Transfer the tube to a 42°C water bath and incubate for 45-50 sec. Chill on ice 
for 2 min. Add 1 ml of LB or (preferably) SOC medium with no antibiotic. Incubate at 
37°C for 1 hr with vigorous shaking (250 rpm). Pellet cells by centrifuging at 2,500 rpm 
for 5 min in a table top centrifuge. Discard supernatant and resuspend pellet in 100µl of 
the selection medium and spread on the appropriate plates. Incubate plates at 37°c for 24 
hr (LB/amp selection only), or for 36-48 hr (for nutritional selection on M9 medium). 
Typically, 10-100 colonies will be seen on the plate for a successful transformation using 
isolated yeast plasmid. A parallel transformation using the control pUC19n DNA should 
be used to calculate the transformation efficiency. 
2.3.1.15 Isolating Plasmid DNA from the E. coli transformants 
This can be done using a standard plasmid mini-prep procedure to isolate plasmid DNA 
from the E. coli transformants. (Sambrook et al., 1989) 
2.3.3.16 Analysis of Isolated AD:cDNA Plasmids 
The LEU2 AD:cDNA library plasmids isolated from the leuB E. coli strain can now be 
characterized by restriction enzyme (AluІ, HaeІІІ) digestion and agarose gel 
electrophoresis. Restriction enzymes that digest on the 5′ and 3′ ends of the cDNA are 
vector- and library-specific; check the AD:cDNA library plasmid information. This 
analysis will group the plasmids by insert size and restriction pattern. Restriction enzyme 
analysis should be carried out on 4–5 library plasmid isolates from each Y2H positive. If 
more than one type of library plasmid is isolated from a single Y2H positive, further 
analysis should be carried out with each unique isolate. Independent positives with 
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similar-sized inserts should not be considered duplicates until sequence information can 
be produced.  
2.3.1.17 Reconstruction of Two-Hybrid System Positives 
Plasmid DNA isolated from the leuB E. coli strain is transformed back into the Y2H yeast 
strain containing the BD:bait plasmid. Thus, a representative from each plasmid group is 
tested for activation of both the HIS3 and lacZ reporter genes when in combination with 
the original BD:bait plasmid. This is accomplished using the high-efficiency 
transformation protocol mentioned above. Transformed cells are plated onto SC-W-L as 
well as SC-W-L-H + 3-AT media. Growth on SC-W-L confirms the presence of both the 
BD:bait and AD:cDNA library plasmids. Colony formation on SC-W-L-H + 3-AT 
demonstrates activation of the HIS3 reporter gene. These His+ colonies can also be tested 
for activation of lacZ reporter using the β-galactosidase assay. 
2.3.1.18 Failure of Y2H Positives to Reconstruct 
The failure to obtain colonies on SC-W-L-H + 3-AT medium while generating colonies 
on SC-W-L medium suggests that the AD:cDNA library plasmid used in the 
transformation was not responsible for activation of the reporter genes in the original 
Y2H positive. There are two specific situations that are known to give rise to this. The 
first is the presence of multiple AD:cDNA library plasmids in the original Y2H positive, 
caused by transformation with high library plasmid DNA concentrations. The second is 
alteration of the BD:bait plasmid in the yeast strain.  
2.3.1.19 Multiple Library AD:cDNA Plasmids 
The presence of multiple AD:cDNA library plasmids in a single yeast Y2H positive is a 
relatively common occurrence if high plasmid DNA concentrations were used in the 
library transformation reaction. This situation will be immediately apparent if multiple 
restriction digestion patterns are identified among the 4–5 AD:cDNA library plasmids 
originally isolated. Each plasmid type should be tested for reconstruction. If each of the 
4–5 AD:cDNA library plasmids have identical restriction patterns and do not reconstruct 
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reporter gene activation, it is likely that your Y2H positive contains multiple AD:cDNA 
library plasmids. An additional 10–20 E. coli colony should be isolated from the yeast 
DNA preparation and analyzed to identify others plasmids that may be responsible for 
reporter gene activation. Failure to identify other AD:cDNA library plasmids in a Y2H 
positive suggests that it may be nontypical. Depending on the numbers of positives from 
the screen, these nontypical positives can be retired for later analysis.  
2.3.1.20 Sequencing Positives 
Representative members of each group of AD:cDNA library plasmids that reconstruct 
should be sequenced to identify those positives that contain ORFs in-frame with the 
GAL4 AD Double-stranded plasmid DNA can be sequenced using various commercial kits 
or companies. The primers used to sequence any GAL4-based Y2H vector can be found 
in Table 8.  
 
Table 8. Sequencing Primers 
DNA sequence information can be analyzed using your favorite DNA analysis software 
package. Complete or partial THS vector sequence files can be found either at GenBank 
http://www.ncbi.nlm.nih.gov or the Vector database (http://seq.yeastgenome.org/vectordb/). 
The sequences from AD:cDNA library plasmids should be analyzed using the BLAST 
2.2.9 algorithm  (http://www.ncbi.nlm.nih.gov/BLAST/) to identify previously cloned 
genes in the GenBank database. In addition, the amino acid sequence of the predicted in-
frame ORF can be used to search for similarities in a protein database. Positives found to 
encode short fusion proteins of under 20 amino acids can usually be eliminated from 
further analysis; however, this decision should be made with reference to additional 
Primers Vectors
5' -TCA TCG GAA GAG AGT AG -3' pGBKT7, pGBT9, pAS1, pAS2
5' -TAC CAC TAC AAT GGA TG -3' pGADT7, pGAD10, pGAD424, pACT, pACT2
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criterion. For example, the Y2H was used to successfully identify short peptides that 
interact with a protein of interest (Yang, Wu et al. 1995).   
2.3.1.21 ONPG Test 
Ortho-Nitrophenyl-β-galactoside (ONPG) is a colorimetric and spectrometric substance 
for detection of beta-galactosidase activity. This compound is normally colorless. 
However if β-galactosidase is present, it hydrolyses the ONPG molecule into galactose 
and ortho-nitrophenol. The latter compound has a yellow coloration that can be used to 
check for enzyme activity by means of a colorimetric assay. Beta-galactosidase is 
required for lactose utilization, so the intensity of the color produced can be used as a 
measure of the rate that Beta-galactosidase can hydrolyze lactose 
Co-transform the two supposedly interacting plasmids which need to be assayed into an 
appropriate yeast strain like AH109. Prepare overnight cultures in the appropriate liquid 
SD selection medium. Vortex and transfer 2 ml of this to 8 ml of YPD medium and grow 
the cells at 30°C with shaking  (250 rpm) until they reach an OD600 of 0.5-0.8.  Transfer 
1.5 ml culture onto three 1.5 ml tubes and centrifuge at 14,000 rpm for 30 sec. Resuspend 
the cell pellet in 1.5 ml of Z-buffer, centrifuge again and finally disperse the cells in 300 
µl of Z-buffer. Note the concentration factor. Transfer 100 µl of cell suspension into a 
fresh tube and subject it to several freeze thaw cycles using liquid nitrogen for complete 
cell lysis. Set up a blank tube with 100 μl of Z buffer. Add 0.7 ml of Z buffer + β-
mercaptoethanol to the reaction and blank tubes. Immediately add 160 μl of ONPG in Z 
buffer to the reaction and blank tubes and incubate at 30°C until the development of 
yellow color. Stop the reaction by adding 400 µl of 1 M Na2CO3. Record time elapsed in 
minutes. Centrifuge reaction tubes for 10 min at 14,000 rpm and measure the OD420 of 
the supernatant against the blank using the spectrophotometer. The ODs should be 
between 0.02–1.0 to be within the linear range of the assay. 
Calculate the ß-galactosidase units using the formula β-galactosidase units = 1,000 x 
OD420 /(t x V x OD600) where: t = elapsed time (in min) of incubation, V = 100 µl x 
concentration factor and OD600 = A600 of 1 ml of culture 
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2.3.2 Rabbit Reticulocyte Lysate 
Rabbit reticulocyte lysate is a highly efficient in vitro eukaryotic protein synthesis system 
used for translation of exogenous RNAs (either natural or generated in vitro). In vivo, 
reticulocytes are highly specialized cells primarily responsible for the synthesis of 
hemoglobin, which represents more than 90% of the protein made in the reticulocyte. 
These immature red cells have already lost their nuclei, but contain adequate mRNA, as 
well as complete translation machinery, for extensive globin synthesis. 
Coupled in vitro transcription / translation 
 
Figure 4. The principle of Coupled Invitro transcription/translation 
This method is used for transcription and translation of genes cloned into appropriate 
vectors downstream from the SP6 (circular plasmid DNA), or T3 and T7 (linear DNA) 
RNA polymerase promoter. 
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Table 9. The components to be used for In vitro transcription/ translation reaction 
Rapidly thaw the components mentioned in the table at 25°C and assemble the reaction 
components together on ice. Mix them gently and incubate the reaction mixture at 30°C 
for 90 minutes. Once the translation reaction is complete, denature the proteins by adding 
SDS sample buffer and heating at 100°C for 2 minutes. Load a small aliquot of the 
denatured proteins onto a SDS-PAGE.  After electrophoresis, place the gel in a plastic 
box and cover it with fixing solution (50% methanol, 10% glacial acetic acid and 40% 
water) and agitate slowly in a shaker for 30 minutes. Now soak the gel in 7% acetic acid, 
7% methanol, 1% glycerol for 5 minutes to prevent the gel from cracking and place them 
on a sheet of Whatmann® 3MM filter paper, cover with plastic wrap and dry at 80°C for 
30-90 minutes under a vacuum using a conventional gel drier. Expose the gel on Kodak® 
X-ray film for 6-15 hours at room temperature with autoradiography.  
2.3.2.1 Co-Immunoprecipitation (Co-IP from in vitro transcripted / translated 
proteins) 
Co-IP is the technique of precipitating a protein antigen out of a solution using an 
antibody that specifically binds to that particular protein. This process can be used to 
isolate and concentrate a particular protein from a sample containing many thousands of 
different proteins and can be used to study protein-protein interaction. The SP6, T7 – 
TNT®   Lysate Reactions
Component Standard reaction Using [35S]methionine
TNT® Rabbit Reticulocyte Lysate 25µl
TNT®  Reaction Buffer 2µl
TNT® RNA Polymerase (SP6, T3 or T7; 1ml of appropriate polymerase[s]) 1µl
Amino Acid Mixture, Minus Methionine, 1mM 1µl
[35S]methionine (>1,000Ci/ mmol at 10mCi/ml) 2µl
RNasin® Ribonuclease Inhibitor (40u/µl) 1µl
DNA template(s) (0.5µg/µl) 2µl
Nuclease-Free Water to a final Volume of 50µl
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based coupled transcription and translation system, with rabbit reticulocyte lysate (TNT, 
Promega) and Easy Tag [35S] methionine-L was used to produce radiolabled proteins and 
peptides. Briefly, equal amounts of 35S labeled proteins (bait and prey) were mixed 
together in 200µl of interaction buffer (20 mM Tris (pH 8.3), 150 mM NaCL, 1% 
Nonidet P-40. 0.1% Tween 20, and 1 mg/ml bovine serum albumin or cocktail protease 
inhibitors).Each reaction was carried out in triplicate for 30 minutes on ice. Subsequently 
each reaction mixture was nonspecifically immunoprecipitated with rabbit IgG or mouse 
IgG for 1 h. Following pulling down of nonspecific immune complexes with protein A/G 
sepharose beads, supernatants were subjected to co-immunoprecipitation with specific 
primary antibodies (anti-myc or anti-HA, anti E2-2). Immnune complexes were pulled 
down with protein A/G beads. Beads were washed 5 x with interaction buffer, suspended 
in SDS sample buffer, heated at 75°C for 10 min, and loaded on SDS-PAGE for analysis. 
Following electrophoresis, the gels were fixed, dried and subjected to autoradiography 
either at -80°C overnight or 6-10 h room temperature. 
2.3.3 Phenol: Chloroform Purification of DNA 
20-30µgs of plasmid DNA to be purified was diluted in 100 µl water. To this, 60 µl of 
Phenol: chloroform mixture was added and vortexed. Centrifuge for 1 min at max speed 
and transfer the upper phase to a new eppi. Add 50 µl of chloroform to the upper phase 
and vortex. Centrifuge for 1 min at max speed and transfer the upper phase to a fresh 
eppi. Measure the upper phase volume. Add 2.5 volume (of upper phase) of ice cold 
ethanol (-20°C) and 0.1 volume of 3 M sodium acetate pH 5.2 and incubate for 20 min -1 
h at -80°C. Remove and centrifuge for 5 min at max speed. Discard the upper phase. Add 
50 µl of ethanol to the pellet, centrifuge, remove supernatant and air dry. Resuspend 
purified DNA pellet in 20-30 µl water and measure the concentration using nano drop or 
spectrophotometer. 
2.3.4 Sequencing of plasmids 
Sequencing was carried out using an automated DNA sequencer based on the principle of 
chain terminating inhibitors (Sanger, Nicklen et al. 1977) using ABI PRISM TM system. 
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Reaction mix: 
Ready reaction premix (DNA polymerase, dNTPs, fluorescent marked ddNTPs) – 4 µl 
5 x Big dye sequencing (Terminator) buffer  – 2 µl 
Primer - 10 pmol 
Template – (200ng -1µg) depends on the template used 
The reaction mixture were amplified in the thermocycler       
 
 
       25 x 
 
 
95°C   (Denaturation)  
 
30 sec 
  
37 – 60°C (annealing - varies with the primers used) 
 
30 sec 
 
60°C (extension)     
 
4 min 
Table 10. The thermocycling reaction performed using the PCR 
Annealing temperature is calculated using the formula Tm = 4(G + C) + 2(A + T) oC. 
Preparation of reaction mix for sequencing: 
To the reaction mixture add 5 µl of 125 mM EDTA, followed by 75 µl of 100% ethanol 
in an eppi. Mix them by inverting the tube several times. Incubate at room temperature 
for 15 min in dark. Centrifuge at 13000 rpm at room temperature for 15 min and carefully 
remove the supernatant. Add 200 µl of 70% Ethanol and incubate for 5 min at room 
temperature. Centrifuge, discard supernatant and air dry the pellet. The pellet is finally 
dissolved in 12 µl TSR sequencing buffer and denatured for 2 min by the automatic 
sequencer. 
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2.3.5 Western Blot 
Western Blot is an analytical method that involves the immobilization of proteins on 
membranes before detection using monoclonal or polyclonal antibodies. Concentration of 
protein samples were measured using the standard Bradford assay. The proteins were 
dissolved in SDS sample buffer and denatured at 95°C for 3 min or 75°C for 10 min. The 
samples were loaded on a SDS - polyacrylamide gel (NuPAGE 4%-12% bis-tris, 
Invitrogen) and subjected to electrophoresis for 90 min. Depending on the experiment 
proteins can also be visualized without blotting by doing a Coomassie staining. The 
proteins were then wet transferred to a nitrocellulose membrane by blotting them for 2 hr 
at 30 V. The membrane is then washed with water and a red alert staining is performed to 
visualize the protein bands which confirm the proper transfer of the proteins onto the 
nitrocellulose membrane. The membrane is then washed for 30 min in TBS buffer 
followed by blocking the membrane with 3% milk powder prepared in TBST for 1 hr at 
room temperature with gentle agitation. The membrane is then incubated with the 
respected primary antibodies specific to the proteins (diluted in 3% milk powder-TBST) 
either 1 hr at room temperature or overnight at 4°C. Wash the membrane 5x 5 min in 
TBST and add the secondary antibody diluted 1:5000 – 1:10000 (HRP conjugated anti 
mouse IgG or anti rabbit IgG) and incubate the membrane for 45 min at room 
temperature. The membrane is then washed 5 x 5 min in TBST and the proteins were 
detected using chemiluminescent detection system (Super Signal ® West Femto, Pierce).      
2.3.6 Cloning strategies 
All plasmids were cloned either by subcloning into another factor in frame or by PCR 
amplification. After PCR amplification with Taq Polymerase (Eppendorf) or Expand 
High Fidelity Polymerase (Roche) and specific primers (see 3.1.7.1), fragments were 
cloned into the pGEM-T-vector (Promega), pCR TOPO 2.1 or pCR TOPO II 
(Invitrogen). After digestion with restriction endonuclease enzymes, positive clones were 
analyzed using agarose gel electrophoresis to verify the proper length of the insert and 
vector and finally were sequenced using primers from both sides. All sequencing 
reactions were prepared with ABI 310 Genetic Analyzer sequencer (Perkin Elmer). After 
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verification of the clones, fragments were cut out with restriction enzymes and subcloned 
into the target vectors. All sequence and alignments were prepared using data bases at 
www.ncbi.nih.gov BLAST 
2.3.7 Cell culture  
Frozen C2C12 or HEK 293 or 10T1/2 cells were rapidly thawed in 37°C bath and 
distributed into 10 ml of DMEM (Dulbecco’s Modified Eagle’s Medium) with 1% 
glucose, 1% penicillin/streptomycin and 10% FCS (Fetal calf serum) in a 100 mm tissue 
culture dish (Nunc). Incubate cells at 37°C in 10% CO2. The medium is changed after all 
cells have adhered. Cells were routinely split 1:5 – 1:10 when they get dense, usually 
every 2 days. C2C12 cells should not be allowed to reach confluence as they will begin to 
differentiate, even in normal growth media. Cells are usually grown to about "70% - 
80%" confluence. Cells were fed every alternate days.. 
 To differentiate C2C12 cells, they were allowed to grow to about "90%" confluence. 
Switch dense cells into DM (differentiation medium) and feed every day. Ideally, the 
cells should be plated on collagen coated dishes before differentiating (for better 
adherence of the myotubes). In a healthy culture, one must see some spontaneous 
twitching of the myotubes. To get maximum differentiation of C2C12 cells, they can be 
treated with AraC (10 mM) when switched into DM to eliminate dividing cells. This 
keeps the myoblasts from crowding out the myotubes, and allows a myotube culture to be 
maintained for about 2 weeks. 
2.3.7.1 Culture of primary chicken myocytes 
Chicken eggs were bought from the farmer and kept in the incubator at 37°C with timely 
rotations for the proper orientation of the embryos. Fertilized chicken embryos that were 
11 – 13 days old were cleaned with 70% ethanol and placed on a small beaker with its 
round side facing upwards. The shell was carefully broken and the embryo was taken out 
with a forceps and decapitated. The thin outer skin near the breast muscle was carefully 
removed. Small pieces of tissue of the breast muscle was picked with sharp forceps and 
suspended in DMEM with 10% FCS. This procedure was repeated with all the embryos 
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and finally the muscle tissues were pooled together. Mince them into as small pieces as 
possible with the help of micro scissors. Transfer the tissue along with the medium to a 
50 ml falcon tube and homogenize by pipetting up and down. Centrifuge at 1000 rpm for 
5 min. Discard the supernatant carefully and add 0.25% trypsin without EDTA (Gibco) 
and incubate at 37°C for 15 min. Repeat this procedure if the cells are not completely 
dissociated. Pass the cells through a 100 micron nylon filter (BD Bioscience) and add 
primary culture medium (DMEM + 10% horse serum + 2% chicken embryo extract) and 
plate the cells densely. The medium is changed the following day and the cells are set for 
transfection using the CaCl2 method. 
2.3.7.2 Primary chicken Cardiomyocytes 
 Embryonic chick cardiomyocytes were isolated using a method (Budinger, Chandel et al. 
1996) modified from (Barry, Pober et al. 1980). Briefly, hearts were removed from 11-
day-old chick embryos and washed in Hanks' balanced salt solution lacking magnesium 
and calcium (Life Technologies). The ventricular tissue was minced and then dissociated 
using 4-6 cycles of trypsin (0.025%, Gibco) digestion with gentle shaking at 37°C. After 
8 min, the trypsin digestion was stopped by transferring the cells to a trypsin inhibitor 
solution. The cells were then filtered (100-µm mesh), centrifuged for 5 min at 1,200 rpm 
at room temperature, and resuspended in growth medium with 6% heat-inactivated fetal 
bovine serum, penicillin (100 U/ml), and streptomycin (100 mg/ml). Cells were preplated 
for 45 min on a petri dish in a humidified incubator (5% CO2-95% air at 37°C) to 
promote early adherence of fibroblasts. The nonadherent cells were counted with a 
hemacytometer, and their viability was assessed using trypan blue (0.4%). Approximately 
1 × 106 cells in nutritive medium were plated onto glass coverslips (25 mm) in 
35 × 10 mm dishes. Cells were maintained in a humidified incubator for 2-3 days, at 
which time synchronous contractions of the monolayer of cells were noted though not 
always. 
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2.3.7.3 Cell stocks 
Cells were trypsinized and then spun down. Cells were resuspended in DMEM (500 µl 
per 100 mm dish) containing 20% FCS. Now DMSO was added slowly and finally 
accomplished by adding to the resuspended cells an equal volume of DMEM containing 
20% fetal calf serum and 20% DMSO. Cells were placed in a well-insulated box that has 
been pre-chilled in the freezer and put the box in the -70°C freezer overnight. Transfer 
the cells to liquid nitrogen the following day for long term storage. 
2.3.8 Transfection  
Transfection is the process of introducing nucleic acids into cells by non-viral methods. 
Cells were grown to 40-50% confluence and the medium was changed 2 – 4 hr before 
transfection. Cells were transfected either using FuGENE 6 transfection reagent (Roche) 
or CaCl2 method. In the CaCl2 method method, CaCl2 was pipetted to the eppi containing 
DNA. Now 2 x HEPES buffer was added dropwise with simultaneous mixing. The 
mixture was incubated for 15-20 min at RT for precipitate formation. This precipitate was 
added to the cells slowly with constant mixing for even distribution. Cells were incubated 
at 37°C for 6-8 hr. Then cells were washed with serum free medium and exposed to 
glycerol shock buffer (3 parts glycerol 15%, 7 parts water, 10 parts 2 x HEPES) for 1-3 
min. Wash the cells with serum free medium and finally add the respected growth 
medium and incubate at 37°C for 24-48 hr. Cells are later lysed for protein extraction or 
fixed to make immnunocytochemistry. 
In the FuGENE system, the FuGENE reagent was directly added to the medium, mixed 
and incubated for 5 min at room temperature. Plasmid DNA was added to this mixture 
and incubated for 15 min at room temperature. Remove culture dish from the incubator 
and add the transfection reagent: DNA complex to the cells in a drop-wise manner. Swirl 
the dish to ensure even distribution. Cells were incubated for 24-48 hr for protein 
expression. 
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2.3.9 Immunocytochemistry  
Immunocytochemistry is a common lab practice which uses antibodies that target specific 
peptides or protein antigens in the cell via specific epitopes. Cells were washed with PBS 
and fixed with 4% PFA (Para formaldehyde) for 15 min at room temperature. Wash them 
with PBS. Fixed cells were permeabilized with 0.01% triton X-100 for 15 min and 
washed again with PBS. Add blocking buffer (1% BSA in PBS) and incubate the cells for 
30 min at room temperature. Add antigen specific primary antibody diluted in 1% BSA-
PBS and incubate the cells for 1 hr at room temperature. Wash the cells 3-5 timed with 
PBS. Now add the biotinylated secondary antibody (anti rabbit IgG or anti mouse IgG) 
and incubate for 45 min. Add Dapi to a final dilution of 1:2000 and incubate the cells for 
10 min. Wash the cells 3-5 times with PBS. Finally the cells were washed with water (to 
remove the salts) and air dried. The cover slips were mounted on glass slides with moviol 
for microscopic imaging of the expressed proteins. 
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3. Results 
3.1   Expression of the transcriptional co-activator VITO1 
in different cell types 
Previous studies showed that VITO1 is a skeletal muscle specific gene expressed in the 
somatic myotome from E8.75 of mouse embryonic development and its transient domain 
expression during embryogenesis was found in the branchial arches, Pharyngeal pouches 
and clefts, cranial pharynx and Rathkes pouch (Mielcarek, Gunther et al. 2002). VITO-1 
was identified as the first known co-activator of TEFs (Gunther, Mielcarek et al. 2004), 
which modulates transcription enhancer factors’ activity in a tissue specific manner. To 
analyze and compare the subcellular localization in different cell types, VITO-1 was 
over-expressed in HEK 293, C2C12 and CH10T1/2 cell line. 
 
3.1.1 Over-expression of VITO-1 in HEK 293 cell is predominantly 
cytoplasmic 
Human Embryonic Kidney 293 cells, also often referred to as 293 cells, are a specific cell 
line originally derived from human embryonic kidney cells grown in cell culture. HEK 
293 cells are very easy to grow and transfect very readily and have been widely-used in 
cell biology research for many years. They are also used by the biotechnology industry to 
produce therapeutic proteins and viruses for gene therapy.  
To investigate the expression of VITO-1 in HEK 293 cell line, VITO-1 was ectopically 
expressed by transfection using FuGene 6 reagent. Different concentration of the plasmid 
DNA ranging from 0.5 to 2 µg was tested to optimize for higher transfection efficiency. 
Using 1 µg of VITO-1 dsRed along with 3 µl of Fugene reagent in serum free DMEM, 
HEK 293 cells were transfected and incubated for 12 hr in serum free medium. The 
medium was later changed to growth medium i.e. DMEM with 10% FCS and antibiotics 
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and the cells were further incubated until 24 hr. The cells were fixed with 4% PFA at two 
different time points, 24 hr and 48 hr. The nucleus was stained using Dapi.  After 24 hrs 
of transfection, VITO-1 dsRed showed a cytoplasmic distribution (Fig. 5A). Even after 
48 hrs, VITO-1 still remained in the cytoplasm showing no nuclear localization (Fig. 5C).  
Although VITO-1 is a co-activator of TEFs, this cytoplasmic distribution may be 
attributed to the absence of endogenous VITO-1 or   TEFs. 
 
 
Figure 5.  Subcellular localization of Vito1 (red) in HEK 293 cell line. 
 VITO-1 DsRed was transfected in HEK 293 cells using Fugene 6 reagent to see the 
expression pattern. (A) Cells expressing VITO-1 showed a cytoplasmic distribution after 
24 hrs of transfection. (C) After 48 hrs of transfection, VITO-1 still remained in the 
cytoplasm. Nuclei were stained with dapi.  
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3.1.2 VITO-1 shows a predominant nuclear localization in C3H-10T ½ 
cell line  
The clonal mouse embryo cell line, C3H/10T1/2, clone 8 (10T1/2) provides a unique 
opportunity to examine the molecular genetic regulation of both the developmental 
determination of vertebrate stem cell lineages and their subsequent differentiation. 
10T1/2 is an apparently multipotential cell line that can be converted by 5-azacytidine 
(Constantinides, Jones et al. 1977) into three mesodermal stem cell lineages. Since these 
cells have the ability to differentiate into muscle cells on external stimulation, we decided 
to test the expression of VITO-1 in these undifferentiated cells.  
VITO-1 DsRed was transfected using Fugene 6 and Calcium phosphate to test different 
concentrations of plasmid DNA to optimize the transfection efficiency. Since FuGene 6 
yielded a better efficiency with 1.3 µg of DNA in 6 well plates, VITO-1 DsRed was 
transfected by this method and incubated for 18 hrs in Serum free DMEM without any 
antibiotics. Afterwards the medium was replaced with DMEM containing 10 % FCS and 
antibiotics (penicillin/streptomycin). Cells were fixed with 4% PFA and permeabilized 
using 0.05% Triton. To score for any cytoskeletal changes, microtubules were stained 
using mouse α – tubulin (1:500) as the primary antibody and detected by Alexa 488 
(1:1000) as the secondary antibody (Fig. 6B, 6F). The nuclei were stained with dapi (Fig. 
6C, 6G) and the cells were mounted on glass slides for microscopic analysis.  
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Figure 6. Distribution of VITO-1-DsRed overexpressed in C3H-10T1/2 fibroblast cell 
line. Expression of VITO-1 dsRed at different time points after transfection. (A) After 24 
hrs VITO-1 is distributed uniformly all over the cells. (E) But after 48 hrs, VITO-1 
localizes primarily to the nucleus (histograms represent quantitation using Image J 
software) although some punctated cytoplasmic distribution could be seen. (B, F) 
Microtubules were stained for α-tubulin as a control for normal cytoskeletal organization 
in cells expressing VITO-1. (C, G) Nuclei were visualized using Dapi staining. 
 
After 24 hrs of transfection VITO-1 was localized all over the cells showing diffused 
expression in the cytoplasm (Fig. 6A). After 48 hrs, VITO-1 translocated into the nucleus 
and showed more than 70% nuclear intensity (Fig. 6D). The corrected total cell 
fluorescence (CTCF) was quantitated using Image J software.  
CTCF = Integrated Density – (Area of selected cell X Mean fluorescence of 
background readings) 
This translocation into nucleus could possibly be due to the presence of endogenous 
TEFs or other regulatory molecules, which facilitate nuclear translocation of VITO-1. 
3.1.3 VITO-1 Localizes prominently in the nucleus of undifferentiated 
C2C12 cells 
C2C12 cell line is a subclone of the mouse myoblast cell line established by D. Yaffe and 
O. Saxel. The C2C12 cell line differentiates rapidly, forming contractile myotubes and 
producing characteristic muscle proteins. Care should be taken not to allow the cells to 
become confluent as this will deplete the myoblastic population in the culture. 
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Diffentiation and myotube formation of C2C12 cells is stimulated when the medium is 
supplemented with 2% horse serum instead of FCS. 
Northern blot analysis using RNA from C2C12 cells had revealed the presence of m-
VITO-1 RNA in proliferating C2C12 cell indicating expression of the gene in dividing 
myoblasts that have not yet undergone terminal differentiation (Mielcarek, Gunther et al. 
2002). The expression level in C2C12 myoblasts was lower compared to differentiated 
C2C12 myotubes.  
To investigate the localization of VITO-1 in C2C12, cells were cultured on 6 well 
fibronectin coated plates and transfected with 0.8 µg of VITO-1 pEGFPc2 using FuGene 
6 reagent. After transfection, cells were incubated with serum free medium without 
antibiotics for 8 hrs after which the medium was replaced with DMEM containing 10% 
FCS and penicillin/streptomycin). Cells were fixed with methanol-acetone for 10 min and 
the nucleus was stained with Dapi.  
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Figure 7. Expression of VITO-1 (green) in undifferentiated C2C12 muscle cell line. 
VITO1-GFP was transfected into C2C12 cells using Fugene 6 and the distribution 
pattern was monitored at different time points. (A) After 12 hrs, VITO1 show a puntacted 
distribution all over the cytoplasm in most of the cells. (C) After 24 hrs, VITO1 is 
distributed both in the cytoplasm as well as the nucleus. (E) After 48 hrs, VITO1 is 
associated prominently in the nucleus which supports its role as a transcriptional co-
activator.  
 
After 12 hrs of transfection, VITO-1-GFP was found predominantly in the cytoplasm in a 
punctuated pattern in most of the cells although some cells still show a weak nuclear 
localization (Fig. 7A). In 24 hrs, one can observe the distribution of VITO-1 both in the 
nucleus as well as in the cytoplasm (Fig. 7C). After 48 hrs, VITO-1 completely 
translocates into the nucleus (Fig. 7E). VITO-1 shows an endogenous expression in 
undifferentiated C2C12 myoblasts and the localization of VITO-1 in the nucleus could 
support its possible role as a co-activator where it might interact with TEFs or other 
transcriptional factors that are involved in the terminal differentiation of muscle cells and 
control gene regulation. 
3.1.4 Expression of VITO-1 in differentiated C2C12 myotubes 
Proliferating C2C12 cells can be triggered to differentiate into myotubes by culturing 
them in low growth factor medium when they are confluent. To monitor the expression of 
VITO-1 in differentiated myotubes, a GFP tagged fusion plasmid (VITO-1-pEGFP-c2) 
was used. C2C12 (mouse myoblast cell line) cells were grown on 6 well plates in DMEM 
containing 10% FCS and Penicillin/Streptamycin (P/S) antibiotics. When the cells 
reached 60% confluence, they were transfected with 2 µgs of the plasmid VITO-1-GFP 
using FuGENE 6 reagent and incubated for 48 hrs. When the cells reached ~ 100% 
confluence, the medium was replaced with DMEM containing 2% Horse serum. Cells 
were allowed to differentiate for 4 – 5 days until the formation of multinucleated mature 
myotubes. Later the cells were fixed with 4% PFA and the nuclei were stained with 
DAPI. The cover slips containing the fixed cells were visualized using a fluorescence 
microscope. 
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Figure 8. Over expression of VITO-1 in matured myotubes of C2C12 cells. The top four 
panels show the expression of VITO-1-GFP in C2C12 cells after differentiation into 
myotubes. Nuclei were stained using Dapi (bottom panels).  
 
VITO-1-GFP was predominantly expressed in differentiated myotubes (Fig. 8 top panels) 
indicating that cells expressing VITO-1 showed an increased property to form myotubes 
compared to their neighboring untransfected cells which did not form the mature 
myotubes. These findings show that VITO-1 might play an important role in association 
with transcription factors to facilitate terminal differentiation of muscle cells.  
3.1.5 Expression of mutant VITO-1 constructs in C2C12 cells shows the 
requirement of SID domain to translocate to the nucleus. 
VITO-1 mediates interaction with TEFs and other proteins through its scalloped 
interaction domain (SID) [(Gunther, Mielcarek et al. 2004)]. We hypothesized that, 
VITO-1 lacking the SID domain may not interact with TEFs or probably may not 
associate with other proteins, thus losing its functional properties. To provide further 
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evidence of the importance of SID domain, a mutant construct lacking the SID domain 
was fused to IRES-GFP (VITO-1 Δ SID-GFP). This construct was transfected into 
C2C12 cells plated in 6 well chambers with 1 µg of plasmid DNA using the FuGene 6 
reagent and were fixed using 4% PFA. After 48 hrs of transfection, full length VITO-1 
was mainly expressed in the nucleus (Fig. 9A). VITO-1 lacking the SID domain did not 
translocate into the nucleus even after 48 hrs and displayed a prominent cytoplasmic 
localization (Fig. 9B). The corrected total cell fluorescence (CTCF) was quantitated using 
Image J software.  
 
 
 
 
Figure 9. Sub cellular localization of VITO-1 mutant in C2C12 cells. 
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 (A) Full length VITO-1-GFP localized mainly in the nucleus after 48 hrs of transfection. 
(B) VITO-1 mutant lacking the SID domain (VITO-1∆ SID-GFP) is distributed 
throughout the cells with prominent punctated pattern. (Histograms represent total cell 
fluorescence quantitated using Image J software) 
 
The results demonstrate the SID domain of VITO-1 is instrumental for an efficient 
translocation into nuclei where it may act as a transcriptional co-activator to regulate 
expression of target genes. 
3.2 Over-expression of TEF3 together with VITO-1, results in a 
complete recruitment of VITO-1 into the nucleus in various cell types 
The expression of VITO-1 was analyzed in various cell types like C2C12, HEK293 and 
10T1/2 in the presence of TEF3. VITO-1 – GFP was co-transfected with TEF3-pCDNA5 
in an equimolar ratio using the FuGene 6 reagent. After 48 hrs of transfection, cells were 
fixed with 4% PFA and nucleus was stained by DAPI. VITO-1 when transfected alone in 
these cell lines did not completely localize in the nucleus. After 24 hrs of co-transfection, 
VITO-1 still remained in the cytoplasm in most of the cells and did not show much 
difference with cells transfected with VITO-1 alone. But interestingly after 48 hrs, VITO-
1 was completed translocated into the nucleus in all cell types including HEK 293 cells 
(Fig. 10). It should be noted that VITO-1 transfected alone never showed a nuclear 
expression (Fig. 5). This is probably due to the association of VITO1 with the 
transcription factor TEF3 during translocation into the nucleus. The endogenous 
expression of TEF transcription factor seems not sufficient to drag over-expressed VITO-
1 into the nucleus. 
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Figure 10. Full length VITO-1 translocates completely into the nucleus in the presence 
of TEF3 in different cell types. 10T1/2, C2C12 and HEK 293 cells were trasnfected with 
VITO-1-GFP and TEF3. In the presence of TEF3, VITO-1 completely translocated to the 
nucleus in all three cell types. Nuclei were stained with Dapi. 
 
The next important question was whether VITO-1 lacking the SID domain translocates 
into the nucleus in the presence of TEF3.  To investigate this, VITO-1 Δ SID-GFP was 
co-transfected in C2C12 cells with TEF3 in an equimolar concentration with a total DNA 
concentration of 1.5 µg using FuGene 6 into cells plated in 6 well chambers. 
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Figure 11. Subcellular localization of VITO-1ΔSID-GFP in the presence of TEF3.  
VITO-1ΔSID-GFP is distributed all through the cell and not restricted to nuclear 
compartment alone.  
 
Cells were fixed and stained as stated previously and visualized in the microscope. It 
should be noted that after 48 hrs of transfection, cells expressing VITO-1 Δ SID-GFP did 
not completely translocate into the nucleus even in the presence of TEF3 (Fig. 11). This 
shows the requirement of the SID domain to activate TEF3 and its downstream target 
genes. These findings underline the importance of the SID domain in mediating 
interaction of VITO-1 with other proteins such as TEF3. 
3.3 Screening for novel interacting partners of VITO-1 
using the Yeast Two Hybrid (Y2H) system 
The yeast two-hybrid system is a versatile method to identify new interaction partners of 
individual proteins. To identify additional binding partners of VITO-1 which are involved 
in skeletal muscle regulation and other important biological processes, the yeast two 
hybrid method was chosen. The yeast two-hybrid system is an invaluable tool for the 
successful identification of novel protein–protein interactions, both in standard laboratory 
screens and in high-throughput automated formats.  
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Figure 12. Sequence of the GAL4 DNA-BD recognition sites in the GAL1, GAL2, and 
MEL1 UASs and the UASG 17-mer consensus sequence (Giniger and Ptashne 1988) 
 
The screening is based on the GAL4 UASs system in which either an intact GAL1, GAL2 
or MEL1 UAS or an artificially constructed UAS consisting of three copies of the 17-mer 
consensus binding sequence, is used to confer regulated gene expression on the reporter 
genes.  
The yeast strains Saccharomyces cerevisiae AH109 (MATa, trp1-901, leu2-3, 112, ura3-
52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-
ADE2, URA3::MEL1UAS-MEL1TATA-lacZ, MEL1) and Y187 (MATα, ura3-52, his3-200, 
ade2-101, trp1-901, leu2-3, 112, gal4Δ, met-, gal80Δ, URA3::GAL1UAS-GAL1TATA-lacZ, 
MEL1) were employed as hosts in the two-hybrid assay. AH109 contains 2 nutritional 
reporter genes for adenine and histidine. Both AH109 and Y187 harbor the LacZ reporter 
gene. The HIS3 reporter of the AH109 and the LacZ reporter of Y187 are all tightly 
regulated by the intact GAL1 Promoter (including the GAL1 UAS and GAL1 minimal 
promoter). The ADE2 reporter of AH109 is tightly regulated by the intact GAL2 
promoter, whose induction properties are similar to those of the GAL1 promoter. In 
AH109, LacZ is under the control of the MEL1 UAS and minimal promoter. 
VITO-1 (1 – 291 amino acids) was cloned into the pGBKT7 vector containing the cMyc 
epitope tag (Bait) and the plasmid was expressed in the yeast strain AH109. A human 
skeletal muscle library was used as the Prey as VITO-1 expression is confined to skeletal 
muscle tissue. The library was already cloned into the protein-encoding sequence of 
pGADT7 containing a HA epitope tag and pre-transformed into the Y187 strain. 
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           - MatchmakerTM Library Construction & Screening kits user manual (modified) 
 
Figure 13. Overview of the Y2H screen for identifying potential VITO-1 interacting 
target genes. Vito1 was cloned into the DNA binding vector pGBKT7 and transformed 
into AH109 strain. The human skeletal muscle cDNA library was already cloned into the 
AD vector pGADT7 and pretransformed into the Y187 strain. These pretransformed 
plasmids were subjected to overnight mating and were plated the following day onto 
plates containing nutritional selection markers which allows the growth of colonies 
(clones) expressing the reporter genes. These clones were confirmed positive after doing 
an X-α-Gal assay or a ß-Gal colony lift filter assay. 
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3.3.1 Detecting expression of VITO-1 in yeast cells 
After generating the bait plasmid (VITO-1-pGBKT7), expression levels in yeasts were 
tested by western blot. For this, VITO-1 pGBKT7 was transformed into the AH109 strain 
and plated on agar plates lacking -Trp. Liquid cultures were prepared by inoculating a 
single colony and grown at 30°C with shaking (250 rpm) until the OD600 reaches 0.4-
0.6. Cells were centrifuged and the pellet was either stored at -80°C or proceeded with 
protein extraction. 
Proteins from yeast cannot be extracted simply by boiling or sonication. Protein was 
extracted by the Urea/SDS method as described in materials and methods. The extracted 
sample was loaded on a SDS PAGE and electro blotted onto nitrocellulose membrane. 
The protein was detected using c-myc monoclonal antibody against the c-myc epitope tag 
of pGBKT7 vector. 
 
Figure 14. Expression of VITO-1-pGBKT7 transformed into AH109. Proteins 
trsnaformed into yeast were extracted and a western blot was performed to test its 
expression level. pGBKT7-53 was used as a positive control 
 
VITO-1 could be detected as a 33 kD protein (Fig.14) which confirmed its expression. 
pGBKT7-53 that expresses a 57 kD protein was used as a positive control (Fig. 14). 
Before proceeding for screening, the bait was tested for toxicity and auto-activation of the 
reporter gene. 
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3.3.2 Testing bait for Toxicity 
It is important to demonstrate that the bait protein is not toxic when expressed in yeast. If 
the bait is toxic to the yeast cells, both solid and liquid cultures will grow more slowly.  
To test if VITO-1 is toxic to yeast cells, 0.1 µg of empty pGBKT7 and VITO-1 pGBKT7 
were transformed into the AH109 strain and 100 µl was plated on SD/ -Trp agar plates 
with 1:10 and 1:100 dilutions. Plates were grown at 30°C for 3-5 days. 
If VITO-1 (Fig. 15B) is toxic, then one should notice the colonies significantly smaller 
compared to the control empty pGBKT7 vector (Fig. 15A), which was not the case. 
 
 
 
 
 
Figure 15. VITO-1 is not toxic when expressed in yeast. VITO-1(B) and empty pGBKT7 
vector (A) was transformed in yeast and plated at dilutions of 1:100. The colony size of 
VITO-1 is similar to the control which indicates its non-toxicity to grow in yeast cells. 
 
3.3.3 Testing VITO-1 for Auto-activation 
To maximize sensitivity of the HIS3 reporter gene, the AH109 strain already expresses a 
basal level of HIS3. Additionally, bait proteins often contain a certain level of 
transcriptional activity. This is enough to initiate some transcription at the most sensitive 
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reporter in the system, HIS3. Moreover VITO-1 being a transcriptional co-activator, it is 
very important to check for auto-activation of the reporter gene and to delete this property 
before initiation of the screen.  
 
To test for auto-activation of VITO-1, 0.1 µg of plasmid DNA was transformed into 
AH109 and mated with empty AD vector pGADT7 in Y187 strain without the prey and 
were plated on SD/-Leu-Trp and SD/-Leu-Trp-His agar plates and incubated for 3 days at 
30°C. Slight growth of the yeast colony was noticed in SD/-Leu-Trp-His agar plates 
which showed auto-activation by VITO-1 as confirmed by β-galactosidase assay.  
 
HIS3 encodes an enzyme involved in histidine biosynthesis, which can be specifically 
inhibited in a dose-dependent manner by 3-Amino-1,2,4-Triazole (3AT). The 
concentration of 3-AT was determined empirically and included in plates lacking 
histidine, such that even slight increases in HIS3 reporter gene expression are detected. 
This will enhance the probability of detecting weak protein-protein interactions. To 
suppress the auto-activation of VITO-1, colonies from SD/-Leu-Trp were replica plated 
onto SC-Leu-Trp-His plates containing 3AT at concentrations of 0 mM, 10 mM, 25 mM, 
50 mM, 75 mM, and 100 mM (Fig. 16) and the plates were incubated for 3-5 days at 
30°C. 
 
 
 
 
 
 
Figure 16. Reporter gene auto-activation test for VITO-1.  
10mM concentration of 3AT was sufficient to suppress the auto-activity of the reporter 
gene by VITO-1. This concentration of 3-AT was used forVITO-1 in all further yeast 
experiments. 
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The lowest concentration of 3AT that inhibits the growth of the cells from transformation 
(containing bait and pGADT7) is the basal amount of 3AT added to all plates lacking 
histidine. It was found that 10 mM of 3 AT was sufficient to inhibit the auto-activation of 
the reporter genes by VITO-1 and subsequently this concentration was used for all future 
experiments during screening.  
3.3.4 Two-Hybrid Library Screening Using Yeast Mating 
Screening was performed as described in materials and methods. A concentrated 
overnight culture of the bait strain VITO-1 pGBKT7 was prepared by inoculating a fresh 
large colony (2-3 mm) in SD/-Trp  and incubate shaking (250–270 rpm) at 30°C until the 
OD600 reached 0.8 (16–20 hr). Cells were harvested and resuspended at a density of > 
1x108 cells per ml in SD/–Trp (5 ml). The 1 ml skeletal muscle cDNA library strain pre-
transformed in Y187 was thawed and combined with the bait strain together with 45 ml 
of 2xYPDA liquid medium (with 50 μg/ml kanamycin) under aerobic conditions and 
incubated at 30°C for 20–24 hr with slowly shaking (40 rpm). 
VITO-1 pGBKT7 in MAT α AH109 was mated with human cDNA skeletal muscle 
library-pGADT7 in MAT α Y187. Co-culturing the two strains overnight produces an 
array of diploid yeast clones, each co-expressing the bait with a different library prey 
protein.  
                              
                        
Figure 17. Formation of diploid yeast clones during mating as seen under the light 
microscope. 
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The mated culture (100 μl) was spread with dilutions of 1/10, 1/100, 1/1,000, and 
1/10,000 dilutions on SD/–Trp, SD/–Leu, SD/–Leu/–Trp (DDO) and SD/-Trp/-Leu/-His 
and incubated for 5 days at 30°C. The number of screened clones (diploids) was 
calculated by counting the colonies from the DDO plates after 5 days. 
• Number of Screened Clones = cfu/ml of diploids x resuspension volume (ml) 
 In the case of VITO-1, 23 colonies grew on the 1/1,000 dilution on DDO plates. 
 
Number of clones screened for VITO-1 = 23 x 11.5 x 10 x 1,000 = 2.65 million 
     
The mating efficiency (percentage of diploids) was calculated as follows 
No. of cfu/ml of diploids/No. of cfu/ml of limiting partner x 100 = % Diploids 
 
• No. of cfu/ml on SD/–Leu = viability of the Prey Library (1.4 x 107) 
        (140 colonies grew on the 1/10,000 dilution on SD/–Leu) 
 
• No. of cfu/ml on SD/–Trp = viability of Bait (1.8 x 108) 
    (1800 colonies grew on the 1/10,000 on SD/–Trp) 
 
• No. of cfu/ml on SD/–Leu/–Trp = viability of diploid (3.4 x 105) 
    (34 colonies grew on the 1/1,000 dilution on DDO plates) 
Since the Prey Library was the limiting partner in this screen,  
 Mating efficiency is (3.4 x 105 / 1.4 x 107) x 100 = 2.42 %  
3.3.5 High stringency selection of VITO-1 clones 
The VITO-1 clones obtained from SD/-Trp/-Leu/-His are the ones that express the 
appropriate reporter genes and markers, indicating the presence of interacting hybrid 
protein pairs. However these clones might also contain false positives which can further 
be eliminated by selecting them using high stringency conditions. This was achieved by 
replica plating the clones onto SD/-Trp/-Leu/-His/-Ade (QDO) which provides a tight 
control to select positive clones that activate both HIS3 and ADE2.  
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These VITO-1 clones were further confirmed positive by subjecting them to either X-α- 
Galactosidase assay or a ß-Galactosidase colony lift filter assay.  
 
 
Figure 18. Interaction of Vito1-pGBKT7 with the skeletal muscle cDNA library clones 
by (A) X-alpha-Gal and (B) ß-galactisodase colony lift filter assay. 
 (A) - Yeast strains producing alpha-galactosidase the chromogenic substrate X-alpha-
Gal can be used to assay GAL4-based two-hybrid interactions directly on the nutritional 
selection plates which gives a quick report about the protein-protein interactions 
(B) - ß-galactisodase colony lift filter assay to confirm the interaction of VITO-1 with its 
partner clones as identified by the activation of HIS reporter gene. The ß-galactosidase-
producing colonies were identified by aligning the filter and the agar plate using the 
orientation marks. ß-galactocidase assay is 10 times more sensitive than X-α-gal assay 
and hence can be used to identify even weak interactions between the bait and its 
partners. 
 
In yeast, alpha-D-galactoside galactohydrolase, an enzyme encoded by the MEL1 gene is 
regulated by several GAL genes. Secretion of this enzyme in response to GAL4 activation 
leads to hydrolysis of X-α-Gal in the medium causing yeast colonies (positives) to 
develop a blue colour. A big advantage of this reporter system is that the result can be 
X-alpha-GAL ß-GAL colony lift filter 
A B 
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seen immediately on the selection plates (Fig. 18A). The ß-gal colony lift filter assay is 
much more sensitive than X-α-Gal assay and is used to measure ß-galactosidase activity 
to screen large number of cotransformants that survive the HIS3 growth selection. This 
assay is particularly useful when the cells to be assayed contain one or only a few copies 
of the lacZ reporter gene. (Fig. 18B) shows the positive clones of VITO-1 after ß-gal 
colony lift filter assay. 
3.3.6 Novel interaction partners of VITO-1 
From a total of 79 clones obtained after screening for VITO-1, 48 clones were identified 
truly positive as identified by X-α-Gal and ß-gal colony lift filter assay. The clones are a 
mixture of both Gal4 DBD and Gal4 AD plasmids. DNA was extracted from these yeast 
clones and was transformed into E.coli and plated on ampicillin plates to select for Gal4 
AD (pGADT7) inserts alone. The DNA of the interacting clones was extracted from 
E.coli using the Qiagen mini prep kit. The plasmids were cut using the restriction enzyme 
Alu1 which is a frequent cutter to eliminate repetitive or identical clones. Unique putative 
clones were sequenced. The sequence of around 25 clones which is a mixture of both 
overlapping as well as identical clones showed similarities with known proteins (Table. 
11). 
Since VITO-1 is a transcription co-activator of TEFs, we expected members of the TEF 
family or other transcription factors or repressors to surface in our yeast two hybrid 
screen. Surprisingly none of the newly identified binding partners directly had an 
annotated function in the regulation of transcription. We focused our interests on 
Telethonin (T-cap) and Myozenin1 (MYOZ1) because they were isolated as independent 
overlapping clones. All other clones were either single clones like PKIA, PKM2, 
ARDBK1, DUSP13, MT2A and UNC 119 or identical clones such as ADAMTS8, 
ATP2A2 and FTL. 
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Genes Identified Expression profile No. of 
clones 
Telethonin (T-Cap) Muscle, heart larynx peripheral nervous 
system, prostate, pancreas, tongue, bone, liver, 
lung, placenta, skin, eye 
4 
Myozenin-1 (MYOZ1) muscle, heart, soft tissue, prostate, larynx, 
tongue, kidney, eye, lung 
2 
Protein kinase inhibitor 
alpha (PKIA) 
heart, muscle, brain, PNS, liver, thymus, 
prostate 
1 
Pyruvate kinase muscle 
(PKM2)      
all tissues 1 
Adrenergic beta receptor 
kinase 1 (ADRBK1)             
thymus, lymph node, blood, PNS, muscle and 
all other tissues except heart and larynx 
1 
Dual specificity 
Phosphatase 13 
(DUSP 13) 
muscle, heart, bone marrow, PNS, pancreas, 
prostate, testis, eye, liver, brain 
1 
Metallothionein 2A 
(MT2A)           
muscle, liver, vascular, prostate and almost 
all other tissues 
1 
Adam Metallo peptidase 
with thrombospodin type 
1 motif 8 (ADAMST8) 
lung, prostate, blood, brain, colon, placenta, 
ovary, pancreas, testis 
2 
ATPase Ca transporting, 
cardiac muscle slow 
twitch 2 (ATP2A2) 
muscle, heart, larynx, PNS, and everywhere 
except in thymus 
2 
   UNC 119 homolog 
(C.elegans) 
eye, cervix, ovary, PNS, thymus, uterus, 
muscle, heart… 
1 
Ferritin light polypeptide 
(FTL)              
 
all tissues 
7 
 Galactosyl transferase 
polypeptide          
(B4GALT5) 
blood, ovary, PNS, muscle, heart and all other 
tissues 
1 
Proteosome subunit beta 
type 4 (PSMB4)     
skin, cervix in all other tissues except thymus 1 
Chaperonin containing 
TCP1 subunit 7  (CCT7)         
     
all tissues 
1 
 
Table 11. Clones identified for VITO1 as potential interaction partners by Yeast Two 
hybrid screening using a human skeletal muscle library. 
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3.4 Interaction of VITO-1 with Telethonin and Myozenin1 
3.4.1 VITO-1 interacts with both Telethonin and Myozenin1 in the yeast 
two hybrid system 
To confirm the interaction of VITO-1 with T-cap and MYOZ1, VITO1-pGBKT7 was co-
transformed with the overlapping clones of T-cap-pGADT7 and MYOZ1-pGADT7 in 
individual experiments and were plated on SD/-Trp/-Leu/-His (TDO) plates and 
incubated at 30°C for 4-5 days.  
 
Figure 19. Yeast two hybrid (Y2H )- Interaction of VITO-1 with Telethonin and 
Myozenin. Yeast clones obtained after screening were cloned into pGADT7 and retested 
for interaction by lacZ test. pGBKT7-Lam + pGADT7-T were used as a negative control 
(A, B, C # 1) and pGBKT7-53 + pGADT7-T as a positive control (A, B, C # 2, 3). The 
already known interaction between p0071 and different clones of E-cadherin were used 
as additional positive control (A, B, C # 4, 5, 6). Interaction of Vito1 with its screening 
partners, MYOZ1 (A, B, C # 7, 8) and different T-cap clones (A, B, C # 9 and 10) were 
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tested. Clones were streaked onto plates lacking -trp and -leu as a control to confirm the 
growth (A- clones 1-10). The same clones were streaked onto – trp, -leu, -his to test for 
reporter gene activation (B- clones 1-10). These colonies (B- clones 1-10) were subjected 
to a ß-gal colony lift LacZ filter assay to confirm the interaction between the bait and 
prey (C- clones 1-10). Vito1 was found to interact with both MYOZ1 (C- clones 7,8) and 
the different overlapping clones of T-cap (C- clones 9, 10).  
 
The colonies were replica plated again on TDO plates as streaks and were allowed to 
grow until a thick patch of yeast growth was observed. These patches of yeast colonies 
were analyzed for positive interaction by ß-gal colony lift filter assay. As a negative 
control, pGBKT7-Lam was co-transformed with pGADT7-T while pGBKT7-53 co-
transformed with pGADT7-T served as the positive control. Moreover already known 
interaction between p0071 and E-cadherin clones were included as additional positive 
control (Hatzfeld, Green et al. 2003). As expected VITO1 interacted with both T-cap as 
well as MYOZ1 clones as indicated by activation LacZ reporter gene (Fig 19).  
3.4.2 VITO-1 binds TEFs with greater affinity than T-Cap and MYOZ1  
To determine the binding affinity of VITO-1 with the sarcomeric proteins T-cap and 
MYOZ1 in comparison to the transcription factor TEF3, a ß-galactosidase reporter gene 
liquid culture assay using Ortho-nitrophenyl-β-D-galactopyranoside (ONPG) as substrate 
was carried out. This assay provides a quantitative measurement of the reporter gene 
activity depending on the strength of interaction between two proteins fused to the GAL4 
system. For this experiment, VITO-1 pGBKT7 was co-transformed with either TEFs or 
T-cap or MYOZ1 pGADT7 and the liquid cultures were grown on medium with SD/-
Trp/-Leu/-His + appropriate 3 AT concentration. The cells were allowed to grow until 
mid-log phase and the OD600 was measured. The cell pellet dissolved in Z-buffer was 
subjected to freeze (-80°C) thaw cycle followed by the addition of ONPG and ß-
mercaptoethanol. If ß-galactosidase is present, the colourless ONPG is split into galactose 
and o-nitrophenol, a yellow compound. Samples were incubated at 30°C and the time 
required for the development of yellow color to the sample solutions was recorded. The 
reaction was stopped by the addition of 1M sodium carbonate. The OD420 of the samples 
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were measured and the reporter gene activity was measured by calculating the ß-
galactosidase units.       
 
Figure 20. Quantitative measurement of ß-galactosidase activity using ONPG liquid 
culture assay. Together with Vito1, MYOZ1 shows > 3 fold activation, T-cap > 6 fold 
and TEF3 > 9 fold activation of the LacZ reporter gene.´ 
The binding affinity of Vito1 with its interacting partners was characterized using ONPG 
assay. MYOZ1/T-cap/TEF3 (in fusion with GAL4AD) and Vito1 can efficiently activate 
lacZ reporter gene expression. Enzyme activities are normalized against control 
containing both pGADT7 and pGBKT7.  
Enzyme activities were normalized against control containing both pGADT7 and 
pGBKT7. All experiments were performed in triplicates. It was found that VITO-1 was 
able to synergistically activate the LacZ reporter together with its binding partners 
namely TEf3, T-cap and MYOZ1. However VITO-1 showed a stronger interaction with 
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TEFs (> 9 fold) in comparison with T-cap (> 6 fold) and MYOZ1 (> 3 fold) with respect 
to the controls (Fig 20). 
3.4.3 VITO-1 might require other binding partners of eukaryotic 
cellular environment to stabilize its interaction with Z-disc proteins 
After confirming the interaction of VITO1 with both T-cap and MYOZ1 in Y2H, Co-IP 
from in vitro transcripted/translated protein from rabbit reticulocyte lysate system was 
used to confirm protein interactions in vitro. Full length myc-VITO1 (1-323 aa) and its 
mutants, a) N-terminal myc-∆VITO1 (1-199 aa), b) C-terminal ∆VITO1-myc (1-199 aa) 
which contains the SID domain and c) myc- VITO1∆SID (108-323 aa) without the SID 
domain were used to investigate their interaction with T-cap in subsequent co-
immunopecipitation experiments.  Proteins were fused either with a c-myc tag or with a 
hemagglutinin (HA) tag. Myf-5 and E2-2 known to form stoichiometric complexes with 
each other were used as positive controls.  
 
VITO-1 constructs, Telethonin and Myozenin used for subsequent co- 
immunoprecipitation experiments: 
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Proteins were translated in vitro by using a TNT T7 polymerase-coupled reticulocyte 
lysate system (Promega). 2 µl of the protein samples were loaded on SDS PAGE gels and 
were detected for proper and specific translation of each protein (Fig. 21 – Lysate). Myf-
5 and E2-2 known to form stoichiometric complexes with each other were used as 
positive controls. 10 µl of the translated VITO1 and Telethonin were incubated with 6 µl 
of c-myc antibody and were immunoprecipitated using Protein A sepharose beads. For 
Co-Immunoprecipitation, 10 µl of the translated proteins (to be analyzed for interaction) 
were mixed together, precipitated using 5 µg c-myc antibody (for VITO1 - T-cap 
interaction) and were detected by autoradiography. VITO-1 did not co-immunoprecipitate 
with T-cap (Fig. 21). Myf5 and E2-2 complex was precipitated using 2 µg E2-2 antibody 
as a positive control (Fig.21). 
 
 
Figure 21. VITO-1 does not co-immunoprecipitate with T-Cap in the rabbit reticulocyte 
model. 
Myc-VITO-1 was radiolabelled with 35S and mixed with T-cap HA. The known 
interacting partners Myf-5 and E2-2 were used as positive controls. The protein 
complexes were immunoprecipitated with c-myc antibody and subjected to SDS PAGE 
and autoradiography. Protein lysates before immunoprecipitation were loaded as input 
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controls. Telethonin did not co-precipitate with VITO-1. The positive control complex 
partners, Myf5 and E2-2 were co-precipitated.  
 
 
 
Figure  22. Co-Immunoprecipitaion of VITO-1 deletion constructs with T-cap.  
VITO1 deletion constructs myc-∆VITO1 and myc-VITO1∆SID were radiolabelled with 
35S and mixed with T-cap HA. The known interacting partners Myf-5 and E2-2 were used 
as positive controls. The protein complexes were immunoprecipitated with c-myc 
antibody and subjected to SDS PAGE and autoradiography. Protein lysates before 
immunoprecipitation were loaded as input controls.  Telethonin did not Co-precipitate 
with VITO-1. The positive control complex partners, Myf5 and E2-2 were co-
precipitated. 
 
Two VITO1 deletion constructs, N-terminal myc-∆VITO1 (1-199 aa), which contains the 
SID domain and myc-VITO1∆SID (108-323 aa) without the SID were tested for 
interaction with T-cap from proteins that were invitro transcripted/translated. Translated 
proteins from different plasmids were loaded on SDS PAGE and detected by 
autoradiograpgy to check for proper translation as input controls (Fig. 22). Myf-5 and E2-
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2 known to form stoichiometric complexes with each other were used as positive 
controls. 10 µl of the translated VITO-1 deletion constructs and T-cap were incubated 
with 6 µl of c-myc antibody and immunoprecipitated using Protein A sepharose beads to 
avoid any unspecific cross reactivity between the protein and antibody. For Co-
Immunoprecipitation, 10 µl of the translated proteins (to be analyzed for interaction) 
were mixed together, precipitated using 5 µg c-myc antibody and were detected by 
autoradiography. The positive control Myf5/E2-2 complex was co-immunoprecipitated 
with 2 µg E2-2 antibody (Fig. 22).  
Telethonin did not co-immunoprecipitated with either myc-∆VITO1 or myc-VITO1∆SID 
(Fig. 22). 
A similar experiment was carried out with the same conditions and procedure to find if 
VITO-1 interacts with Myozenin-1 (Fig 23). VITO-1 did not co-immunoprecipitate with 
Myozenin-1.  
 
Figure 23. VITO-1 does not co-immunoprecipate with Myozenin1 in the rabbit 
reticulocyte system. Myc-VITO-1 was radiolabelled with 35S and mixed with Myozenin-
HA tagged fusion protein. The known interacting partners Myf-5 and E2-2 were used as 
positive controls. The protein complexes were immunoprecipitated with c-myc antibody 
and subjected to SDS PAGE and autoradiography. Protein lysates before 
immunoprecipitation were loaded as input controls.  Myozenin1 did not Co-precipitate 
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with VITO-1. The positive control complex partners, Myf5 and E2-2 were co-
precipitated.  
 
 The rabbit reticulocyte system system failed to provide evidence of physical interactions 
between VITO-1 / T-Cap and VITO-1 / Myozenin1. These results did not support or 
confirm the physical interaction of VITO-1 with T-cap and MYOZ1 previously observed 
in the Yeast 2 Hybrid system. 
The failure of this system to detect VITO-1/T-cap and VITO-1/MYOZ1 interactions in 
the coupled in vitro transcription / translation system could be due to various reasons. 
Analysis of protein-protein interactions in the transcription / translation system is 
artificial since additional components that might facilitate or stabilize interactions are 
missing. In addition, newly synthesized proteins in the reticulocyte system are not 
properly modified, which might also compromise molecular interactions. It seems 
possible that VITO-1 requires other proteins to form a complex to allow a stable 
interaction, which is missing in this in vitro system or requires post-translational 
modification. Although yeast two hybrid system has its own disadvantages, it embodies 
an in vivo technique using the yeast host cell as a live test tube reflecting processes in 
higher eukaryotic cells better than most in vitro approaches. Thus VITO-1 might require 
other binding partners of eukaryotic cellular environment to mediate its interaction with 
T-cap and MYOZ1. To verify the Y2H interaction of VITO-1 with T-cap and MYOZ1, 
we hence switched to mammalian cell lines where the proteins are expressed in their 
native environment. Due to high transfection efficiency and easy handling, HEK 293 and 
C2C12 cell lines were chosen for the Co-IP assay.  
3.4.4.1 VITO-1 does not bind with T-cap in both HEK 293 cells and undifferentiated   
C2C12 cells 
HEK293 cells  
HEK 293 cells were grown until 50% confluency and were transfected using FuGene 6 
reagent. VITO-1 full length myc-VITO1 (1-323 aa) and mutant constructs, N-terminal 
myc-∆VITO1 (1-199 aa), C-terminal ∆VITO1-myc (1-199 aa) which contains the SID 
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domain and myc- VITO1∆SID (108-323 aa) without the SID domain were co-transfected 
with Telethonin-HA (T-cap-HA). Cells were harvested after 48 hrs of transfection and 
Co-IP was performed as described in experimental procedures. Proteins in total cell 
lysate were quantified using the standard Bradford assay and 10% of total protein lysate 
used for IP was loaded as input controls. Proteins were immunoprecipitated with 5 µg c-
myc and the bound proteins were detected by western blot analysis using mouse anti-HA 
(1:200 dilution) and mouse anti-c-Myc (1:100 dilution). HRP conjugated goat α mouse 
(1:5000) was used for chemiluminescent detection.  
VITO-1 full length and their mutant constructs did not co-immunoprecipitate with T-cap 
in HEK293 cells (Fig. 24). 
 
 
Figure 24. Co-immnunoprecipitation of Vito1 constructs with T-cap from transfected 
HEK 293 cells.  
HEK 293 cells were cotransfected using Fugene 6 with either myc-VITO1, myc- ∆ 
VITO1, ∆VITO1-myc, myc-VITO1-∆SID together with telethonin-HA. Protein lysates 
saved before immunoprecipitation and 10% of total protein lysate used for IP was loaded 
as input controls. Telethonin was not co-precipitaed with Full length VITO-1(myc-
VITO1) and its deletion constructs (myc- ∆ VITO1, ∆VITO1-myc and myc-VITO1-∆SID).   
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C2C12 cells  
Since VITO-1 is a muscle specific protein, C2C12 cells which is a muscle cell line was 
chosen to address the interaction of VITO-1 with telethonin. VITO-1 full length myc-
VITO1 (1-323 aa) and mutant constructs myc-∆VITO1, ∆VITO1-myc and myc- 
VITO1∆SID were co-transfected with Telethonin-HA (T-cap-HA). Cells were harvested 
after 48 hrs when the C2C12 cells were still in undifferentiated state (myoblasts). 
Proteins in total cell lysate were quantified using the standard Bradford assay and 10% of 
total protein lysate used for IP was loaded as input controls (Fig. 25). Proteins were 
immunoprecipitated with 10 µg c-myc and the bound proteins were detected by western 
blot analysis using mouse anti-HA (1:200 dilution) and mouse anti-c-Myc (1:100 
dilution). HRP conjugated goat α mouse (1:5000) was used for chemiluminescent 
detection.  
VITO-1 full length and their mutant constructs did not co-immunoprecipitate with T-cap 
in undifferentiated C2C12 cells (Fig. 25). 
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Figure 25. VITO-1 does not co-immunoprecipitate with T-cap in C2C12 myoblasts 
C2C12 cells were cotransfected using Fugene 6 with either myc-VITO1, myc- ∆ VITO1, 
∆VITO1-myc, myc-VITO1-∆SID together with telethonin-HA. Protein lysates saved 
before immunoprecipitation were loaded as input controls. Full length VITO-1(myc-
VITO1) and its deletion constructs (myc- ∆ VITO1, ∆VITO1-myc & myc-VITO1-∆SID) 
did not co-immunoprecipitate with telethonin-HA. 
 
3.4.4.2 VITO-1 did not interact with Myozenin 1 in both HEK293 cells and 
undifferentiated C2C12 cells 
With similar experimental conditions as the previous experiment, VITO-1 full length 
myc-VITO1 (1-323 aa) and mutant constructs myc-∆VITO1, ∆VITO1-myc and myc- 
VITO1∆SID were co-transfected with Myozenin1-HA (MyoZ-HA) in HEK293 cells and 
undifferentiated C2C12 cells.  
 
 
 
Figure  26.  VITO-1 does not co-immunoprecipitate with Myozenin-1 in HEK 293 
cells.. HEK 293 cells were cotransfected using Fugene 6 with myc-VITO1, myc- ∆ 
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VITO1, ∆VITO1-myc, myc-VITO1-∆SID together with Myozenin-HA. Protein lysates 
saved before immunoprecipitation and 10% of total protein lysate used for IP was loaded 
as input controls. Full length VITO-1 (myc-VITO1) and its deletion constructs (myc- ∆ 
VITO1, ∆VITO1-myc & myc-VITO1-∆SID) did not co-immunoprecipitate with Myozenin-
HA. 
 
VITO-1 full length and their mutant constructs did not co-immunoprecipitate with  
Myozenin 1 in both HEK293 cells (Fig. 26) and undifferentiated C2C12 cells (Fig. 27). 
 
 
 
Figure 27. VITO-1 does not co-immunoprecipitate with Myozenin 1 in C2C12 
myoblasts Undifferentiated C2C12 cells were cotransfected using Fugene 6 with myc-
VITO1, myc- ∆ VITO1, ∆VITO1-myc, myc-VITO1-∆SID together with Myozenin-HA. 
10% of total protein lysate used for IP was loaded as input controls before 
immunoprecipitation. Full length VITO-1 (myc-VITO1) and its deletion constructs (myc- 
∆ VITO1, ∆VITO1-myc & myc-VITO1-∆SID) did not co-immunoprecipitate with 
Myozenin-HA in C2C12 cells. 
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3.4.5 VITO1 interacts with the Z-disc proteins T- cap and MYOZ1 in 
differentiated C2C12 cells and Chicken primary Myocytes via its 
Scalloped Interaction Domain (SID) 
Based on Northern blot analysis, it was known that VITO-1 is specifically expressed in 
skeletal muscles and upregulated in differentiated C2C12 myotubes. Since we failed to 
detect stable protein-protein interaction with VITO-1 and the sarcomeric proteins T-cap 
and myozenin1 by Co-IP in undifferentiated C2c12 cells, we wondered whether 
interaction of VITO-1 and the Z-disc proteins requires additional components not present 
in undifferentiated cells. It seemed possible that other proteins expressed during 
differentiation of muscle cells or during formation of sarcomeric proteins serve as a 
bridging complex facilitating the interaction of VITO-1 with telethonin and myozenin1. 
To verify this hypothesis, differentiated myotubes from C2C12 cells and primary chicken 
myocytes which form mature sarcomeres were chosen for the Co-IP experiments.  
3.4.5.1 Interaction of VITO-1 with T-cap in differentiated C2C12 myotubes 
C2C12 cells were grown to 50% confluence in DMEM with 10% FCS and were co-
transfected using Lipofectamine 2000 reagent with Telethonin-HA (T-cap-HA) and 
VITO1 constructs (myc-VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID).  
After 48 hrs, when the cells were almost 100% confluent, the medium was replaced with 
differentiating medium (DMEM with 2% Horse Serum) and the cells were allowed to 
differentiate for 72-96 hrs until the formation of mature myotubes Removal of growth 
factors from proliferating C2C12 cells causes them to reversibly withdraw from the cell 
cycle and to rapidly begin expressing a variety of muscle-specific proteins.  
Medium was changed every day until the cells were well differentiated showing 
formation of large mature myotubes. Cells were harvested and Co-IP was performed as 
described in experimental procedures. Proteins in total cell lysate were quantified using 
the standard Bradford assay and 10% of total protein lysate used for IP was loaded as 
input controls (Fig. 28). 
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Figure  28. Vito1 co-immunoprecipitates with T-cap in differentiated C2C12 myotubes. 
C2C12 cells were transfected using Lipofectamine 2000 with VITO-1 constructs (myc-
VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID) and T-cap and were allowed 
to differentiate to form mature myotubes before harvestion for the immunoprecipitation 
(IP) experiment. Protein lysates from the diffentiated myotubes were loaded as input 
controls (10% of total lysate used for IP). Telethonin Co-precipitated with all the three 
VITO-1 constructs (myc-VITO1, myc-∆VITO1 and ∆VITO1-myc which contained the SID 
domain. VITO-1 mutant lacking the SID domain (myc-VITO1∆SID) did not Co-
Immunoprecipitate with T-cap.  
 
Proteins were immunoprecipitated with 10 µg of c-myc antibody and the bound proteins 
were detected by western blot analysis using mouse anti-HA (1:200) and mouse anti-c-
myc (1:100). T-cap co-immunoprecipitated with Full length myc-VITO1 (1-323 aa) and 
its mutants, N-terminal myc-∆VITO1 (1-199 aa) and C-terminal ∆VITO1-myc (1-199 
aa), all containing the SID domain (Fig. 28). It should be noted that myc- VITO1∆SID 
(108-323 aa) without the SID domain did not interact with T-cap. These results suggest 
the requirement of the Vito1 SID domain to mediate interaction with its binding partners 
like T-cap or TEFs. 
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3.4.5.2 VITO-1 Co-immunoprecipitates with T-cap when over-expressed in Primary 
Chicken Myocytes 
Primary myocytes from chicken embryos are a good model to study the interaction of 
various Z-disc proteins as they form well defined sarcomeres, easy to handle and mainly 
due to its high transfection efficiency when studying ectopically expressed proteins such 
as VITO-1.  
Primary myocytes were isolated from 11 day old chicken embryos as described in 
materials and methods and plated at 60% confluency in DMEM containing 10% FCS. 
The following day, medium was changed and the cells were transfected using the 
Calcium phosphate method with with Telethonin-HA (T-cap-HA) and VITO1 expression 
constructs (myc-VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID). After 8 hrs 
of transfection, the medium was changed to DMEM with 10% Horse serum. Cells were 
allowed to differentiate for 72 hrs until they formed multinucleated myotubes and 
matured into functional myofibers. At this stage the cells were harvested, lysed and 
subjected to immunoprecipitation using 10 µgs of c-myc antibody. Precipitated proteins 
were detected using anti-HA (1:200) and anti-c-myc (1.100) by immunoblotting. HRP 
conjugated goat α mouse (1:5000) secondary antibody was used for chemiluminescent 
detection. Proteins in total cell lysate were quantified using the standard Bradford assay 
and 10% of total protein lysate used for IP was loaded as input controls. 
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Figure  29. Vito1 interacts with T-cap in vitro via its SID domain. 
 Primary myocytes were isolated from 11 day old chicken embryo transfected using 
Calcium Phosphate method with Vito1 contructs (myc-VITO1, myc-∆VITO1, ∆VITO1-
myc and myc-VITO1∆SID) and T-cap. 10% 0f total protein lysates from differentiated 
myocytes were loaded as input controls.  
Telethonin Co-precipitated with all the three VITO-1 constructs (myc-VITO1, myc-
∆VITO1 and ∆VITO1-myc which contained the SID domain. VITO-1 mutant lacking the 
SID domain (myc-VITO1∆SID) did not co-immunoprecipitate with T-cap. 
 
T-cap co-immunoprecipitated with full length myc-VITO1 (1-323 aa) and its mutants, N-
terminal myc-∆VITO1 (1-199 aa) and C-terminal ∆VITO1-myc (1-199 aa), all containing 
the SID domain (Fig. 29). VITO1 mutant without the SID domain myc-VITO1∆SID 
(108-323 aa) did not physically associate interact with T-cap (Fig.29).  
3.4.5.3 VITO-1 associates with MYOZ1 in both differentiated C2C12 myotubes and 
primary chicken myocytes. 
Since VITO-1 associated with T-cap in C2C12 myotubes and primary chicken myocytes, 
we used the same model and conditions to test the physical interaction of VITO-1 with 
Myozenin1 (MYOZ1).  
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Figure 30. VITO1 Co-immunoprecipitates with MYOZ1 in differentiated C2C12 
myotubes. C2C12 cells were transfected using Lipofectamine 2000 with VITO-1 
constructs (myc-VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID) and 
Myozenin1 were allowed to differentiate to form mature myotubes before harvestion for 
the immunoprecipitation (IP) experiment. 10% of total protein lysates from the 
diffentiated myotubes were loaded as input controls. Myozenin1 Co-precipitated with all 
the three VITO-1 constructs (myc-VITO1, myc-∆VITO1 and ∆VITO1-myc which 
contained the SID domain. VITO-1 mutant lacking the SID domain (myc-VITO1∆SID) 
did not Co-immunoprecipitate with Myozenin1.  
 
 
 
Figure  31.  Interaction of VITO-1 with MYOZ1 in chicken primary myocytes required 
the SID domain. Primary myocytes were isolated from 11 day old chicken embryo 
transfected using Calcium Phosphate method with VITO1 contructs (myc-VITO1, myc-
∆VITO1, ∆VITO1-myc and myc-VITO1∆SID) and HA-tagged Myozenin1. 10% of total 
protein lysates (used for IP) from differentiated myocytes were loaded as input controls.  
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Myozenin1 Co-precipitated with all the three VITO-1 constructs (myc-VITO1, myc-
∆VITO1 and ∆VITO1-myc which contained the SID domain. VITO-1 mutant lacking the 
SID domain (myc-VITO1∆SID) did not Co-Immunoprecipitate with Myozenin1. 
 
The experimental procedures for Co-IP were the same as previously described for 
telethonin. C2C12 cells were co-transfected using Lipofectamine 2000 reagent with 
Myozenin-HA and VITO1 constructs (myc-VITO1, myc-∆VITO1, ∆VITO1-myc and 
myc-VITO1∆SID) and allowed to form mature myotubes before harvesting for IP 
experiment. Proteins in total cell lysate were quantified using the standard Bradford assay 
and 10% of total protein lysate used for IP was loaded as input controls (Fig. 30). 
For primary chicken myotubes, myocytes were isolated from 11 day old chicken embryos 
and transfected using calcium phosphate method. Cells were allowed to differentiate for 
72 hrs until they form multinucleated myotubes and harvested for IP. Proteins in total cell 
lysate were quantified using the standard Bradford assay and 10% of total protein lysate 
used for IP was loaded as input controls (Fig. 31).  
Proteins were immunoprecipitated with 10 µg of c-myc antibody and the bound proteins 
were detected by western blot analysis using anti-HA and anti - c-myc. Myozenin1 co-
immunoprecipitated with full length myc-VITO1 (1-323 aa) and its mutants, N-terminal 
myc-∆VITO1 (1-199 aa) and C-terminal ∆VITO1-myc (1-199 aa), in both differentiated 
C2C12 myotubes (Fig. 30) and primary chicken myocytes (Fig. 31). All these VITO1 
constructs contained the SID domain. VITO1 mutant without the SID domain myc-
VITO1∆SID (108-323 aa) did not interact with Myozenin1 in both the cell types (Fig. 30 
and Fig. 31) 
3.4.5.4 VITO-1 forms a complex with Z-disc proteins by physically interacting with 
T-cap and MYOZ1 in differentiated C2C12 myotubes and Chicken primary 
myocytes 
To verify if VITO-1 forms a complex with both T-cap and MYOZ1, VITO-1 constructs 
(myc-VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID), Telethonin-HA 
tagged and Myozenin1-HA tagged were over-expressed transiently in equimolar 
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concentrations in both differentiated C2C12 myotubes (using Lipofectamine 2000) and 
Chicken primary myocytes (calcium phosphate method) as described earlier. 
 Protein complex were immunoprecipitated with 10 µg of c-myc antibody and the bound 
proteins were eluted after washing the beads to remove unspecifically bound proteins. 
Eluted proteins were detected by western blot analysis using mouse anti-HA (1:200) and 
mouse anti-c-Myc (1:100). Proteins in total cell lysate (C2C12 myotubes) were quantified 
using the standard Bradford assay and 10% of total protein lysate used for IP was loaded 
as input controls (Fig. 32). Both the Z-disc associated proteins Telethonin and Myozenin1 
co-immunoprecipitaed with full length myc-VITO1 (1-323 aa) and its mutants, N-
terminal myc-∆VITO1 (1-199 aa) and C-terminal ∆VITO1-myc (1-199 aa), in C2C12 
myotubes (Fig. 32).  
.  
 
Figure 32. VITO-1 Co-immunoprecipitates with T- Cap and Myozenin in C2C12 
myotubes forming a complex. C2C12 cells were transfected using Lipofectamine 2000 
with VITO-1 constructs (myc-VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID), 
Telethonin and Myozenin. 10% of total protein lysate used for IP was loaded as input 
controls. All the three VITO-1 constructs (myc-VITO1, myc-∆VITO1 and ∆VITO1-myc 
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which contained the SID domain co-immunoprecipitated with telethonin and myozenin1 
thus forming a complex. VITO1 mutant without the SID domain myc-VITO1∆SID did not 
show interactions with Telethonin and/or Myozenin1. 
 
For primary chicken myotubes, myocytes were isolated from 11 day old chicken embryos 
and transfected using calcium phosphate method. Cells were allowed to differentiate for 
72 hrs until they form multinucleated myotubes and harvested for IP. Proteins in total cell 
lysate (primary chicken myotubes) were quantified using the standard Bradford assay and 
10% of total protein lysate used for IP was loaded as input controls (Fig. 33). Both the Z-
disc associated proteins Telethonin and Myozenin1 co-immunoprecipitaed with full 
length myc-VITO1 (1-323 aa) and its mutants, N-terminal myc-∆VITO1 (1-199 aa) and 
C-terminal ∆VITO1-myc (1-199 aa), in primary chicken myotubes  (Fig. 33). 
Thus VITO-1 forms a complex with Telethonin and Myozenin1 in both differentiated 
C2C12 myotubes and primary chicken myocytes. Again, VITO1 mutant without the SID 
domain myc-VITO1∆SID did not show interactions with Telethonin and/or Myozenin1 in 
both the cell models (Fig. 32 and Fig. 33). 
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Figure 33. VITO-1 Co-immunopecipitates with Telethonin and MYOZ1 in chicken 
primary myocyte forming a complex. Primary myocytes were isolated from 11 day old 
chicken and were transfected using Calcium Phosphate method with VITO-1 contructs 
(myc-VITO1, myc-∆VITO1, ∆VITO1-myc and myc-VITO1∆SID), Telethonin and 
Myozenin. 10% of total protein cell lysate used for IP was loaded as input controls. All 
the three VITO-1 constructs (myc-VITO1, myc-∆VITO1 and ∆VITO1-myc which 
contained the SID domain co-immunoprecipitated with telethonin and myozenin1 thus 
forming a complex. As anticipated, VITO1 mutant without the SID domain myc-
VITO1∆SID did not show and interaction with Telethonin and/or Myozenin. 
 
Our results confirm that VITO-1 interacts with Telethonin and Myozenin1 in 
differentiated C2C12 myotubes and primary chicken myocytes and forms a complex with 
both these Z-disc proteins. Since more T-cap proteins co-immunoprecipitated with 
VITO-1 compared to MYOZ1, it seems likely that VITO-1 interacts more efficiently with 
T-cap compared to MYOZ1. This is consistent with the findings from ONPG reporter 
gene assay (Fig.20). From the above Co-IP experiments it is clear that the functional SID 
domain of VITO-1 is required to mediate its interaction with the Z-disc proteins. VITO-1 
also associates with TEFs via its SID domain (Gunther, Mielcarek et al. 2004). It would 
be interesting to see if TEFs and the Z-disc proteins (T-cap and MYOZ1) both compete 
for the same binding sites in the SID domain or have different binding sites. 
 
3.5 VITO-1 localizes at the sarcomeres of both cardiomyocytes and 
primary myocytes and translocates between the nucleus and cytoplasm 
 
VITO-1 being a transcriptional co-activator is supposedly expressed in the nuclei of 
different muscle cell types where it interacts with TEFs. But its interaction with the 
sarcomeric proteins prompted us to investigate if VITO-1 shuttles between the nucleus 
and cytoplasm. Since the interaction between VITO-1 and the Z-discs proteins T-cap and 
MYOZ1 occurs in differentiated and striated muscle cells, differentiated C2C12 
myotubes, primary chicken myocytes and mouse cardiomyocytes were used as a model 
system.  
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3.5.1 Ectopically expressed VITO-1 is localized predominantly in the 
nucleus of cardiomyocytes isolated from mouse 
 
Figure 34. VITO-1 localizes prominently in the nuclei of cardiomyocytes. 
Cardiomyocytes were electroporated with VITO-1DsRed using the nucleofector kit and 
the expression was analyzed after 72 hrs. (A, C) - Majority of the transfected cells 
expressing VITO-1 were confined to the nucleus. (B) - α-actinin staining as a sarcomeric 
marker control. (D) – dapi nucler staining. 
 
Even though VITO-1 is a skeletal muscle specific protein, cardiomyocytes isolated from 
mice were used to analyze the exogenous expression of VITO-1 as these cells mimic 
muscle cells in many aspects like striated pattern, stress-sensor proteins, etc. We chose 
this model to study the localization VITO-1 in Cardiomyocytes. 
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Neonatal cardiomyocytes were isolated from mouse as described in experimental 
procedures and these cells were immediately electroporated using the Nucleofector kit to 
transiently express VITO-1-DsRed. After electroporation, the cells were plated on 
collagen coated cover slips and were incubated in DMEM with 10% FCS for 2-3 days. 
Cells were later fixed with acetone and stained using mouse monoclonal sarcomeric 
alpha-actinin (1:100), a marker for Z-discs and detected with ALEXA 488 (green) goat 
anti mouse secondary antibody (dilution 1:1000) for visualization. Cells were further 
prepared for fluorescent microscopy 
VITO-1 was localized mainly in the nuclei of cardiomyocytes (Fig. 34 A, C) although 
one could see some diffused pattern in the cytoplasm. This association in the nucleus 
could possibly be due to the presence of increased amount of endogenous TEFs or other 
transcription factors to which VITO-1 might interact with to form a complex. 
3.5.2 VITO-1 is localized at the Z-discs of sarcomeres in mouse 
cardiomyocytes 
As described previously, even though VITO-1 was mainly localized in the nucleus of 
cardiomyocytes, some cells still showed a diffused cytoplasmic localization. Neonatal 
cardiomyocytes were prepared and electroporated with Vito-1 DsRed as described 
previously. Interestingly we found cells where VITO-1 was expressed in the Z-discs of 
cardiomyocytes (Fig. 35 A). 
 This may be due to high expression of its Z-disc interacting partners in thses cells which 
might have undergone terminal differentiation.  
The question remains open, under what circumstances VITO-1 shuttles between the 
nucleus and Z-discs.  This could be due to some external stimuli or stress conditions or 
many other external factors which needs a closer and deeper analysis.  
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Figure 35. VITO-1 (red) associates at the Z-discs of neonatal mouse cardiomyocytes. 
Cardiomyocytes were freshly isolated from neonatal mice and were electroporated with 
Vito1-DsRed using the Cardiomyocyte-Neonatal Nucleofector kit and the cells were 
plated on collagen coated dishes. (A) – After 72 hrs, VITO-1-DsRed localized at the Z-
discs. (B) - α-actinin staining a marker for Z-discs. 
3.5.3 VITO-1 localizes at the Z-discs of primary chicken myocytes after 
over-expression of T-cap 
VITO-1 physically interacted with T-cap in the Co-IP experiments from isolated 
myocytes from chicken embryos. Hence we attempted to look for the sarcomeric 
association of both these proteins. T-cap is a well known Z-disc protein found in striated 
and cardiac muscle that serves as a scaffold to which myofibrils and other muscle related 
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proteins are attached. Primary chicken myocytes cultures form well-structured 
sarcomeres and are comparatively easier to transfect than cardiomyocytes which are quite 
challenging. Hence this model was chosen to test our hypothesis that VITO-1 might 
associate with T-cap at the sarcomeres.  
 
 
 
 
Figure 36. VITO-1 (red) colocalizes with T-cap (green) at the z-bands of sarcomere 
from primary myocytes.  
Primary myocytes were isolated form 11 day old embryo and cotransfected with VITO-1-
DsRed and T-cap-GFP and allowed to differentiate. After 72 hrs (C) VITO1-dsRed and 
(D) Telethonin-GFP associated at the Z-discs and (E) co-localized with each other. A) 
VITO1-GFP transfected alone localized at the nucleus.  
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Primary chicken myocytes were isolated from the breast muscle of 11 days old chicken 
embryos and were plated on collagen coated 6 well culture dishes containing cover slips 
in DMEM with 10% FCS. The following day, when the cells reached a confluence of 
70%, VITO-1-DsRed and T-cap-GFP were co-transfected using calcium phosphate 
method. After 8 hrs of transfection, the medium was replaced with DMEM containing 
10% Horse serum and the cells were allowed to differentiate for 3 to 5 days until the 
formation of mature myofibers. The cells were later fixed with 4% PFA and the cover 
slips were mounted on glass slides with moviol.   
 
VITO-1 was expressed strongly at the sarcomeres and localized at the Z-discs where it 
associated with Telethonin (Fig. 36 C, D & E). VITO1-GFP transfected alone, localized 
at the myoctes’ nuclei (Fig. 36 A). This shows that VITO-1 translocates from the nucleus 
to cytoplasm when its Z-disc partners are expressed abundantly in striated muscle cells. 
 
3.6 Vito1 might be involved in the initial stage of myofibrillogenesis 
Myofibrillogenesis occurs basically in three stages from premyofibrils to nascent 
myofibrils to mature myofibrils. It is known from literature that a premyofibril model for 
myofibrillogenesis accounts for sarcomeric formation in skeletal muscle cells. 
Premyofibrils are the starters of sarcomeres, which are composed of Z-bodies containing 
mainly the muscle specific isoform of alpha-actinin. When titin and muscle myosin II 
filaments are expressed, they modify the premyofibrils in such a way that they align to 
form nascent myofibrils. Several Z-bodies fuse together to form Z-bands in which muscle 
myosin II filaments are eliminated finally resulting in the formation of mature myofibrils.  
Telethonin does not represent a static component of the myofibril, but might be a protein 
involved in the dynamic control of early events of Z-disc formation during of 
myofibrillogenesis where it co-localizes with titin and thus plays an important role in 
myofibril turnover. Since VITO-1 interacts with T-cap in both yeast two hybrid system 
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and protein binding assays, we asked whether VITO-1 is also associated in the early 
stages of myofibrillogenesis.  
 
 
 
 
 
 
Figure 37. Vito1 might be involved during myofibrillogenesis of skeletal muscle cells. 
Skeletal muscle cells were isolated from 11 day old chicken embryo and cotransfected 
with Vito1 GFP and T-cap N1.  VITO1 could be seen involved in myofibrillogenesis 
where it localized to the Z-bodies and nascent myofibrills and thus might play an 
important role in skeletal muscle myogenesis 
Primary myocytes cultures from 11 day old chicken embryos were isolated as described 
in materials and methods. Cells were transfected with VITO-1 GFP and T-cap-N1 using 
calcium phosphate method and the spreading edge of myocyte expressing VITO-1-GFP 
was monitored over a 15h time period. Cells were fixed at two different time points 
expressing VITO-1-GFP (4 hrs and 8hrs) and visualized under a fluorescent microscope. 
VITO-1 is expressed in punctuated patterns which are supposedly premyofibrils or 
nascent myofibrils containing the z-bodies which later mature to form Z-bands containing 
mature myofibrils (Fig. 37). These findings need to be confirmed by using early 
myofibrillogenesis markers like muscle alpha-actinin, muscle myosin II, titin, etc.
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4. Discussion 
Translocation of proteins from nucleus to cytoplasm plays a very important role in 
regulating gene expression. In the past it was assumed that regulatory factors are confined 
to either the nucleus or the cytoplasm, until an appropriate signal triggers transport of 
these factors to the other side of the nuclear envelope. Recently several pieces of 
evidence suggest that most of these proteins are moving in and out of the nucleus thus 
transmitting various signals necessary for gene regulation. Depending on the equilibrium 
between import and export rates, such proteins localize either in the nucleus or in the 
cytoplasm. Compared to the model of retention versus transport, continuous shuttling 
may allow for a tighter regulation of protein activity. Firstly, interaction of transport 
receptors with shuttling proteins most often generates inactive protein complexes, thus 
preventing action in the lack of appropriate signals. Secondly, the existence of a 
permanent pool of the protein in both compartments favors a more rapid association to 
target molecules upon signal induction, without the delay associated with translocation 
across the nuclear envelope. Interfering with nucleocytoplasmic shuttling opens a novel 
and exciting window to manipulate cellular processes. 
4.1 Other partners of VITO-1 obtained from the Y2H 
Screen 
The Y2H screen of VITO-1 also displayed some other interesting candidates which have 
to be still investigated. A single clone of the dual specificity phosphotase (DUSP13) was 
detected as a possible partner of VITO-1. Members of the protein-tyrosine phosphatase 
superfamily cooperate with protein kinases to regulate cell proliferation and 
differentiation. This superfamily is separated into two families based on the substrate that 
is dephosphorylated. One family, the dual specificity phosphatases (DUSPs) acts on both 
phosphotyrosine and phosphoserine/threonine residues. This gene encodes different but 
related DUSP proteins through the use of non-overlapping open reading frames, alternate 
splicing, and presumed different transcription promoters (Lang, Hammer et al. 2006). 
Expression of the distinct proteins from this gene has been found to be tissue specific and 
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the proteins may be involved in postnatal development of specific tissues. A protein 
encoded by the upstream ORF was found in skeletal muscle MDSP (Muscle-restricted 
dual specific phosphotase), whereas the encoded protein from the downstream ORF was 
found only in testis TMDP (Testis and Muscle specific dual specificity phosphatase). In 
the mouse, a similar pattern of expression was found. Multiple alternatively spliced 
transcript variants were described, but the full-length sequence of only some were 
determined. Both MDSP and TPDP, has been reported as a nuclear protein in cultured 
cells (Tanner, Trievel et al. 1999; Todd, Tanner et al. 1999) and to be diffusely 
distributed in the cytosol of resting T-cells (Alonso, Rahmouni et al. 2003). Hsu-Hsin 
Chen, Ralf Luche et al (Chen, Luche et al. 2004) overexpressed untagged MDSP in 
differentiated C2C12 myotubes and performed a direct immunofluorescence. MDSP 
displayed a diffuse staining in the cytosol and was apparently excluded from all nuclei. 
The same results were obtained COS-1, Hela cells and also when C2C12 myoblasts were 
transfected with MDSP prior to induction of differentiation and hence concluded that 
MDSP is primarily cytosolic. VITO-1 is also present in a diffuse pattern in the 
cyotoplasm when over-expressed alone. In the presence of T-cap, VITO-1 is strongly 
expressed in the cytosol and translocate into the nucleus in the presence of TEF. It is 
quite possible that MDSP dephosphorylates VITO-1 and this post-translational 
modification might be involved in the shuttling effect of VITO-1 in regulating TEF 
dependent genes as well as the Z-disc proteins. However the true interaction of VITO-1 
with MDSP needs to be established before coming to any final conclusions.  
4.2 Nucleocytoplasmic translocation of VITO-1 might 
play an important role in skeletal muscle myogenesis.  
Initially VITO-1 was identified as a co-activator of TEFs in regulating the transcription 
of muscle specific genes. Reporter gene assays indicate that VITO-1 by itself was not 
able to trans activate the reporter gene but was able to do so in the presence of TEFs 
(Gunther, Mielcarek et al. 2004). This indicates that VITO-1 plays a supportive but 
significant role in activating the TEFs from its dormant state to regulate its target genes.  
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MyoD, a member of the myogenic regulatory factors (MRFs) family, is a key protein in 
regulating muscle differentiation. This gene encodes a nuclear protein that regulates 
muscle cell differentiation by inducing cell cycle arrest, a prerequisite for myogenic 
initiation and also plays a role in muscle regeneration. Being one of the earliest markers 
of myogenic commitment, it activates its own transcription which may stabilize 
commitment to myogenesis. VITO-1 seems to be an important component of this 
program that appears to be necessary to activate TEF-1 transcription factors. The knock 
down of VITO-1 using siRNA inhibits expression of myogenin and results in the 
attenuation of C2C12 myotube formation. The supportive role of VITO-1 in MyoD 
mediated myogenic conversion of 10T1/2 fibroblasts into muscle cells further established 
the role of VITO-1 as an important co-factor of the muscle regulatory program. Studies 
from this thesis work reveal a novel interaction between VITO-1 and the Z-disc proteins 
T-cap and MYOZ1. When T-cap is over-expressed, VITO-1 shuttles from nucleus to the 
cytoplasm where it localizes at the Z-discs of sarcomeres. Quantitative ONPG reporter 
gene assay show that VITO-1 binds to TEFs with stronger affinity than with T-cap or 
Myozenin1 suggesting that relative amounts of interaction partners as well as their 
binding activity will dictate the eventual localization of VITO-1. 
Several other muscle proteins are known to shuttle between the cytoplasm and nucleus. 
The muscle LIM protein (MLP) is a muscle-specific LIM-only factor that exhibits a dual 
subcellular localization (Kong, Flick et al. 1997), being present in both the nucleus and in 
the cytoplasm. Overexpression of MLP in C2C12 myoblasts enhances skeletal 
myogenesis, whereas inhibition of MLP activity blocks terminal differentiation as 
observed for VITO-1. MLP functions through a physical interaction with the muscle 
basic helix-loop-helix (bHLH) transcription factors MyoD, MRF4, and myogenin but 
does not associate with the myocyte enhancer factor-2 (MEF2) protein, which acts 
cooperatively with the myogenic bHLH proteins to promote myogenesis. Similar to 
VITO-1, MLP also lacks a functional transcription activation domain and serves as a 
cofactor for the myogenic bHLH proteins by increasing their interaction with specific 
DNA regulatory elements.  
                                                                                                                         Discussion                                                                                            
 
 108
Cardiac ankyrin repeat protein (CARP, also known as Ankrd1) has been independently 
identified by several groups as a cytokine-inducible transcriptional regulator, a protein 
interacting with transcription factor YB-1, and a cardiac doxorubicin-responsive protein. 
In skeletal muscles, CARP expression is up-regulated under particular conditions 
including hypertrophy, eccentric contraction, denervation, and muscular dystrophy 
(Carson, Nettleton et al. 2002; Tsukamoto, Senda et al. 2002; Nakada, Tsukamoto et al. 
2003; Barash, Mathew et al. 2004; Witt, Labeit et al. 2005; Hentzen, Lahey et al. 2006). 
Although CARP is known to be involved in the regulation of gene expression in the 
heart, Bang et al. 2001demonstrated that CARP located to both the sarcoplasm and 
nucleus, suggesting a shuttling of CARP in cellular components. CARP also localizes in 
cardiac sarcomere although the roles of “sarcomeric CARP” are not fully elucidated. 
Several reports have demonstrated that CARP binds titin/connectin, myopalladin, and 
desmin at the Z/I-region of sarcomere. Myopalladin can also bind nebulin and alpha-
actinin, (Bang, Mudry et al. 2001) and these proteins are able to bind other members of 
the Z-disc, thus constituting a network of interactions. Unlike VITO-1 and MLP, CARP 
expression is up-regulated not only by myogenin and MyoD, but also induced by 
myocyte enhancer factor 2 (MEF2), which acts as a transcriptional regulator of skeletal 
muscle remodeling and is expressed from embryogenesis through to adulthood. 
Ankrd2 (also known as Arpp) is a sarcomeric protein found in the I band, (Kemp, 
Sadusky et al. 2000; Moriyama, Tsukamoto et al. 2001; Pallavicini, Kojic et al. 2001) 
that is involved in skeletal muscle hypertrophy. Ankrd2 is able to interact with the Z-disc 
protein telethonin and with three other transcription factors PML, p53 and the ubiquitous 
transcription factor YB-1 similar to CARP (Kojic, Medeot et al. 2004). The Ankrd2 gene 
is significantly up-regulated in response to prolonged mechanical induced stretch1 as 
well as denervation4 and the protein is up-regulated upon myoblast differentiation 
(Pallavicini, Kojic et al. 2001). It should be noted that VITO-1 is also upregulated in 
differentiated C2C12 myotubes although some expression was found in proliferating 
myoblasts. Ankrd2 has putative binding motifs for the muscle specific transcriptional 
factor MyoD (Pallavicini, Kojic et al. 2001). Camilla Bean et al (Bean, Salamon et al. 
2005)used MyoD – silenced C2C12 cells to demonstrate that Ankrd2 is a MyoD 
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downstream target gene. The promoter activity of Ankrd2 was investigated under 
conditions where C2C12 cells express altered levels of MyoD and found that a minimal 
region of 290 bp contains putative E-boxes and is the critical regulator of Ankrd2. 
Ankrd2 expression is regulated by MyoD during earlier stages of myogenic 
differentiation (1d time-point) and later (3d and 6d time-points) seems to be replaced by 
unknown alternative mechanism in regulating Ankrd2 expression. 
It was previously shown that NFAT proteins translocate from the cytoplasm to the 
nucleus in response to sustained Ca2+ mobilization and return to the cytoplasm when the 
Ca2+ signal ends. NFATc remained completely cytoplasmic when both the Rel-similarity 
domain (RSD NLS) and the NFAT-homology region (NHR) nuclear localization signal 
(NLS) were mutated (Beals, Clipstone et al. 1997). After having translocated to the 
nucleus and bound to DNA, NFAT proteins can enhance transcription by recruiting or 
facilitating the binding of AP-1 transcription factors to NFAT–AP-1-binding sites (Luo, 
Burgeon et al. 1996). The components of the AP-1 transcription factor (Fos and Jun 
polypeptides) then mediate the induction of transcription by recruiting co-activators such 
as CBP (CREB-binding protein), p300 and JAB1 (Jun activation domain binding 
protein), through their transcriptional activation domains (Karin, Liu et al. 1997). These 
co-activators augment transcription activity by recruiting the basal transcription 
machinery through direct protein–protein interactions and by acetylating histones, which 
increases accessibility of nucleosomal DNA to transcription factors (Hertel, Lynch et al. 
1997). Co-transfection of ribosomal S6 kinase (RSK2) and NFAT3 markedly enhanced 
multinucleated myotube differentiation of C2C12 myoblasts (Cho, Yao et al. 2007). In 
addition, RSK2 mutation or knockdown dramatically decreased NFAT3 activity and 
promoter activity of NFAT3 target genes as well as myotube differentiation. These 
results suggest that NFAT3 is critical for myotube differentiation. Moreover, RSK2 is 
shown to be a key protein kinase that phosphorylates NFAT3, which is critical in the 
process of differentiation. 
The functional complex of VITO-1 with TEFs and the Z-disc proteins reveals a novel 
mechanism for both initiating and maintaining the myogenic program and suggests a 
global strategy by which VITO-1 proteins may control a variety of developmental 
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pathways. The mechanism by which VITO-1 promotes skeletal muscle differentiation 
remains to be investigated. Further functional analyses are required to understand the 
molecular basis of the relationship of VITO-1 and other genes mentioned above with 
MyoD and to clarify their direct role in muscle development or other pathological 
situations. 
4.3 The subcellular localization of VITO-1 is modulated 
by TEFs and the Z-disc proteins 
VITO-1 functionally and physically interacts with TEF-1 factors (Gunther, Mielcarek et 
al. 2004) as reported also for Vgl-2 (Maeda, Chapman et al. 2002) which is a homologue 
of VITO-1. The contribution of the interaction of VITO-1 with TEFs in muscle-specific 
gene regulation needs to be further studied in detail. Chen et al (Chen, Mullett et al. 
2004), showed that the amount of endogenous TEF-1 that binds to the MCAT DNA 
sequence decreases as skeletal muscle differentiation progresses. This might suggest that 
TEF-1 expression declines with muscle differentiation. Alternatively, an up-regulation of 
VITO-1 expression during muscle differentiation might modulate TEFs-DNA 
interactions resulting in a reduction of the occupancy of MCAT binding sites by TEFs. 
Differentiation of muscle cells into myotubes and finally into mature myofibers requires 
the interplay of many proteins that are involved in sarcomere assembly. In striated muscle 
cells, the Z-disc constitutes the border of individual sarcomeres, where anti-parallel actin 
filaments spanning the sarcomeres are cross-linked. The Z-disc plays a key role in the 
supramolecular assembly of the sarcomeric unit during myogenesis, in the transmission 
of the tension generated by various sarcomeres along myofibrils and in the regulation of 
contractile activity. Mutations in Z-disc components have been found to be responsible 
for various forms of muscle disorders, proving the importance of these proteins in 
maintaining the integrity of striated skeletal muscle cells (Dalkilic and Kunkel 2003). 
Some of the Z-disc proteins including -actinin 2 (Luther 2000), telethonin (Mues, van 
der Ven et al. 1998), ZASP-1 (Faulkner, Pallavicini et al. 1999), FATZ-1 (filamin, -
actinin and telethonin binding protein of the Z-disc; also termed myozenin-1 or calsarcin 
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2) (Faulkner, Pallavicini et al. 2000; Frey, Richardson et al. 2000; Takada, Vander 
Woude et al. 2001), myotilin (Salmikangas, Mykkanen et al. 1999) and myopalladin 
(Beggs, Byers et al. 1992; Bang, Mudry et al. 2001) are primarily or exclusively found at 
that location. According to this study, VITO-1 is a novel Z-disc associated protein which 
interacts with both telethonin, myozenin1 as well as the transcription factor TEFs. Over-
expression of VITO-1 together with T-cap results in the translocation of VITO-1 from 
Nucleus to the Z-discs in mouse cardiomyocytes as well as in chicken primary myocytes. 
From the ONPG reporter gene assay it is clear that VITO-1 binds to TEFs with a higher 
efficiency compared to either T-cap or Myozenin1.  
When VITO-1 was over-expressed in the presence of TEF in differentiated C2C12 
myotubes, VITO-1 translocates into the nucleus (Fig. 38 D, I, N) as observed in other 
cells types like HEK293 cells and 10T1/2 cells. On the other hand, when VITO-1 is over-
expressed together with T-cap VITO-1 does not show any specific localization in the 
nucleus but is completely distributed all over the differentiated cell (Fig. 38 C ,H, M). 
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Figure 38. VITO-1 translocates between cytoplasm and nucleus in differentiated 
C2C12 myotubes. (D, I, N) - VITO-1 GFP is completely transported to the nucleus when 
co-transfected with TEF3. (C, H, M) – When VITO1 is co-transfected with T-cap, VITO-1 
is distributed throughout the cells. (E ,J, O) - Co-transfection of all three plasmids, 
VITO-1, T-cap and TEF3 directs VITO-1 to the nucleus as well as cytoplasm. However 
VITO-1 was more intensely expressed in the nucleus. 
Interestingly, when VITO-1 was co-expressed with TEF-3 and T-cap, VITO-1 is 
distributed both in nucleus as well as cytoplasm (Fig. 42 E, J, and O). However it should 
be mentioned that VITO-1 is localized at the nucleus with more intensity where it 
supposedly interacts with TEF-3 than in the cytoplasm where it might associate with T-
cap. This is consistent with the ONPG assay in which VITO-1 activated the reporter gene 
with TEF-3 two to three folds more than with T-cap or MYOZ1 (Fig. 20). This 
nucleocytoplasmic property of VITO-1 needs to be analyzed further to attribute the 
significance of VITO-1’s role in different cellular components.  
4.4 Post-translational modification might be involved in 
trafficking VITO-1 
Posttranslational modification is the chemical modification of a protein after its 
translation. It is one of the later steps in protein biosynthesis for many proteins. During 
protein synthesis, 20 different amino acids can be incorporated in proteins. After 
translation, the posttranslational modification of amino acids extends the range of 
functions of the protein by attaching to it other biochemical functional groups such as 
acetate, phosphate, various lipids and carbohydrates, by changing the chemical nature of 
an amino acid or my making structural changes, like the formation of disulphide bonds. 
Transcriptional factors and co-factors are modified quite often by phosphorylation, 
SUMOylation, ubiquitination, glycosylation, acetylation, methylation and many others 
that change the regulation of genes thus inducing structural changes and addition of other 
proteins or peptides. The computational biology software NetPhos 2.0 Server predicted 
several phosphorylation sites and two potential sumoylation sites for VITO-1 (Fig. 43w) 
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VITO-1 sequence 
   
MSCLDVMYQVYGPPQPYFAAAYTPYHQKLAYYSKMQEAQECASPGSSASGSSSFSNPTPASVKEE
EGSPEKERPPEAEYINSRCVLFTYFQGDISSVVDEHFSRALSHPSSYTPSCTSSKAHRSSGPWRAEGT
FPMSQRSFPASFWNSAYQAPVPAPLGSPLAAAHSELPFATDPYSPATLHGHLHQGAADWHHAHPH
HAHPHHPYALGGALGAQASAYPRPAVHEVYAPHFDPRYGPLLMPAATGRPGRLAPASAPAPGSPP
CELAAKGEPAGSAWAAPGGPFVSPTGDVAQSLGLSVDSGKRRRECSLPSAPPALYPTLG                                                                                   
  
Potential Phosphorylation sites predicted:  Serine (S): 19  
                                                              Threonine (T): 2; Tyrosine (Y): 3 
 
Sumoylation sites predicted: 2 – VKEE, AKGE 
 
The amino acids underlined and highlighted in yellow color is the SID domain through 
which VITO-1 mediates its interaction with other partners.  
 
 
                 
 
Figure 39. Phosphorylation sites of VITO-1 as predicted from Netphos 2.0 software 
As predicted from Netphos software, VITO-1 has 19 Serine (green), 2 Threonine (gray) 
and 2 tyrosine potential phosphorylation sites. Importantly considered should be the 
phosphorylation sites in the SID domain of VITO-1 (60 – 156 amino acids) as VITO-1 
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requires the SID domain to interact and activate the TEF-1 and TEF-3 genes (Gunther, 
Mielcarek et al. 2004) and control the regulation of their dependent genes. VITO-1 also 
interacts with the sarcomeric Z-disc proteins T-cap and MYOZ1 (FATZ) through its SID 
domain as seen from the yeast two hybrid, Co-IP and immunocytochemistry experiments. 
The SID domain of VITO-1 contains 10 serine, 1 threonine and 1 tyrosine 
phosphorylation sites. Although one might be tempted to look at the consensus sequence 
containing the phosphorylation sites, even phosphorylation at non-consensus sites might 
be important to modify the function of VITO-1 to transclocate from nucleus to the 
sarcomeres in striated muscle cells. Point mutagenesis at different serine residues in the 
SID domain of VITO-1 will help to evaluate the potential impact of phosphorylation 
events at these sites. The nucleoplasmic shuttling of many proteins is modulated by 
different kinases and phosphotase responsible for the posttranslational modifications thus 
exporting the protein from nucleus to cytoplasm and vice versa in response to various 
stimuli and extracellular growth factors. Vestigial, a homologue of VITO-1 interacts with 
Scalloped (sd) through a 56-amino-acid domain, as Sd does not bind to a deleted Vg 
protein missing only these amino acids, and a construct encoding only this portion of the 
protein will still bind to Sd. Significantly, a duplicate panel of Vg deletion proteins 
probed with TEF-1 shows that TEF-1 interacts with Vg via the same protein domain. 
Affinity columns containing this protein fragment of Vg bind Sd and TEF-1 protein as 
well as full-length Vg (Halder and Carroll 2001). This Sd/TEF-1-binding domain of Vg is 
serine rich and includes putative phosphorylation sites (Williams, Bell et al. 1991). 
Phosphorylation of Vg at these sites may potentially modify the Vg–Sd interaction 
similar to that of VITO-1 and TEF.  
Muscle LIM protein (MLP) and myopodin are two sarcomeric proteins of the Z-band that 
bind α-actinin and move between the sarcomere and the nucleus: muscle LIM protein 
(MLP) and myopodin. Faul et al (Faul, Dhume et al. 2007) showed how phosphorylation 
and dephosphorylation regulate myopodin’s localization to the Z bands or nucleus. 
Phosphorylation of myopodin by either protein kinase A (PKA) or calcium-calmodulin–
dependent protein kinase II (CaMKII) induces myopodin’s release from α-actinin, its 
binding partner in the Z band, and its entry into the nucleus. Dephosphorylation of 
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myopodin by the calcium-activated phosphatase calcineurin permits myopodin to remain 
or relocalize to the Z band. If the phosphatase activity of calcineurin is inhibited, 
myopodin moves into the nuclei of cardiac myocytes. Moreover, pharmacological 
inhibition of the phosphorylation action of PKA reduced or abolished the import of 
myopodin into the nucleus. Activation of PKA by pharmacological agents leads to 
diffuse Z-band localization and nuclear localization of myopodin in adult 
cardiomyocytes. The mechanism of MLP movement from the Z band into the nucleus has 
not been determined. Protein kinase inhibitor α (PKIA) was also identified as a single 
clone from the VITO-1 Y2H screen. VITO-1 might also be phosphorylated by PKA or 
CaMKI kinase which leads to the translocation of VITO-1 from the sarcomeres into the 
nucleus. De-phosphorylation of VITO-1 by DUSP-13 (Dual specificity phosphatase) 
which is another potential interaction partner might control the relocation of VITO-1 
back to the Z-discs. 
VITO-1 interacts with telethonin and is localized at the Z-discs in its presence. It is 
known that telethonin can be phosphorylated by the kinase region of titin. This domain of 
titin is, surprisingly, located in the M-band region of the A band, about as far apart as two 
partners might be in a sarcomere. These disparate locations led to speculation that titin 
might be released from the middle of the thick filaments to phosphorylate the telethonin 
in the Z band.. Studies also reveal the presence of T-cap in the nucleus however its role in 
the nucleus is not yet investigated. VITO-1 as a transcriptional co-factor is located in the 
nucleus even in the absence of T-cap. It seems that unbound T-cap translocates to the 
nucleus where it associates with VITO-1 and induces posttranslational modifications that 
lead to a release from the nucleus into the sarcomere. Such hypotheses have to be 
analyzed carefully. The predicted phosphorylation sites of VITO-1 should be confirmed 
by eastern blotting or mass spectrometry. Unpublished previous work from Mielcarek et 
al claim that VITO-1 protein was most probably phosphorylated in 293T, 3T3 and C2C12 
cell lines since an additional band with a molecular weight shift of 1-2 kD was observed. 
Nevertheless this needs further confirmation. 
VITO-1 might also undergo sumoylation by SUMO proteins as VITO-1 sequence 
contains 2 sumoylation sites (marked in pink in the VITO-1 sequence) and especially the 
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one at the beginning of the SID domain (VKEE) adjacent to the serine residue. SUMO is 
a member of multiple ubiquitin family proteins that becomes covalently attached to other 
proteins via an amide linkage between the C-terminal carboxyl group of the ubiquitin 
family protein and lysine side chains in the target proteins (Melchior, Schergaut et al. 
2003; Seeler and Dejean 2003; Verger, Perdomo et al. 2003; Johnson 2004; Hay 2005). 
Conjugation of ubiquitin, the best characterized member of the family, to other proteins 
usually marks these proteins for destruction by the 26S proteasome; the 
ubiquitin/proteasome pathway is the major pathway for regulated protein degradation in 
eukaryotic cells. In contrast, conjugation of SUMO to proteins does not mark them for 
destruction, but modifies their properties in other ways. Previous genetic analyses have 
demonstrated a role for the sumoylation machinery in embryonic patterning. For 
example, in C. elegans embryos, loss of SUMO, Ubc9, or the SUMO activating enzyme 
results in homeotic transformations apparently due to a role for sumoylation in the 
function of the Polycomb group protein SOP-2 (Zhang, Christoforou et al. 2004). In 
Drosophila embryos, loss of Ubc9 results in the deletion of variable numbers of thoracic 
and anterior abdominal segments, but in this case the relevant sumoylation target is not 
known (Epps and Tanda 1998). Previous genetic analysis also suggests a role for 
sumoylation in immune system function as mutations in sumo or ubc9 compromise the 
Drosophila innate immune response by attenuating the LPS-induced expression of genes 
encoding anti-microbial peptides such as Cecropin A1 (Bhaskar, Smith et al. 2002). 
Sumoylation significantly stimulates the function of the Drosophila rel family protein 
Dorsal since rel family proteins play critical roles in both vertebrate and invertebrate 
innate immunity. Finally, a recent yeast two-hybrid screen indicates that Dof, a 
cytoplasmic component of the FGF signaling pathway, interacts with multiple 
components of the SUMO conjugation pathway. This suggests possible roles for SUMO 
conjugation in the morphogenetic processes controlled by FGF receptors such as 
mesodermal and tracheal morphogenesis (Battersby, Csiszar et al. 2003). Preliminary 
results obtained from sumoylation assay by unpublished data from the dissertation work 
of Michael Mielcarek (2007) suggested that VITO-1 is a potential candidate to bind 
SUMO protein covalently, since two additional bands, which caused an increase of the 
MW of 10-15 kDa were found. Addition of GAM1 protein leads to inhibition of the 
                                                                                                                         Discussion                                                                                            
 
 117
global sumoylation machinery. Co-transfection of VITO-1 with GAM1 efficiently 
inhibited formation of several VITO-1 bands. Takanaka et al (Takanaka and Courey 
2005) show that the SUMO machinery acts to augment Vestigial (Vg) function. SUMO 
loss-of-function mutations act as genetic enhancers of vg loss-of-function mutations. 
Flies doubly heterozygous for recessive hypomorphic vg alleles and recessive sumo or 
ubc9 alleles exhibit wing notching that is as severe as that exhibited by flies homozygous 
for the vg mutant alleles. In addition, co-overexpression of SUMO and Vg in the wing or 
eye significantly exacerbates the phenotype due to overexpression of Vg alone.  
Conjugation of SUMO with VITO-1 might direct VITO-1 to specific subcellular locales 
including the nuclear PML oncogenic domains (PODs) as shown by (Ishov, Sotnikov et 
al. 1999). PML is critical for ND10 formation and recruits the PML-interacting protein 
daxx to this nuclear structure when modified by SUMO-1. Sumoylation can also stabilize 
proteins by antagonizing ubiquitylation (Desterro, Rodriguez et al. 1999; Lin, Liang et al. 
2003) and can also modulate the function of VITO-1 which eventually might have an 
effect on TEFs transcriptional activity. There are two lysine residues (Lys 67 and Lys 
269) that are located in a motif resembling the consensus sumoylation site. Lys 67 is 
located in the sequence VKEE and Lys 269 in the sequence AKGE, while the 
sumoylation consensus is ψKxE (with ψ signifying a hydrophobic residue). Mutagenesis 
of lysine to arginine should significantly reduce the ability of VITO-1 to serve as a target 
for sumoylation. It may be well possible that sumoylation of VITO-1 occurs at non-
consensus sites. There are multiple precedents for such non-consensus sites in other 
sumoylation targets (Johnson and Blobel 1999; Rodriguez, Dargemont et al. 2001). The 
prediction of a likely role for sumoylation in VITO-1 adds to a growing body of evidence 
suggesting pleiotropic roles for sumoylation in the development and function of 
multicellular organisms. 
4.5 VITO-1 a novel Z-disc protein? 
Z-discs are not simple mechanical joints but are a compartment built by a complex set of 
proteins which contribute to well defined structures that act as stress sensors in 
transmitting signal from the extracellular membrane into the nucleus and regulating the 
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fate of many cardiac and skeletal muscle specific genes. These include a subset of 
adaptor molecules that have putative binding motifs. The accumulation of signaling-
related proteins at z-discs and their physiological significance were extensively reviewed 
by Pyle and Solaro (Pyle and Solaro 2004).  
 
                                     -  Hoshijima, M. 2006, Am J Physio Heart Circ Physiol (modified) 
Figure 40. Z-disc associated cytosketal structure proteins. Many of these proteins have 
been linked to intrinisic mechanical sensor-signal modulator functions. VITO-1(red) 
seems to be a novel member of this complex interacting with T-cap and Myozenin in 
addition to oits role as a co-factor of TEFs (green). VITO-1, T-cap, MYOZ1, PDZ-3LIM, 
one-PDZ and 3-LIM domain protein, MLP/CRP3, Titin, Ankrd2, MARPS, α-actinin, 
actin, nebulin, FHL2, MURFS and other proteins of the a and I band of the Z-discs is 
shown above.  
In this study, Telethonin and Myozenin1 were identified as interaction partners of VITO-
1 which is a co-factor of TEF dependent skeletal muscle gene regulation. Yeast two 
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hybrid analysis, Co-IPs and immunocytochemistry experiments clearly suggest that 
VITO-1 physically interacts with T-cap and MYOZ1. However the physical interaction 
of VITO-1 with these Z-disc proteins could only be established in differentiated muscle 
types and not in non-muscle or undifferentiated muscle cells. VITO-1 requires the 
striated muscle environment where it needs the assistance of other cofactors or 
chaperones to mediate interaction with T-cap and MYOZ1.  
Studies suggest that a hypo-phosphorylated rather than a hyper-phosphorylated form of 
MyoD may be more subject to acetylation as cells undergo differentiation (Mal et al., 
2001). MyoD is highly phosphorylated in proliferating myoblasts, but undergoes 
substantial de-phosphorylation once these cells are induced to differentiate (Kitzmann et 
al., 1999). Thus acetylation of MyoD occurs only in differentiated cells. 
Similarly VITO-1 might undergo certain post-translational modifications in differentiated 
cells and/or undergo a conformational change which facilitates interaction with telethonin 
and myozenin. Although yeasts do not have sarcomeres, VITO-1 still interacts with 
telethonin and myozenin in the Y2H system. A similar modification of amino acid 
residues might possibly occur in VITO-1 during or after translation thus exposing their 
protein binding sites to interact with telethonin and myozenin. Some proteins might 
specifically interact when they are co-expressed in the yeast, although in reality they are 
never present in the same cell at the same time. However, in most cases it cannot be ruled 
out that such proteins are indeed expressed in certain cells or under certain circumstances. 
Co-IPs also revealed T-cap and MYOZ1 both precipitating together with VITO-1 thus 
forming a complex. MYOZ1 (FATZ-1), together with FATZ-2 and FATZ-3, belongs to a 
family of proteins, named calsarcins, and they interact with sarcomeric calcineurin, a 
calcium/calmodulin-dependent phosphatase involved in the regulation of genes affecting 
muscle differentiation and the formation of different fiber types (Delling, Tureckova et al. 
2000; Frey, Richardson et al. 2000; Frey, Barrientos et al. 2004). MYOZ1 interacts with 
actinin-2, Zasp, T-cap, filamin and myotilin which is mainly expressed in striated muscle. 
Interaction between these two proteins was established by yeast two-hybrid studies, 
biochemical and cell transfection assays as in the case of VITO-1. Pathogenic mutations 
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in the myotilin gene cause a subset of myofibrillar myopathies and limb girdle muscular 
dystrophy (LGMD) type 1A that are characterized by streaming of Z-discs and 
degeneration of myofibers (Hauser, Horrigan et al. 2000; Hauser, Conde et al. 2002; 
Selcen and Engel 2004). Mutations in T-cap also cause LGMD. Telethonin interacts with 
ZASP, Titin, MINK, myostatin, MURFs, MYOZ1, PKD and Ankrd2. Ankrd2 is also an 
interesting protein with bi-functional action in both nucleus and Z-discs like VITO-1. 
Ankrd2 can interact with p53, Pre-myelocytic leukemia protein (PML) and YB-1, in vitro 
(Kojic, Medeot et al. 2004) and can translocate from the I-band into the nucleus after 
muscle injury (Tsukamoto, Hijiya et al. 2008). Recent studies show that Ankrd2 is 
expressed mainly in slow muscle type and is not involved in hypertrophy. Unpublished 
data also reveal that VITO-1 is a slow muscle type protein whose knock out results in a 
loss of slow fibers, which are markedly increased in atrophic conditions. CARP, a 
transcription factor, is known to be involved in the regulation of gene expression in the 
heart. Bang et al (Bang, Mudry et al. 2001) demonstrated that CARP localized to both the 
sarcoplasm and nucleus, suggesting a shuttling of CARP in cellular components. CARP, 
ankrd-2/Arpp, and DARP, are three members of the conserved gene family of muscle 
ankyrin repeat proteins whose expression is induced upon injury and hypertrophy 
(CARP), stretch or denervation (ankrd2/Arpp), and during recovery following starvation 
(DARP), suggesting that they are involved in muscle stress response pathways. Stretch of 
fetal rat cardiac myocytes for 90 minutes resulted in a striking increase of CARP staining 
in both the nucleus and on myofibrils, in most, if not all, myocytes, relative to 
unstretched control cells (Miller, Bang et al. 2003). Stretch did not appear to affect 
ankrd2/Arpp staining, titin N2A or α-actinin, showing that stretch did not cause 
myofibrillar damage. It would be interesting to study the expression of VITO-1 under 
such stretch conditions to see if VITO-1 remains in nucleus or at the Z-discs or results in 
an increased expression in both the nucleus and Z-discs as in the case of CARP.  
To conclude, we can say that Z-disc proteins have not only a single or two partners, but 
are generally associated with a bundle of proteins depending on the extracellular stimuli 
and pathological conditions involved and change their functions thereby acting as a 
component of the mechanical sensor that signals to the transcription machinery (Fig. 40). 
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VITO-1 is a novel member of this family of proteins with a dual role and it can expected 
that VITO-1 probably associates with other partners amidst T-cap, MYOZ1 and the 
transcriptional factor TEFs, playing an active role in the signaling cascade between the 
nucleus and sarcomeres to regulate skeletal muscle-specific genes and muscle stress 
response pathways. 
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5. Summary 
Transcriptional regulation in heart and skeletal muscle is controlled by the combined 
action of 3 major families of transcription factors namely the the bHLH, MADs box 
transcription factors and the Transcriptional enhancer factor (TEFs) which play important 
roles for the development of muscle tissues and regulated expression of muscle specific 
genes. MCAT element (5'-CATTCCT-3') has been found in a number of cardiac, smooth, 
and skeletal muscle-specific genes, including cardiac troponin T, β-myosin heavy chain 
(β-MHC), smooth and skeletal muscle -actin. The proteins that bind to the MCAT 
element belong to the TEF family of transcription factors. VITO-1 was identified as an 
essential co-factor of TEF1 and activates TEF1 through its SID domain, which results in 
the transcription of genes involved in muscle cell differentiation. In this thesis, I have 
analyzed various molecular characteristics of VITO-1 and studied its role in different cell 
types.  
To analyze and compare the subcellular localization in different cell types, VITO-1 was 
over-expressed in HEK 293, C2C12 and CH10T1/2 cell line. VITO-1 displayed a 
predominant localization in the nucleus of C2C12 and CH10T1/2 cells whereas a 
cytoplasmic distribution in HEK 293 cells which might be attributed to the absence of 
endogenous TEFs in this cell line. Co-expression of TEFs with VITO-1 in HEK 293, 
C2C12 CH10T1/2 cell lines resulted in a complete translocation of VITO-1 into the 
nucleus. Expression of VITO-1 deletion mutant constructs in C2C12 cells proved the 
requirement of SID domain to translocate into the nucleus. In the presence of VITO-1, 
differentiated C2C12 cells formed large myotubes which supports its role in muscle cell 
formation. To identify additional binding partners of VITO-1, a yeast two hybrid screen 
was performed with a skeletal muscle cDNA library using the GAL4 system. From a total 
of 48 positive clones we focused on Telethonin (T-cap) and Myozenin1 (MYOZ1, 
FATZ) as they were isolated as independent overlapping clones. Telethonin (T-cap) is 
one of the most abundant transcripts expressed in striated muscle at the Z-discs. MYOZ1 
is also a sarcomeric protein that is known to interact with T-cap. The interactions of T-
cap and MYOZ1 clones with VITO-1 were reconfirmed using the Y2H assay. An ONPG 
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β-galactosidase reporter gene assay revealed that VITO-1 binds TEFs with greater 
efficiency than T-cap and MYOZ1. A failure of Co-IP using the in vitro transcripted / 
translated proteins to substantiate the interaction between these proteins might be due to 
the absence of native cellular environment. Since VITO-1 is known to be up regulated in 
differentiated C2C12 cells and T-cap and MYOZ1 are Z-disc proteins, we used 
differentiated C2C12 myotubes and chicken primary myocytes for the Co-IP 
experiments. Indeed VITO-1 containing the SID domain co-immunoprecipitated with T-
cap and Myozenin1 in differentiated C2C12 myotubes and primary chicken myocytes 
thus demonstrating efficient physical interaction. This interaction is mediated through the 
SID domain as VITO-1 lacking the SID domain did not interact with T-cap and MYOZ1. 
Immunohistochemistry analysis showed that VITO-1 co-localizes with T-cap in HEK 293 
and cos-1 cells. Ectopically expressed VITO-1 was localized both in the nucleus and the 
Z-discs of neonatal cardiomyocytes. When VITO-1 was co-expressed with T-cap in 
chicken myocytes, it was localized predominantly at the Z-discs of sarcomeres. A co-
expression of VITO-1 with TEF and T-cap in differentiated C2C12 myotubes showed 
that VITO-1 is distributed both in nucleus as well as cytoplasm. VITO-1 is localized at 
the nucleus with more intensity where it supposedly interacts with TEF-3 than in the 
cytoplasm where it might associate with T-cap. This nucleo-cytoplasmic property of 
VITO-1 needs to be further analyzed. To summarize, the transcriptional co-activator 
VITO-1 plays a novel role by interacting with the transcriptional machinery (TEFs) as 
well as the Z-disc (T-cap and MYOZ1) to regulate muscle specific genes.  
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6. Zusammenfassung 
Die Genexpression in der Skeletalmuskulur unterliegt hauptsächlich der gemeinsamen 
Kontrolle von drei Transkriptionsfaktor-Familien (bHLH, MADs and TEFs. Diese 
spielen eine wichtige Rolle in der Muskelentwicklung und bei der Expression von 
muskelspezifischen Genen. Das MCAT-Element (5´-CATTCCT-3´) konnte in 
herzspezifischen Genen, wie Troponin T und in der schweren kette bes β-Myosins (β-
MHC), sowie in Skelett- und Glattmuskelzellen α - Aktin nachgewiesen werden. MCAT 
bindende Protein gehören zur Familie der TEF-transkriptionsfaktoren. Ein essentieller 
Ko-faktor von TEF1 ist VITO-1. Die SID-Domäne des VITO-1 interagiert mit TEF1 und 
ist involviert in die Aktivierung von TEF Target-Genen, die verantwortlich für die 
muskelspezifische Genregulation sind. In dieser Arbeit sollte VITO-1 charakterisiert 
werden und die funktionelle Rolle von VITO-1 für das myogene Programm untersucht 
werden. 
Die Beteiligung von VITO-1 an Prozessen der Muskelzellbildung konnte durch die 
Ausbildung von großen Myotuben aus differenzierten C2C12-Zellen in Anwesenheit von 
VITO-1 bestätigt werden. Zur Analyse und zum Vergleich der subzellulären Localisation 
wurde VITO-1 in verschiedenen Zellenlinien überexprimiert. In C2C12- und CH10T1/2- 
Zellen konnte VITO-1 hauptsächlich im Zellkern nachgewiesen werden. Bei 
Überexpression in HEK 293-Zellen war VITO-1 jedoch im Zytoplasma localisiert,  
wahrscheinlich aufgrund der niedrigen Konzentration von endogenen TEFs. Die Co-
Expression von TEF3 and VITO-1 in HEK-Zellen, sowie in der Zelllinien C2C12 and 
CH10T1/2 zeigte eine Translocalisation von VITO-1 im Nucleus. Durch ein in C2C12-
Zellen eingebrachtes verkürztes VITO-1 Konstrukt konnte nachgewiesen werden, dass 
die SID-Domäne fur diese Translocalisation notwendig ist.  
Zur Identifizierung weiterer VITO-1 Bindungspartner wurde ein Yeast-two-Hybrid 
Screen durchgeführt. Insgesamt konnten 48 positive Klone isoliert werden, von denen 
Telethonin (T-cap) und Myozenin1 (MYOZ1, FATZ) weiter untersucht werden. Die 
Interaktion der beiden sarkomerischen Proteine Telethonin und MYOZ1 konnte durch die 
Verwendung eines Y2H-assays bestätigt werden. Durch eine ONPG β – Galactosidase- 
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Analyse wurde gezeigt, dass VITO-1 effizienter an TEF3 bindent, als an T-cap oder 
MYOZ1. Die Interaktionen zwischen VITO-1 und T-Cap, sowie T-Cap und MYOZ1 
wurden in vitro nachgewiesen. Hierfur wurden differenzierte C2C12 Myotuben und 
primäre Myozyten aus dem Huhn verwendet. Es konnte gezeigt werden, das VITO-1 mit 
T-cap und Myozenin-1 interagiert. Diese Interaktionen sind abhängig von der SID-
Domaene von VITO-1. Immunohistochemische Analysen und konfokale Mikroskopie 
zeigten eine Co-Localization von VITO-1 mit T-cap in HEK 293- und Cos-1 Zellen. 
Ektopische experimentes VITO-1 war sowohl im Zellkern, als auch in den Z-Banden von 
murinen neonatalen Kardiomyozyten lokalisiert. Die Koexpression von VITO-1 und T-
cap in Myozyten aus dem Huhn war hauptsächlich in den Z-Banden der Sarkomere zu 
finden, wobei in differenzierten C2C12 Myotuben VITO-1 sowohl im Zytoplasma, als 
auch im Nukleus nachgewiesen werden konnte. Zur Aufklarung der genauen Funktion 
von VITO-1 im Nukleus und im Zytoplasma bedarf es weiterer Studien. 
Zusammenfassend lasst sich sagen, dass VITO-1 durch die Bindung mit 
Transkriptionsfaktoren (TEFs) und Z-Scheiben-specifischen Proteinen (T-cap und 
MYOZ1) eine Rolle bei der Regulation versciedener muskelspezifischer Gene spielt.  
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7. Abbreviations 
3-AT     3-amio 1, 2, 3-triazole 
A     Adenine 
ADP     adenosine di phosphate 
AMP     adenosine mono phosphate 
Amp     Ampicillin 
ANF     Atrial natriuetic factor 
ATCC     American type culture collection 
ATP     Adenosine Tri-phosphate 
bHLH     Basic helix-loop-helix 
BHLH-PAS    Basic helix-loop-per-arnt-sim 
BLAST    Basic Local Alignment search Tool 
BMP-2    Bone morphogenetic protein 2 
Bp     Base pairs 
BSA     Bovine Serum Albumin 
C     Cytosine 
CaCl2     Calcium Chloride 
CaM     Calmodulin-like 
CAT      Chloramphenicol Acetyl Transferase 
cDNA     DNA complementary to mRNA 
cMLC2    Cardiac myosin light chain 
C-myc     Myc protein implicated in cancer cells 
cTNC     Cardiac troponin C 
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cTNT     Cardiac troponin T 
DCM     Dilated cardiomyopathy 
DM     Diffentiation medium 
ECM     Extracellular matrix 
EDTA     Ethylenediaminetetraacetic acid 
EM      Electron Microcropy 
EM     E-box-M-CAT hybrid motif 
ES     Embryonic stem cells 
EST     Expressed Sequence Tag 
EtOH     Ethanol 
FACS     Fluorescence activated cell sorter 
FATZ     Filamin, actinin, telethonin binding protein of the Z-
     discs 
FeCl3     Ferric chloride 
FGF     Fibroblast growth factor 
G     Guanine 
GAL4 AD    Gal4 transcription activation domain 
GAL4 BD    Gal4 DNA binding domain 
GFP     Green Fluorescence Protein 
GM     Growth Medium 
HA     Hem agglutinin 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Ig     Immunoglobin 
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kD     Kilo Dalton 
KH2PO4    Potassium dihydrogen phosphate 
Lac Z     β – galactosidase reporter gene 
LB     Luria Broth 
LCR     Locus control region 
LGMD    Limb-girdle muscular dystrophy  
MAPK     Mitogen Activated Protein Kinase 
MEF2     Myocyte Enhancer Factor 
MRF     Myogenic Reulatory Factor 
mRNA    Messenger RNA 
MYOZ1    Myozenin 1 
Na2HPO4    Disodium hydrogen phosphate 
NaCl     Sodium Chloride 
NaVO4    Sodium Orthovanadate 
NES      Nuclear Export Signal 
NH4Cl    Ammonium chloride 
NLS     Nuclear Localization Signal 
OD     Optical Density 
ORFs     Open reading frame 
PMSF     phenylmethylsulfonyl fluoride 
RNA     Ribonucleic acid 
RNAP I    RNA polymerase I 
rRNA     Ribosomal RNA 
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SC-H     Synthetic medium without histidine 
SD     Snythetic Dropout 
SDS     Sodium dodecyl sulphate (SDS) 
siRNAs    small interfering RNAs 
SMC     Smooth muscle cells 
SOC medium   Super Optimal Broth 
SUMO    Small Ubiquitous Modifier 
T-cap     Titin cap – Telethonin 
TE     Tris EDTA 
TEF     Transcription Enhancer Factor 
TRABS    transcription balancing sequences 
tRNA      Transfer RNA 
VEGF     Vascular Endothelial Growth Factor 
VITO     Vestigial and TONDU related protein 
X-GAL    bromo-chloro-indolyl-galactopyranoside 
Y2H     Yeast two hybrid 
YAP65    Yes Associated Protein 65 kD 
β-ME     β - Mercaptoethanol 
β-MHC    β – myosin heavy chain
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